Functional Analysis of the Human Telomeric Protein TRF2 by Smogorzewska, Agata
Rockefeller University
Digital Commons @ RU
Student Theses and Dissertations
2001
Functional Analysis of the Human Telomeric
Protein TRF2
Agata Smogorzewska
Follow this and additional works at: http://digitalcommons.rockefeller.edu/
student_theses_and_dissertations
Part of the Life Sciences Commons
This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and
Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact mcsweej@mail.rockefeller.edu.
Recommended Citation
Smogorzewska, Agata, "Functional Analysis of the Human Telomeric Protein TRF2" (2001). Student Theses and Dissertations. 347.
http://digitalcommons.rockefeller.edu/student_theses_and_dissertations/347
Functional analysis o f t h e h u m a n telomeric 
protein T R F 2 
A thesis presented to the faculty of The Rockefeller University in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy 
By 
A g a t a S m o g o r z e w s k a 
Advisor 
Titia d e L a n g e 
September 2001 
The Rockefeller University 
New York, New York 
To all m y teachers 
A c k n o w l e d g m e n t s 
It is impossible for me to say how grateful I am to Titia de Lange for her guidance, her 
encouragement, her scientific knowledge and her enthusiasm about science and my projects. If I 
had to create the perfect advisor, I would not be able to do any better. Titia, I thank you. 
I would like to thank all of my collaborators: Jan Karlseder, with whom I set up the retroviral 
expression system, shared many reagents for the length regulation studies, and collected billions 
(no kidding) of cells for the t-loops experiments; Bas van Steensel, who made the HTC75 cell 
lines as presented in this thesis and who started many of the experiments using them; Jack 
Griffith, who patiently scored the t-loops; and Anna Jauch, who performed and interpreted the M-
FISH experiments presented in Chapter 1. 
Many thanks to all of the scientists who supplied reagents that were used in my research, 
especially Scott Lowe, who was generous with his knowledge and materials as used in the 
retroviral studies and Arnie Levine for sharing the antibodies against p53, HDM2, SV40 Tag, and 
pericentrin. 
Thanks go to the current and past members of the de Lange lab: Jan Karlseder, for our many 
scientific interactions; Diego Loayza; Susan Smith; Giulia Celli; Alessandro Bianchi, for our 
discussions; Bas van Steensel; and Dominique (Kiki) Broccoli, for sharing the knowledge when I 
had just started in the lab. Thanks to all who have ensured that the lab functioned properly and 
have patiently handled my requests: Rita Rodney; Heidi Moss; Amy Himelblau; Laura Chang; 
Jason Lue; Heather Parsons; and Vanessa Marrero. Thanks to the sabbatical professors in 
IV 
attendance in our lab for sharing their knowledge and for showing me different styles of working 
(hmmm, which one will I chose?): Carolyn Price; Daniela Rhodes; and Jim Haber. 
Special thanks to Stewart (Stew) Barnes, whose help with the computers and administrative 
matters has been invaluable to me. 
Great thanks to the MD/PhD program and its leaders, especially Olaf Andersen and Tom Sakmar, 
for placing such strong emphasis on science, and to the Rockefeller University for creating a 
magnificent environment for young scientists to flourish. The graduate student lunches with 
Friday speakers were one of the many highlights for me on and off campus. 
I would like to thank my PhD advisory committee, Arnie Levine, Bob Roeder, and Titia de Lange, 
for their guidance, their insight, their enthusiasm and their willingness to dedicate their time so as 
to meet with me on a regular basis. Thanks go to my special committee member, Lea Harrington, 
for participating in the important final stages of my graduate career. 
Thanks to all of my friends who have made these years wonderful and without whom it would be 
a very dull world: Jan, Titia, my softball teammates, my squash partners, Jon Weiner and my 
colleagues in his literature and science course. Great thanks to my husband, Dennis, who was 
with me from the time I applied to MD/PhD programs, who has cheered me on in times of 
success and distracted me in times of scientific draught. I believe we can make it a successful 
science-art union. Very special thanks to my family, who were my first teachers at the 
microscope and the distillation apparatus. Lastly, thanks to my parents for their constant 
encouragement and for always pushing me towards a happy ending. 
T a b l e o f C o n t e n t 
Acknowledgments p iv 
Table of Content p vi 
List of Figures p vii 
List of Tables p x 
List of Abbreviations p xi 
Abstract p 1 
Introduction p 3 
Chapter 1 The role of TRF2 in telomere end protection 
Introduction p 43 
Results p 46 
Discussion p 76 
Chapter 2 TRF?***4 induces senescence through the p53 
and the Rb pathways 
Introduction p 85 
Results p 89 
Discussion p 106 
Chapter 3 TRF2 and telomere length regulation 
Introduction p 112 
Results p 115 
Discussion p 130 
Chapter 4 Chromosome and telomere breakage 
in cells expressing TRF2*B 
Introduction p 136 
Results p 138 
Discussion p 156 
Chapter5 Centrosomal localization of TRF2 and 
centrosomefgenome reduplication in cells 
expressing TRF2ABM or TRF2AB 
Introduction p 164 
Results p 165 
Discussion p 175 
Concluding Remarks p 183 
Materials and Methods p 191 
References p 213 
VI 
List o f Figures 
Figure i-1 Schematic of replication at the very end of a chromosome. p 5 
Figure i-2 Schematic of domain structure of TRF1 and TRF2. p 36 
Figure i-3 Localization of TRF2 to telomeres of human chromosomes. p 37 
Figure i-4 Schematic of t-loop formation. p 39 
Figure 1-1 Schematic of TRF2 alleles used in these studies. p 47 
Figure 1-2 Timeline of experiments using the retroviral delivery system and the 
Tetracyclin-inducible system. p 49 
Figure 1-3 Effects of expression of myc-tagged full length TRF2 and TRF2ABAM 
on endogenous TRF1 and TRF2. p 51 
Figure 1-4 Anaphase bridges in TRF2ABAM-expressing IMR90 human primary 
fibroblasts and HTC75 fibrosarcoma cells. p 54 
Figure 1-5 Telomere fusions in metaphases of TRF2ABAM-expressing IMR90 
human primary fibroblasts. p 57 
Figure 1-6 Telomere length analysis in IMR90 primary fibroblasts expressing 
TRF2abam p 58 
Figure 1-7 TTAGGG repeats at the sites of fusions in a metaphase of TRF2ABAM-
expressing HTC75 cells. p 60 
Figure 1-8 Time course of changes in telomere structure with expression of 
TRF2abam jn HTC75 T4 cell line. p 61 
Figure 1-9 Visualization of fusions in HTC75 cells expressing TRF2ABAM under 
native and denaturing conditions. p 63 
Figure 1-10 Time course of disappearance of G-strand overhang signal in cell 
expressing TRF2ABAM. p 65 
Figure 1-11 T-loop from an IMR90 cells expressing SV40 Tag but no exogenous 
TRF2 allele. P 68 
Figure 1-12 Chromosomal abnormalities observed in mouse embryonic 
fibroblasts expressing TRF2ABAM. p 71 
Figure 1-13 Chromosomal abnormalities in metaphase spreads of IMR90 
fibroblasts expressing TRF2ABAM. p 74 
Figure 1-14 Model of chromosomal events following inhibition of TRF2. p 77 
Figure 1-15 Types of fusions following inhibition of TRF2 p 81 
VII 
Figure 2-1 Schematic of forces that can inhibit p53 and Rb pathways. p 88 
Figure 2-2 Effects of expression of TRF2 and TRF2ABAM on growth of human 
primary fibroblasts. p 90 
Figure 2-3 Cell morphology and senescence-associated p-galactosidase (SA-(3) 
activity at pH 6 in control, TRF2, TRF2ABAM, and senescent fibroblasts. p 94 
Figure 2-4 Effects of expression of TRF2 and TRF2ABAM on cell cycle profile in human 
primary fibroblasts- comparison with senescent and irradiated cells. p 95 
Figure 2-5 Effects of expression of TRF2 and TRF2ABAM on protein profiles in human 
primary fibroblasts- comparison with senescent and irradiated cells. p 97 
Figure 2-6 Effects of expression of TRF2 and T TRF2ABAM on growth of human primary 
fibroblasts that also express SV40 Tag. p 98 
Figure 2-7 Comparison of cellular morphology of cells with or without SV40 Tag, 
expressing no exogenous protein or TRF2ABAM. p 99 
Figure 2-8 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that co-express HPV16 E6, HPV16 E7, HPV16 E6 and E7, p53175H, or pBabe Neo. p 101 
Figure 2-9 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that express or lack endogenous ATM protein. p 103 
Figure 2-10 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that lack ATM and express HPV E7 or Neo control. p 104 
Figure 2-11 Effects of expression of TRF2ABAM on growth of wt primary MEFs and MEFs 
deficient in p53 protein p 105 
Figure 2-12 A model of parallels between events leading to growth arrest in replicative 
senescence and after inhibition of TRF2 in human primary fibroblasts. p 107 
Figure 3-1 immunofluorescent analysis of TRF1 and TRF2 staining in cells with long and 
short telomeres. p 117 
Figure 3-2 Telomere length analysis in FLTRF2-expressing HTC75 cells. p 118 
Figure 3-3 TRF2 expression in P7 and P33 HTC75 cells at various times during 
growth P 120 
Figure 3-4 Cell morphology of P12 HTC75 cells at PD 14. p 122 
Figure 3-5 Effects of expression of TRF2, TRF2ABAM and TRF2AB on telomerase 
activity. P 123 
Figure 3-6 Effects of induction of TRF2 on expression levels of hTERT and 
hTR RNA. P 125 
Figure 3-7 Effects of expression of the dominant negative hTERT in P7, P12, P33 
HTC75 cells on telomerase activity. p 126 
vm 
Figure 2-1 Schematic of forces that can inhibit p53 and Rb pathways. p 88 
Figure 2-2 Effects of expression of TRF2 and TRF2ABAM on growth of human 
primary fibroblasts. p 90 
Figure 2-3 Cell morphology and senescence-associated p-galactosidase (SA-P) 
activity at pH 6 in control, TRF2, TRF2ABAM, and senescent fibroblasts. p 94 
Figure 2-4 Effects of expression of TRF2 and TRF2ABAM on cell cycle profile in human 
primary fibroblasts- comparison with senescent and irradiated cells. p 95 
Figure 2-5 Effects of expression of TRF2 and TRF2ABAM on protein profiles in human 
primary fibroblasts- comparison with senescent and irradiated cells. p 97 
Figure 2-6 Effects of expression of TRF2 and T TRF2ABAM on growth of human primary 
fibroblasts that also express SV40 Tag. p 98 
Figure 2-7 Comparison of cellular morphology of cells with or without SV40 Tag, 
expressing no exogenous protein or TRF2ABAM. p 99 
Figure 2-8 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that co-express HPV16 E6, HPV16 E7, HPV16 E6 and E7. p53175H, or pBabe Neo. p 101 
Figure 2-9 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that express or lack endogenous ATM protein. p 103 
Figure 2-10 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that lack ATM and express HPV E7 or Neo control. p 104 
Figure 2-11 Effects of expression of TRF2ABAM on growth of wt primary MEFs and MEFs 
deficient in p53 protein p 105 
Figure 2-12 A model of parallels between events leading to growth arrest in replicative 
senescence and after inhibition of TRF2 in human primary fibroblasts. p 107 
Figure 3-1 immunofluorescent analysis of TRF1 and TRF2 staining in cells with long and 
short telomeres. p 117 
Figure 3-2 Telomere length analysis in FLTRF2-expressing HTC75 cells. p 118 
Figure 3-3 TRF2 expression in P7 and P33 HTC75 cells at various times during 
growth p 120 
Figure 3-4 Cell morphology of P12 HTC75 cells at PD 14. p 122 
Figure 3-5 Effects of expression of TRF2, TRF2ABAM and TRF2AB on telomerase 
activity. p 123 
Figure 3-6 Effects of induction of TRF2 on expression levels of hTERT and 
hTR RNA. p 125 
Figure 3-7 Effects of expression of the dominant negative hTERT in P7, P12, P33 
HTC75 cells on telomerase activity. p 126 
vm 
Figure 3-8 Telomere length analysis in HTC75 cells co-expressing the dominant 
negative hTERT (DNhTERT) and TRF2. p 127 
Figure 3-9 Telomere length analysis in IMR90 primary fibroblasts infected with control 
virus or with FLTRF2. p 129 
Figure 3-10 Telomere length analysis in BJhTERT fibroblasts infected with control virus 
or TRF2ABAM. p 131 
Figure 4-1 Effects of expression of myc tagged TRF2AB on endogenous TRF1 and 2 
protein localization to telomeres. p 140 
Figure 4-2 Telomeric staining in BJ hTERT SV40 Tag cells expressing TRF2AB. p 141 
Figure 4-3 Telomere length analysis in BJhTERT SV40 Tag, BJhTERT, and HS68 
fibroblasts infected with control virus, FLTRF2, and TRF2AB p 143 
Figure 4-4 Telomere length analysis using a (CCCTAA)4 probe in primary BJ fibroblasts 
infected with control virus, FLTRF2, TRF2AB, and TRF2ABAM. p 146 
Figure 4-5 Telomere length analysis using a (TTAGGG)4 probe in primary BJ fibroblasts 
infected with control virus, FLTRF2, and TRF2AB. p 147 
Figure 4-6 Comparison between the C and the G strand length in BJhTERT SV40 Tag 
fibroblasts infected with control virus, FLTRF2, and TRF2AB. p 148 
Figure 4-7 Chromosomal abnormalities in TRF2AB-expressing cells. p 149 
Figure 4-8 Effects of expression of TRF2AB on growth characteristics, protein expression 
profile and SA P-gal staining of young IMR90 cells- comparison with cells expressing 
TRF2abam p 155 
Figure 4-9 Model of telomere loss and break formation upon induction of TRF2AB. p 157 
Figure 5-1 Genome reduplication visualized on metaphases of TRF2ABAM and TRF2AB-
expressing IMR90 human primary fibroblasts. p 168 
Figure 5-2 Premature chromosome division (PCD) in metaphase spreads of IMR90 
fibroblasts expressing TRF2ABAM p 169 
Figure 5-3 Centrosomal reduplication in IMR90 human primary fibroblasts expressing 
TRF2abam p 171 
Figure 5-4 Localization of TRF2 to centrosomes in HeLal.2.11 cells. p 174 
Figure 5-5 Localization of TRF2 and tankyrase to centrosomes in HeLal.2.11 p 176 
Figure 5-6 Staining of centrosomes with 647, tankyrase, y-tubulin, and centrin in 
HeLal.2.11 cells, cells p 177 
Figure 5-7 Model of reduplication of the genome following telomere dysfunction. pi 79 
IX 
List o f Tables 
Table i-1 Sequences of telomeric DNA in various species p 8 
Table 1-1 Induction of fusions in anaphase and metaphase IMR90 primary fibroblasts 
infected with control vector, full length TRF2, and TRF2ABAM. p 55 
Table 1-2 Induction of fusions in metaphase cells expressing no exogenous protein or 
TRF2dbdm p 56 
Table 1-3 T-loop frequency in IMR90 primary fibroblasts expressing SV40 Tag infected 
with control vector, full length TRF2, and TRF2ABAM. p 69 
Table 1-4 Chromosomal abnormalities in 30 metaphase spreads of primary Lig4+/+p53-
/- and Lig4-/-p53-/- mouse embryonic fibroblasts infected with control vector (pLPCpuro) 
or pLPCTRF2ABAM. p 72 
Table 1-5 Chromosomal abnormalities in metaphase spreads of IMR90 fibroblasts 
infected with control vector (pLPC puro), full length TRF2 (FLTRF2) or the dominant 
negative allele of TRF2 (pLPCTRF2ABAM), as assessed by multiplex fluorescence in situ 
hybridization (M-FISH). p 75 
Table 2-1 Effects of expression of TRF2 and TRF2ABAM on growth of human primary 
fibroblasts. p 92 
Table 4-1 Induction of fusions in metaphase and anaphase HTC75 cells expressing no 
exogenous protein, or TRF2AB. p 150 
Table 4-2 Induction of abnormalities in metaphase and anaphase IMR90 cells 
expressing no exogenous protein, FLTRF2, TRF2AB, TRF2ABAM. p 152 
Table 4-3 Micronuclei formation in primary BJ cells expressing no exogenous protein, 
FLTRF2, TRF2AB, TRF2ABAM. p 154 
Table 5-1 Genomic reduplication in young cells expressing no exogenous protein, 
FLTRF2, TRF2AB, TRF2ABAM. P 166 
Table 5-2 Centrosomal reduplication in young cells expressing no exogenous protein, 
FLTRF2, TRF2AB, TRF2ABAM, and in senescent cells. p 172 
List o f A b b r e v i a t i o n s 
ATM-ataxia telangiectasia mutated 
ATR- ATM and Rad-3 related 
BrdU- bromo-deoxyuridine 
bp- base pairs 
CO-FISH- chromosome orientation FISH 
DAPI-4'6-diamidino-2-phenylindole 
DNA-PK- DNA-dependent protein kinase 
DNA-PKcs- DNA-PK catalytic subunit 
DSB- double-strand break 
EST- ever-shorter telomeres 
FACS- fluorescence activated cell sorter 
FISH- fluorescence in-situ hybridization 
FITC- fluorescein isothiocyanate 
HR - homologous recombination 
hTERT- human telomerase reverse transcriptase 
hTR- human telomerase RNA 
IF- immunofluorescence 
IR- ionizing radiation 
kbp (kb)- kilo base pairs 
KO- knockout 
Lig4- DNA ligase IV 
MEF- mouse embryonic fibroblast 
M-FISH- multiplex fluorescence in-situ hybridization 
xi 
mRNA- messenger RNA 
NBS- Nijmegen breakage syndrome 
NHEJ- non-homologous end joining 
PCD- premature chromosome division 
PD- population doubling 
PNA- peptide nucleic acid 
RNase- ribonuclease 
SA P-gal- senescence associated p-galactosidase 
SCID- severe combined immunodeficiency 
SD- standard deviation 
SPB- spindle pole body 
TRAP- telomeric repeat amplification protocol 
TRF- TTAGGG repeat binding factor 
TRITC- tetramethyl rhodamine isothiocyanate 
WCE- whole cell extract 
XII 
A b s t r a c t 
ITAGGG Repeat Binding Factor 2 (TRF2) is a ubiquitous human telomeric 
protein present at all telomeres throughout the cell cycle. TRF2 has been proposed to 
remodel telomeres into large lasso-like structures named t-loops. Removal of TRF2 
from telomeres by expression of a dominant negative allele of TRF2 (TRF2ABAM) led to 
dissolution of these structures and appearance of end-to-end fusions visible in 
metaphase and anaphase cells. Fusion formation was accompanied by the loss of G-
overhang, but not by the loss of double stranded telomeric DNA, which can be 
documented to persist at the sites of fusions. Fusions were covalent and their formation 
was dependent on the nonhomologous end-joining (NHEJ) pathway as evidenced by the 
failure to form fusions in cells lacking Ligase IV. Furthermore, the fusions initiated 
genomic instability. 
Expression of TRF2ABAM in primary human cells resulted in induction of 
senescence. The arrested cells exhibited elevated levels of p53, stabilization of which 
was accompanied by induction of its downstream effectors p21 and Bax. The Rb 
pathway was also affected, with pRb becoming hypophosphorylated. The importance of 
both the p53 and the Rb pathways was further evident from the fact that the expression 
of SV40 Tag alone bypassed the growth arrest. Separate elimination of p53 or Rb 
function could not do so, and the activity of the ATM PI3 kinase was not necessary for 
the arrest. 
Expression of a different truncation allele of TRF2, TRF2AB also resulted in 
senescence but the growth arrest was accompanied by rapid loss of telomeric DNA. In 
addition, this allele induced an unanticipated chromosome breakage phenotype. 
Long-term overexpression of full length T R F 2 resulted in the gradual shortening 
of telomeres, suggesting that TRF2 is a regulator of telomere maintenance. Although it 
is clear that TRF2 acts through positively regulating the shortening activities at 
telomeres, it is unknown at this time whether it influences the telomerase pathway. 
Besides being present at telomeres, TRF2 also appears to be localized to 
centrosomes. The functional consequences of such localization are not known at this 
time; however, it is shown that telomere dysfunction can result in genome reduplication. 
I n t r o d u c t i o n 
The advent of linear chromosomes created an enormous problem for their 
bearers. Conventional polymerases that replicate circular genomes are unable to 
replicate the very ends of chromosomes. Each time the DNA is synthesized, a few base 
pairs are lost at one of the chromosome tips. This problem has been coined the "end-
replication problem" (Watson 1972; Olovnikov 1973) and it stems from the enzymatic 
characteristics of DNA polymerases, which need a short RNA primer to initiate 
polymerization. Additionally, this primer can be extended only in the 5'-3' direction. 
These requirements give rise to different modes of replication of two DNA strands 
(Figure i-1). One of the strands, the leading strand, is made continuously by the 
extension of one primer and presumably results in the formation of a blunt-ended 
molecule. The other strand, the lagging strand, is formed through the synthesis of 
multiple RNA primers and their extension into Okazaki fragments. Eventually the 
primers are removed and the Okazaki fragments are joined together resulting in a 
continuous strand. Since the primer that is closest to the tip of the chromosome is also 
removed and the leftover gap cannot be filled in by any polymerase, the lagging strand 
synthesis cannot fully replicate the DNA end. Taking into consideration the length of the 
RNA primer, each division would result in disappearance of a minimum of 3 bp of DNA 
per end. The true losses are even greater in most organisms bearing linear 
chromosomes. This is evident from the presence of single-stranded 3' extensions of the 
G strand, which can be from 12-16 nucleotides long in ciliates (Klobutcher et al. 1981; 
Pluta et al. 1982; Henderson and Blackburn 1989), around 30 nucleotides long during S 
phase in S. cerevisiae (Wellinger et al. 1993; Wellinger et al. 1993), and as long as 300 
nucleotides in human cells (Makarov et al. 1997). It also appears that the overhangs 
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Figure i-1. Schematic of replication at the very end of a chromosome 
The replication fork is moving from left to right. 
.ia» RNA primer of leading strand 
<=> RNA primer of lagging strand 
<3 • Okazaki fragment 
the findings that both termini of human chromosomes (Makarov et al. 1997), as well as 
those of Trypanosoma brucei(Munoz-Jordan et al. 2001), and Tetrahymena (Jacob et 
al. 2001), end in an overhang that has been estimated to be up to a few hundred 
nucleotides in length. Such a long overhang on the lagging strand could be explained if 
the last RNA primer was laid down very far from the actual chromosome tip, but leading 
strand synthesis should theoretically result in a blunt end. The finding that it does not, 
suggests a nucleolytic activity that can create the single-stranded overhang, in the case 
of the leading strand, or extend the single stranded overhang, in the case of the lagging 
strand. If such activities were not counteracted, a substantial portion of chromosomal 
DNA would be permanently lost with each division. 
A second pronounced problem that needs to be overcome by organisms with 
linear chromosomes is the physical presence of the DNA ends. Cells have evolved 
elaborate pathways to recognize and repair double-strand breaks (reviewed in Haber 
2000; Hoeijmakers 2001). These pathways are necessary to eliminate chromosomal 
breaks that occur due to environmental stress, internal metabolism, including DNA 
replication, and physiological breaks acquired during development. Natural ends should 
not participate in any of these repair transactions. Therefore, the cellular machinery has 
to differentiate between telomeres and bona fide breaks within the genome. 
These vital functions of compensating for DNA loss during replication as well as 
the protection of chromosomal ends from the repair activities are integrated in the 
telomere. First defined as a "free end" that has no ability to fuse with broken DNA 
(Muller 1938), the telomere is a sophisticated complex of repetitive DNA and associated 
proteins that can be found at all ends of linear chromosomes. 
Telomeric DNA 
Molecular studies of telomeres began with the finding that telomeric DNA was 
highly repetitive. The first telomeric DNA to be sequenced was from the ends of rDNA 
molecules of Tetrahymena and it was shown to consist of repeats of TTGGGG oriented 
5' to 3' towards the chromosome terminus (the so called G strand), and of the 
complementary sequence of CCCCAA on the opposite strand (C strand) (Blackburn and 
Gall 1978). Soon, telomeric DNAs from other species were sequenced (Table i-1), and 
generally they were found to be built from similar simple repeats. There exist some 
exceptions, including the expanded telomeric repeat of K.lactis (McEachern and 
Blackburn 1994) and the irregular repeats of S. cerevisiae (Shampay et al. 1984) and 
S.pombe (Sugawara 1986). The greatest exception of all is the organism in which 
Muller first defined the telomeres. Telomeres of Drosophila melanogaster consist of 
repetitive sequences, but the repeats are retrotransposons of the non-LTR type 
(Biessmann et al. 1990; Levis et al. 1993; Sheen and Levis 1994). Although dipteran 
telomere structure and maintenance is unlike in any other organism, the telomeric 
functions are conserved (see below). 
The telomeric repeat arrays can extend for a considerable length. In 
Tetrahymena, as in yeasts, telomeric tracts are approximately 300 bp in length 
(Blackburn and Gall 1978; Shampay et al. 1984), in human cells TTAGGG repeats range 
from 2 kbp to 25 kbp (Allshire et al. 1988; Moyzis et al. 1988; de Lange et al. 1990; 
Saltman et al. 1993) and in some mouse species including the laboratory Mus musculus, 
the telomeric DNA is as long as 50 kbp (Kipling and Cooke 1990). Taking into account 
the rate of replication-dependent telomere shortening, telomeric DNA can provide a 
substantial buffer against the loss of essential sequences found in the more centromere 
Table i-1 Sequences of Telomeric DNA in Selected Species (adapted from (Henderson 
1995)) 
Telomeric sequence 
T T G G G G 




ACGGAI I IGATTAGGTATGTGGTGT 
TTAGGC 
Het-A and TART retrotransposons* 
TTAGG 














Bombyx mod (silkworm) 
Arabidopsis thaliana 
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(Moyzis et al. 
1988) 
*These are non-canonical since they are not maintained by telomerase. 
proximal regions. However, in order for the single-celled organisms or species to be 
genetically immortal, telomeric DNA needs to be maintained at a stable length through 
the generations. 
Core components of telomerase- RNA and the catalytic subunit 
One of the most efficient and widely used ways of telomere maintenance is 
provided by telomerase, a ribonudeoprotein (Greider and Blackburn 1985; Greider and 
Blackburn 1987), which uses an RNA molecule as a template for addition of species 
specific telomeric repeats (Shippen-Lentz and Blackburn 1990; Yu et al. 1990). The 
RNA serves to align the telomeric 3' overhang with the template, and the catalytic 
subunit of telomerase, telomerase reverse transcriptase (TERT) (Lingner et al. 1997), 
reviewed in Nakamura and Cech 1998) synthesizes one repeat specified by the RNA. 
The enzyme can then relocate to the newly created end or to a different DNA substrate 
and continue synthesis. The synthesis of the G strand is closely followed by synthesis of 
the C strand (reviewed in Price 1997) to form the double stranded repeat array. The G-
overhang found at chromosome ends could be made if the action of telomerase were not 
followed by the C strand synthesis. However, G-overhangs can be found in cells that 
lack telomerase (Dionne and Wellinger 1996; Makarov et al. 1997; Hemann and Greider 
1999; Nikaido et al. 1999) suggesting that the nucleolytic activities mentioned earlier are 
responsible for their formation. 
G-overhangs, as will be discussed later, have multiple functions. Chromosome 
tails can recruit single-stranded DNA binding proteins and can invade the double-
stranded telomeric arrays. The overhangs are also necessary for telomerase-dependent 
telomere maintenance since at least in vitro, telomerase is not capable of extending a 
blunt-ended DNA molecule (Greider and Blackburn 1987; Lingner and Cech 1996). 
Telomerase is less selective about the exact sequence of the overhang, and it elongates 
single-stranded non-telomeric sequences both in vitro (Greider and Blackburn 1987; 
Morin 1989; Harrington and Greider 1991; Morin 1991; Prowse et al. 1993), and in vivo 
(Shampay and Blackburn 1989; Wilkie et al. 1990; Lamb et al. 1993). This activity is 
thought to be important for the "healing" function of telomerase, through which broken 
ends can be capped by de novo addition of telomeric DNA (reviewed in Melek and 
Shippen 1996). 
In unicellular organisms telomerase has a housekeeping function, and its two 
essential subunits are always expressed. However, It has been shown that the levels of 
telomerase RNA can increase at a specific developmental stage, for example during 
macronuclear development in Tetrahymena (Avilion et al. 1996). Mice express both 
telomerase subunits (Blasco et al. 1995; Greenberg et al. 1998; Martin-Rivera et al. 
1998), as well as telomerase activity in most of their tissues (Prowse and Greider 1995). 
The catalytic subunit of the mouse telomerase, in contrast to the RNA subunit, is haplo-
insufficient so that cells heterozygous for mTERT gradually shorten their telomeres (Liu 
et al. 2000). 
Telomerase activity is repressed in most normal human tissues (Kim et al. 1994). 
Activity can be found only in ovaries and testis (Wright et al. 1996), and highly 
proliferative tissues including hematopoietic cells (Broccoli et al. 1995; Counter et al. 
1995). Regulation of telomerase appears to be at the level of hTERT expression. hTR 
is present in many telomerase negative cells (Feng et al. 1995; Nakamura et al. 1997). 
hTERT message is only found in cells that express telomerase activity including most of 
10 
the primary tumors and tumor cell lines tested to date (Kilian et al. 1997; Meyerson et al. 
1997; Nakamura et al. 1997). Additionally, expression of hTERT alone in human 
primary fibroblasts is sufficient to reconstitute functional telomerase activity (Bodnar et 
al. 1998; Vaziri and Benchimol 1998) suggesting that hTERT is the limiting component of 
telomerase in human cells. One of the outstanding questions in telomerase regulation is 
how hTERT gets repressed in most of human somatic tissues and how it gets activated 
in 90% of human tumors (reviewed in Shay and Bacchetti 1997). 
Other telomerase components 
Studies of telomerase components in many organisms have shown that many 
proteins associate with the RNA and the catalytic subunit in vivo. The best understood 
of those are the Estl and Est3 proteins which are necessary for the in vivo telomerase 
function in S. cerevisiae but are dispensable for in vitro activity (Lingner et al. 1997). The 
Est proteins will be discussed later in the section on telomere length regulation. 
Telomerase RNA from S. cerevisiae associates with Sm proteins in vivo (Seto et 
al. 1999). This association has been proposed to be important in the biogenesis of the 
RNA. In particular, the poly A tail is not removed efficiently from the RNA if the Sm 
proteins are precluded from binding to this RNA (Seto et al. 1999). Sm proteins were 
found not to interact with human RNA (hTR) (Le et al. 2000). Instead, two other 
proteins, hStau and L22 were found to interact with hTR in a three-hybrid screen as well 
as in vivo. Although their function is unknown, they are proposed to also play a role in 
hTR processing, assembly or localization (Le et al. 2000). Other components of the 
telomerase RNP might be heterogeneous nuclear ribonudeoprotein AJ. (hnRNP A1) 
(LaBranche et al. 1998), and heterogeneous nuclear ribonudeoprotein Cl and C2 
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(hnRNP C1, hnRNP C2) (Ford et al. 2000). Immunoprecipitation of an amino-terminal 
part of hnRNP A1 (LaBranche et al. 1998), or of hnRNP C1 and C2 (Ford et al. 2000) 
brings down telomerase activity (LaBranche et al. 1998). In addition, all three hnRNPs 
are able to directly interact with hTR (Ford et al. 2000; Fiset and Chabot 2001) and 
hnRNP A1 can influence telomere length in vivo (Fiset and Chabot 2001). The latest 
addition to the proteins able to interact with telomerase RNA is La (Ford et al. 2001). 
Antibodies directed against this protein precipitate telomerase from a number of sources, 
and overexpression of La leads to telomere shortening. 
Through extensive phylogenetic comparison, vertebrate telomerase RNA has 
been found to contain four very well conserved motifs (Chen et al. 2000). So far, only 
one of them, box H/ACA small nucleolar RNA-like domain (snoRNA), has been shown 
to be important for hTR accumulation, hTR 3' processing, and telomerase activity in 
human 293 cells transfection system (Mitchell et al. 1999). The H/ACA RNA motif 
seems to be able to associate with dyskerin (Mitchell et al. 1999), a putative 
pseudouridine synthase mutated in an X-linked form of the human disease dyskeratosis 
congenita (Heiss et al. 1998). Cells from patients with the disease show decreased 
levels of hTR, produce lower levels of telomerase activity, and, although further analysis 
of telomere length regulation is necessary, seem to have difficulty with telomere 
maintenance. 
In Tetrahymena, two proteins, p80 and p95 copurify with telomerase activity and 
the telomerase RNA (Collins et al. 1995). In contrast to the predictions, the two proteins 
are not necessary for the telomerase accumulation or in vitro activity, but seem to play a 
role in telomere length regulation since removal of p80 or p95 lead to increased length of 
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micronuclear and macronuclear telomeres (Miller and Collins 2000). The mechanism of 
their function in telomere length regulation is unknown. 
A human homologue of p80 has been identified (Harrington et al. 1997; 
Nakayama et al. 1997). Even though TEP1 interacts with the telomerase RNA and 
immunoprecipitation with a specific antibody against TEP1 brings down telomerase 
activity, complete removal of the protein in mice has no functional consequences on the 
in vivo telomerase activity or telomere maintenance (Liu et al. 2000), suggesting that 
TEP1 is not required or has a redundant function in the expression of telomerase 
function. 
In general, telomerase associated proteins might be important in regulating 
biogenesis, stability, as well as the catalytic activity of telomerase. Further studies are 
needed to elucidate the exact requirements for all of the proteins. It will be interesting to 
see if there are multiple telomerase complexes in the cell and if so how they influence 
telomere function. 
Alternative mechanism of telomere maintenance 
In the absence of telomerase some cells are able to maintain their telomeres in 
alternative ways. In yeast, such an alternative mode relies on rearrangement and 
amplification of the telomeric regions and is dependent on the RAD52-mediated 
recombination (Lundblad and Blackburn 1993; Lendvay et al. 1996). The human and 
mouse alternative lengthening pathway (ALT) has also been proposed to involve 
recombination (Bryan et al. 1995; Bryan et al. 1997; Dunham et al. 2000; Niida et al. 
2000). Finally, as mentioned above, Drosophila melanogaster and other Dipterans, 
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which lack telomerase altogether, counteract the shortening of their telomeres by 
stochastically placing retrotransposons at the end of their linear chromosomes 
(Biessmann et al. 1990). 
Regulation of telomere maintenance 
Alternative pathways of telomere maintenance are poorly understood and when 
cells use these pathways, length of their telomeres can become heterogenous and 
generally not very well regulated. When telomerase is available, on the other hand, 
telomeres stay stable through many divisions (Shampay and Blackburn 1988; Counter et 
al. 1992; van Steensel and de Lange 1997). To achieve such homeostasis, activities of 
replication, degradation, and DNA addition need to be tightly regulated. Understanding 
of this regulation has recently flourished, especially in S. cerevisiae where multiple 
factors are known to affect telomere length. Generally, factors that regulate length can 
be divided into those that affect activities at the very terminus of the DNA, and those that 
define the length setting of the double-stranded telomeric DNA array. 
Regulation of telomere maintenance: the role of terminus factors 
The best understood activity at the telomere terminus is the addition of telomeric 
DNA by telomerase. As mentioned before, telomerase is a reverse transcriptase with 
two essential subunits, an RNA component (TLC1 in budding yeast, hTR in humans, 
mTR in mouse), and the catalytic subunit (EST2 in budding yeast, hTERT in humans, 
m T E R T in mouse). When one of these essential subunits is missing (Singer and 
Gottschling 1994; McEachern and Blackburn 1995; Lendvay et al. 1996),(Blasco et al. 
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1997; Lingner et al. 1997; Nakamura et al. 1998; Niida et al. 1998; Fitzgerald et al. 1999; 
Liu et al. 2000; Niida et al. 2000), or strongly inhibited (Hahn et al. 1999; Zhang et al. 
1999; Miller and Collins 2000), the length homeostasis is perturbed and telomeres 
gradually and steadily shorten, giving rise to a phenotype which in yeast has been 
coined an Ever Shorter Telomeres (est) phenotype (Lundblad and Szostak 1989). 
Presence of the catalytically active telomerase is not sufficient for stable length 
maintenance, and the recruitment of telomerase to the telomere terminus engages both 
positive and negative regulators (reviewed in Evans and Lundblad 2000) 
Cdc13p seems to orchestrate access of telomerase to the terminus. Based on in 
vitro binding data it is expected that Cdc13p resides on the single-stranded G-overhang 
(Lin and Zakian 1996; Nugent et al. 1996) and is able to interact with Estlp (Qi and 
Zakian 2000), which together with Est2p, TLC1 RNA, and Est3p forms the telomerase 
holoenzyme. The recruitment function of Cdc13p is further evidenced by experiments 
showing that the DNA binding domain of Cdc13p (DBDCdci3) fused to Estlp (Evans and 
Lundblad 1999) or Est3p (Hughes et al. 2000) rescues the est phenotype of cdc13-2esl 
allele, and that Cdc13-Est2p fusion bypasses the requirements for Estlp (Evans and 
Lundblad 1999). 
A number of other proteins positively regulate telomerase function in yeast. 
Mutants in the Mre11p/Rad50p/Xrs2p complex have short telomeres (Kironmai and 
Muniyappa 1997; Boulton and Jackson 1998; Nugent et al. 1998) and are in the 
telomerase epistasis group since double mutants of telomerase and any of the 
components of the complex do not show a more severe phenotype than mutation in 
telomerase itself (Nugent et al. 1998). The complex has multiple biochemical and 
cellular functions (reviewed in Haber 1998) and it is still unclear how it participates in 
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telomere length regulation although it has been proposed that it might prepare the 
terminus for Cdc13p binding and/or telomerase action. The Mre11 complex appears to 
act synergistically with Ku, deletion of which also results in short telomeres (Porter et al. 
1996; Boulton and Jackson 1998; Nugent et al. 1998; Polotnianka et al. 1998). As 
opposed to Mrel 1, Ku deletion also results in changes of the terminal structure of the 
telomere; the G-overhangs that normally are detectable only in S phase in yeast, now 
persist throughout the cell cycle (Gravel et al. 1998; Polotnianka et al. 1998). This 
suggests that Ku participates in telomere protection (discussed separately below) 
although it is not excluded that the two phenotypes of telomere shortening and presence 
of increased single-stranded DNA are related. 
Interference with two other proteins leads to telomere shortening. Teh and Tel2 
were identified in genetic screen for temperature sensitive mutants resulting in altered 
telomere length (Lustig and Petes 1986). Tel2p turned out to be an essential protein 
(Runge and Zakian 1996), which has characteristics of binding to both double-stranded 
and single-stranded telomeric DNA (Kota and Runge 1998; Kota and Runge 1999). 
TeMp, is an ortholog of ATM (Ataxia Telangiectasia Mutated), a PI3 kinase mutated in 
patients with Ataxia Telangiectasia (Greenwell et al. 1995), and its kinase activity is 
necessary for telomere length regulation (Mallory and Petes 2000). Medp, another PI3 
kinase from S.cerevisiae, that is more closely related to ATR, similarly influences 
telomere length (Ritchie et al. 1999). TEL1 or MEC1 deletion leads to telomeres of short 
but stable length. Removal of both of the proteins leads to progressive shortening 
characteristic of the est phenotype, suggesting that TeMp and Medp act in separate 
pathways at telomeres. This is a similar situation to that found in S. pombe where 
simultaneous mutation of both the AT ortholog RAD3 and the ATM ortholog TEL1 lead to 
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a progressive telomere shortening (Naito et al. 1998). Epistasis analysis in S. cerevisiae 
showed that TeMp is in the same pathway as the Mre11p complex described above, 
since the double mutants of teh mrel 1, teh rad50, and teh xrs2 harbor telomeres that are 
of the same length as they were when only a single protein of the pair was mutated 
(Ritchie and Petes 2000). Moreover, TeMp phosphorylates Xrs2p in vitro (Mallory and 
Petes 2000) and in vivo (Usui et al. 2001). This is analogous to the situation found in 
human cells where ATM is able to phosphorylate Nbs, an equivalent, although not 
obviously orthologous protein to Xrs2. 
The proteins discussed above appear to positively regulate telomere length 
maintenance. Some of the same proteins apparently can also negatively regulate 
telomere length. In a recently identified mutant of Cdc13p (cdc13-5) (Chandra et al. 
2001), telomerase elongates telomeres about 1000 bp beyond the usual setting. 
Additionally, the coordination between the G and C strand synthesis is lost with G-
overhangs becoming unusually long in S phase. This aspect of Cdc13p function, as 
previously suggested (Grandin et al. 1997), is mediated by Stnlp, a Cdc13p interacting 
partner, since overexpression of Stnlp suppresses all phenotypes associated with 
cdc13-5. Overexpression of Stnlp also suppresses a telomere elongation defect in 
mutants of DNA polymerase alpha (poll-12, poll-16, and poll-17) pointing to a pathway 
of coordination of G and C strand synthesis by telomeric proteins. A similar coordination 
appears to exist in other organisms. In Euplotes, inhibition of DNA polymerase alpha and 
delta results in increased length heterogeneity of the G strand and changes the length of 
the C strand (Fan and Price 1997). An additional telomeric protein in this pathway in 
yeast might be Tenlp, which interacts with both Cdc13p and Stnlp (Grandin et al. 
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2001). Some mutations in this protein lead to telomere elongation, although the nature 
of this elongation has not been yet compared with elongation of the cdc13-5 mutants. 
The role of helicases at telomeres is just starting to be elucidated. Pif 1 p (Schulz 
and Zakian 1994), a 5'-3' helicase which by chromatin immunoprecipitation localizes to 
telomeres, when overexpressed causes telomere shortening (Zhou et al. 2000). 
Furthermore, Piflp deletion or expression of catalytically dead helicase mutants leads to 
telomerase dependent telomere elongation. Based on the observation of telomere 
length changes and biochemical activity found in Piflp, it has been suggested that Piflp 
could dissociate the RNA template from the telomere thus negatively influencing 
telomerase function. Another helicase, Sgslp has gained considerable attention due to 
its homology with helicases that are mutated in a number of human disorders that 
include Bloom syndrome and Werner syndrome. Mutant sgsl has no effect on telomere 
homeostasis when telomerase is present (Watt et al. 1996). However, a double deletion 
of est2 and sgsl, leads to slightly faster telomere shortening than in est2 mutant alone. 
Biological meaning of this finding is unclear and currently the only telomere function of 
Sgslp is in a choice of the type of alternative pathways used in cells when telomerase is 
not able to maintain telomeres (Cohen and Sinclair 2001; Huang et al. 2001; Johnson et 
al. 2001). 
Regulation of telomere maintenance: the role of proteins bound to duplex 
telomeric DNA 
All of the proteins discussed above, appear to function close to or at the terminus 
of the DNA. Work from S.cerevisiae, S.pombe, and humans, shows that proteins that 
bind along the telomere are also important for in-cis telomere length regulation. Raplp 
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is an integral component of telomeric chromatin in S. cerevisiae (Conrad et al. 1990) and 
it directly interacts with telomeric DNA using its two Myb-like DNA binding domains 
(Konig et al. 1996). Raplp has been established as a negative regulator of telomere 
length based on the facts that overexpression of the full-length protein leads to telomere 
elongation and increase in length heterogeneity (Conrad et al. 1990). Furthermore, 
growth of a strain with a temperature sensitive allele of Raplp at semi-permissive 
temperature led to telomere shortening, which was rescued by expression of the wt 
allele (Conrad et al. 1990; Lustig et al. 1990). Further studies suggested that the 
number of Raplp molecules bound to the chromosome end is counted and used as a 
gauge of the length of the telomeric repeat array (Marcand et al. 1997). In these studies, 
the C-terminal 174 amino acids of Raplp were fused to a heterologous DNA binding 
domain of Gal4. By varying the number of Gal4 sites subtelomeric to an engineered 
telomere, the number of Raplp molecules available for protein counting could be 
altered. A correlation was seen between the number of Raplp C termini present on the 
telomere and the length of that telomere. The more Raplp was tethered to the telomere, 
the shorter the final telomere length. The C terminus of Raplp interacts with two 
proteins (Rapl interacting factor 1 and 2, Rif 1 p and Rif2p) that are implicated in 
telomere length regulation. Overexpression of Riflp and 2 leads to telomere shortening 
and their mutation or deletion lead to telomere elongation (Wotton and Shore 1997). 
Thus, like Raplp they negatively regulate telomere elongation, although the mechanism 
of their function is completely unknown. The Raplp C terminal domain also interacts 
with Sir3p and Sir4p proteins (Moretti et al. 1994), which participate in silencing at 
mating type loci as well as at telomeres in yeast. As opposed to deletion of Riflp or 2, 
which leads to telomere elongation, removal of Sir proteins leads to moderate telomere 
shortening. It has been proposed that this shortening is very indirect and in the cells that 
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do not have Sir proteins, more Raplp molecules are available to interact with Rifl and 
Rif2, tilting the balance towards telomere shortening (Marcand et al. 1997). 
Genetic screens have identified a number of double stranded telomere binding 
proteins that affect telomere length regulation in S. pombe (Cooper et al. 1997; Nimmo 
et al. 1998). A strain with a deleted Tazl protein had very dramatically elongated 
telomeres. Tazl is a ortholog of human TRF1 and TRF2 (see below) and like them uses 
Myb domains for DNA binding. The mechanism by which Tazl regulates telomere 
length is not understood. 
Telomere length regulation in mammals 
Telomere length regulation in mammals will be described in detail in Chapter 3 
of this thesis, but the rules observed in lower eukaryotes also apply to maintenance of 
telomere length in higher organisms. Although the details and molecular mechanisms 
might be vastly different, both the elongating and shortening activities have to be 
regulated and telomere associated proteins are best candidates for such forces. 
As noted above, the overall telomerase activity in human cells is regulated at the 
level of expression of the catalytic subunit (hTERT) and generally, hTERT expressing 
cells have detectable telomerase activity (Kilian et al. 1997; Meyerson et al. 1997; 
Nakamura et al. 1997). However, there is ample experimental evidence that telomerase 
activity is very tightly regulated at each chromosome end. For example, tumor cells 
maintain their telomeres at a stable length, while they express high telomerase activity 
(Counter et al. 1992; Counter et al. 1994; van Steensel and de Lange 1997). Secondly, 
when new telomeres are formed by elongation of a transfected short telomeric "seed", 
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the final length of a new telomere matches that of the other telomeres in the cell. 
(Barnett et al. 1993; Hanish et al. 1994; Sprung et al. 1999). These findings suggest that 
the length of a single telomere can be monitored and adjusted. 
In human cells, the double-stranded DNA binding telomere protein, TRF1 is at 
least in part responsible for telomere length monitoring. When TRF1 is overexpressed in 
a telomerase-positive cell line telomeres shorten (van Steensel and de Lange 1997). 
When TRF1 is removed from telomeres by overexpression of a dominant negative allele 
of TRF1, the telomeres elongate (van Steensel and de Lange 1997). In both cases the 
telomere length stabilizes at a new length setting, which can be maintained for many 
population doubling (Smogorzewska et al. 2000). The level of TRF1 present on the 
telomeres does not influence the telomerase activity detected in the extracts. Based on 
these findings it was proposed that TRF1 acts in cis and regulates length of an individual 
telomere (van Steensel and de Lange 1997). According to this model, long telomeres 
recruit a large amount of TRF1, which blocks telomere elongation. Due to the 
shortening activities, the telomeres then gradually decrease in length until they stop 
recruiting the inhibitory amount of TRF1. At that time, telomerase elongates the DNA 
ends, synthesizing more binding sites for TRF1, so that the cycle continues. This is a 
similar way of regulating telomere length to that of the counting mechanism that was 
discussed above for Rapl (Marcand et al. 1997). 
A number of other proteins clearly influence length regulation in human cells. 
Tankyrase (Smith et al. 1998) and TIN2 (Kim et al. 1999) both bind to TRF1 and most 
likely participate in length regulation through changing the binding of TRF1 to telomeric 
(Ye and de Lange; Smith et al. 1998; Smith and de Lange 2000). TRF2, a homologue of 
TRF1 regulates telomere length independently and through a different mechanism than 
21 
TRF1. Telomere length regulation by TRF2 and the associated factors will be discussed 
in Chapter 3 of this thesis. 
As described earlier, telomerase associated proteins might play a role in 
telomere length regulation by affecting telomerase processing or stability. Telomeres of 
cells deficient in heterogeneous nuclear ribonudeoprotein Al (hnRNP A1) are shorter 
than the telomeres in wt cells (LaBranche et al. 1998), and overexpression of UP1, an 
amino-terminal fragment of A1 leads to telomere elongation. Besides being associated 
with the telomerase RNA, hnRNP A1 has also been reported to interact with the single-
stranded telomeric DNA in vitro (Ishikawa et al. 1993; LaBranche et al. 1998; Fiset and 
Chabot 2001), which led to a proposal that hnRNP might recruit telomerase to the 
telomere (Fiset and Chabot 2001). Mutation in another telomerase RNA binding protein, 
dyskerin, might result in increased shortening rates (Mitchell et al. 1999). Finally, 
overexpression of La, which binds telomerase RNA (Ford et al. 2001) leads to telomere 
shortening. These results suggest that proteins that interact with the telomerase RNA 
can positively and negatively regulate telomere length. Further biochemical and 
molecular studies will have to be done to decipher all of the interactions and the 
mechanism of telomere length regulation by these proteins. 
As in yeast, human proteins involved in DNA damage signaling might also be 
involved in telomere length regulation. Although one study found no difference in 
telomere length homeostasis in cells that were deficient for Ataxia Telangiectasia 
Mutated (ATM), an ortholog of TEL1 (Sprung et al. 1997), primary fibroblasts from 
human patients affected with Ataxia Telangiectasia showed an increased rate of 
telomere shortening when cultured ex vivo (Vaziri et al. 1997). The issue of telomere 
shortening rates in these cells is confounded by the fact that these cells, due to genomic 
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instability, have very slow growth rates and they senesce prematurely, an event that 
might be influenced both by the telomere length as well as by accumulation of DNA 
damage. Peripheral T lymphocytes from patients with Ataxia telangiectasia were shown 
to have accelerated telomere shortening (Metcalfe et al. 1996), but again, AT patients 
are immunodefficient and the shorter telomere lengths might reflect increased turnover 
of stem cells supplying the peripheral leukocytes. In mice deficient for ATM, telomere 
length also appears to be decreased (Hande et al. 2001), suggesting that ATM might 
influence telomere length. Mutations in WRN protein in human cells, like mutations in 
ATM, lead to increased telomere shortening rates in human primary fibroblasts cultured 
ex vivo (Schulz et al. 1996), but again the same caveat about growth rates applies to 
these experiments. 
The role of Ku70, Ku80 and DNA-PKcs in telomere length regulation in 
mammalian cells is controversial. SCID (severe combined immunodeficiency) mutation 
in mice removes part of the DNA-PKcs protein making it non-functional in V(D)J 
recombination. Comparison of telomere length in mice carrying SCID mutation with the 
telomere length in wt mice shows that SCID mice have longer telomeres (Hande et al. 
1999; Goytisolo et al. 2001). When one of the groups compared telomere length of wt 
cells with those that had a complete null DNA-PKcs, the difference disappeared 
(Goytisolo et al. 2001). This could be explained if the SCID mutation created a gain of 
function mutation for telomere length maintenance. It is much harder to explain 
discrepancies in results of telomere length assessment in mice lacking Ku80. Even 
though the two groups worked with mice from the same source, one of the groups 
concluded that the KO cells had shorter telomeres than the wt cells (d'Adda di Fagagna 
et al. 2001), while the other group found no telomere changes between the two strains 
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(Samper et al. 2000). There is some data that suggest a slight shortening phenotype in 
the KO cells in the results of the second group ((Samper et al. 2000), Figure 5, left 
panel), although, the results would have to be very carefully quantified. 
Similar discrepancy arose when these two groups looked at the role of poly(ADP-
ribose) polymerase PARP in telomere length regulation. Again, one group has 
concluded that there was a telomere shortening phenotype (d'Adda di Fagagna et al. 
1999), and the other, that there were none (Samper et al. 2001). This time, the mice 
both groups used were from different origin so there could be some strain differences 
giving rise to different results. It must be said, though, that the results of the group that 
claimed no difference in telomere length in mutant animals (Samper et al. 2001) were 
much more convincing and supplied a much more detailed analysis of the length 
phenotype in the KO animals. Also, this group has correctly concluded that there were 
no end-to-end chromosome fusions arising due to telomere deprotection, and all of the 
fusions that were seen in the mutant animals could be accounted for by the genomic 
instability observed in these animals rather then the telomere deprotection as suggested 
by d'Adda di Fagagna et al. (d'Adda di Fagagna et al. 1999). 
Telomere protection and its regulation 
The first cytological description of fusogenic potential of the broken ends came 
from Barbara McClintock, who observed dicentric chromosomes forming chromatin 
bridges in anaphase cells of Zea mays (McClintock 1938). While being pulled to the 
opposite poles of the dividing cell, dicentric chromosomes will break, resulting in newly 
formed ends moving to daughter cells. Two outcomes were observed. In the first one, 
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the broken end formed by rupture fused with its copy after the chromosome was 
replicated and because this created another dicentric chromosome the breakage-fusion-
bridge cycle would continue through subsequent divisions. This occurred when the 
initial break arose in the endosperm and the breakage-fusion-bridge cycle continued 
through the development of that tissue. When the break occurred in the zygote, on the 
other hand, the cycle would cease and sporophytic tissue that developed behaved as if 
there were no free ends present. In the words of McClintock, the ends were healed. A 
healed chromosome stayed stable even when reintroduced into in the gametophytic or 
endosperm tissue. Two conclusions could be drawn from these observations. First, the 
broken ends were not stable and would fuse with another broken end to form a dicentric 
chromosome, which, in turn, would lead to the formation of a bridge in the next division. 
Second, some tissues were capable of healing broken ends. McClintock did not know it 
at the time, but the healing power in the zygote is most likely supplied by telomerase, 
whose activity is very high at that developmental stage, but very low in endosperm 
(Killan et al. 1998). Telomerase, when present, is able to add telomeric DNA to the 
broken end. The added DNA in turn recruits all the necessary components to create a 
non-fusogenic chromosome end, a telomere. This current interpretation of healing 
implies that to create a proper, protected end, there is a need for telomeric DNA serving 
as a binding site for proteins. If one of those components fails, a telomere will become 
nonfunctional and can become fusogenic. 
There are many examples of failure of protection resulting from the lack of 
sufficient length of telomeric DNA to support proper telomere function. As noted in the 
section describing telomere length regulation, elimination of telomerase activity in all 
organisms studied to date leads to a gradual but constant loss of telomeric DNA (Singer 
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and Gottschling 1994; McEachern and Blackburn 1995; Lendvay et al. 1996),(Blasco et 
al. 1997; Lingner et al. 1997; Nakamura et al. 1998; Fitzgerald et al. 1999; Liu et al. 
2000; Niida et al. 2000). Initially, this loss is associated with no abnormal phenotype 
showing that presence of telomerase per se is not necessary for end protection. 
Eventually telomeres become so short they are non-functional and become fusogenic. 
End-to-end fusions are visible in cells derived from mice without functional 
telomerase due to deletion of the mTR gene (Blasco et al. 1997), but this phenotype only 
develops after the telomerase deficient mice have been bred for a number of 
generations allowing cell division during which the telomeres shorten. The number of 
generations to achieve telomere dysfunction varies from 3 to 6 (Blasco et al. 1997; 
Herrera et al. 1999) and is highly dependent on the initial length of telomeres in the KO 
strain. Similarly, removal of the telomerase catalytic subunit in Arabidopsis thaliana 
produces telomere dysfunction after a delay of 5 generations (Riha et al. 2001). Plant 
cells tolerate chromosomal abnormalities allowing for a spectacular display of fusions in 
very late generations of growth without telomerase. Nearly half of the of anaphases in 
terminal plants (those that do not give rise to offspring) carry at least one bridge. 
A striking outcome of telomere dysfunction is found in S. pombe after loss of its 
telomeric DNA due to growth without the catalytic subunit of telomerase or in absence of 
both Rad3p and TeMp. Molecular analysis of the genome of these cells revealed that all 
three chromosomes were circularized, thus circumventing the need for end protection 
(Naito et al. 1998; Nakamura et al. 1998). This is an example of healing of ends without 
formation of dicentric chromosomes, a pathway that apparently is available if an 
organism has a small number of chromosomes. As an aside, having circular 
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chromosomes is compatible with vegetative growth but meiosis is extremely inefficient in 
such cells (Naito et al. 1998; Nakamura et al. 1998). 
All of the examples above deal with a gradual loss of telomeric DNA leading to 
chromosome fusions. In these cases, de-protection results from lack (or too little) of 
telomeric DNA. A number of recent experiments suggest that the proteins that bind to 
that DNA are ultimately the important players in protection. Based on the molecular 
outcome of their removal, protective proteins can be grouped in different categories. 
There are those that when removed lead to a very rapid destruction of only the C strand 
of the telomere, those that when removed lead to loss of both strands of the DNA and 
finally, there are those that cause deprotection but leave the telomeric DNA evidently 
intact. 
The first category is represented by the Cdc13 complex. Cdc13p, and its 
associated factors Stnlp and Tenlp have been already discussed with regard to their 
function in telomere length regulation. Their essential function at the telomere stems 
from their ability to protect the end from nucleases. Mutations in all three proteins lead 
to rapid and specific degradation of the C strand (Garvik et al. 1995; Grandin et al. 1997; 
Grandin et al. 2001). The exact molecular nature of the protection is not yet understood, 
but it is known that all three proteins can interact with each other. Cdc13p binds to the 
single-stranded overhand and recruits the other two proteins, which in turn inhibit 
degradation. Cdc13p itself is dispensable for protection because anchoring of Stnlp to 
the overhang using the small DNA binding domain of Cdc13p is sufficient to inhibit the 
putative nucleases (Pennock et al. 2001). A less dramatic deprotection resulting in C 
strand degradation is seen in yeast lacking the Ku 70/80 heterodimer. In wild type cells 
long overhangs are present only in S phase, but in both Yku70 and Yku80 mutants, the 
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terminal structure of the DNA is altered and G-overhangs are present throughout the cell 
cycle (Gravel et al. 1998), suggesting that the Ku heterodimer is necessary for proper 
protection. Combining lack of Ku with lack of cdc13 exacerbates single mutant 
phenotypes (Nugent et al. 1998; Polotnianka et al. 1998), thus it seems that these 
proteins have distinct protective activities at the telomere. 
Telomere end-binding protein (TEBP), the first telomeric protein to be isolated, 
binds to the very terminus of a single-stranded overhang found in Oxytricha nova 
macronuclear telomeric DNA (Gottschling and Zakian 1986). It is a heterodimer of a and 
P subunits and forms an extremely stable, non-covalent complex with the DNA. The 
DNA in this complex is completely resistant to Bal 31 exonuclease, establishing that the 
protein is able to protect the terminus in vitro. The crystal structure of the heterodimer 
complexed with its ss DNA substrate (Horvath et al. 1998) shows that the very terminus 
of the DNA is buried deeply in the cleft formed by the two proteins and thus, it is 
inaccessible to any activities that might degrade or extend the overhang. 
Although the exact conserved orthologs of Oxytricha's a and p subunits has been 
only found in Stylonychia mytilis (Fang and Cech 1991), many species, including 
humans, possess a protein that has sequence similarity to the DNA binding domain of 
the a subunit. Functional information on this protein comes from S.pombe, where 
deletion of Potl, the ortholog of the a subunit from Oxytricha TEBP leads to a rapid 
degradation of both strands of telomeric DNA and results in circularization of all 
chromosomes (Baumann and Cech 2001). As opposed to the gradual telomere 
shortening that follows after removal of telomerase activity, these events are obvious 
within the first 5 to 10 generations of growth, showing that Potl is necessary for the 
protection of the DNA. 
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Removal of Taz 1 from the telomeres of S.pombe under certain circumstances 
(nitrogen starvation or rad22-/- background) also results in deprotection of telomeres 
(Godhino Ferreira and Promisel Cooper 2001). Unlike the examples so far, the 
telomeric DNA is not degraded but nevertheless the telomeres become fusogenic. 
Fusions are clearly created due to the non-homologous end joining since they require 
the Ku proteins, suggesting that Tazl is necessary for protection from inappropriate 
repair activities at the telomere. Tazl is itself a double-strand DNA binding protein that 
shares homology with the human TRF1 and TRF2 proteins (Cooper et al. 1997; Li et al. 
2000). The mechanism of end-protection by these double-stranded telomeric DNA 
binding proteins will be explored further in Chapter 1 of this thesis. 
It seems that even the non-canonical telomeres of D. melanogaster are protected 
with the help of a protein. Heterochromatin protein 1 (HP1) is a chromosomal protein 
that among other places is localized to telomeres (James et al. 1989). Although HP1 
associates with transposable elements (van Steensel et al. 2001) it is interesting that its 
localization at telomeres is independent of presence of the retrotransposons since HP1 
can also be found on terminally deleted chromosomes, which lack these elements (Fanti 
et al. 1998). Numerous mutants of HP1 give rise to end-to-end fusions of chromosomes 
(Fanti et al. 1998), showing its role in telomere protection. Currently it is a complete 
mystery how HP1 is able to protect the chromosome ends, especially if one notes that 
HP1 itself does not seem to have DNA binding ability (Singh et al. 1991; Powers and 
Eissenberg 1993). Mutation in another Drosophila protein, UbcD leads to formation of 
fusions. Although the nature of these fusions is unclear, it has been proposed that a 
ubiquitin-conjugating (E2) enzyme activity of UbcD might be necessary for proper 
behavior of telomeres in D. melanogaster (Cenci et al. 1997). 
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Currently, there is also little knowledge about how telomeres are protected in 
human cells. Observation of low level of telomere fusions, which retain telomeric DNA, 
occurring in mouse embryo fibroblasts that lack Ku70, Ku80 and DNA-PKcs (Bailey et al. 
1999; Samper et al. 2000; Goytisolo et al. 2001), implicates this complex in end 
protection. Although Ku has been reported to interact with both of the double strand 
binding telomeric proteins TRF1 and TRF2 (Hsu et al. 2000),(Song et al. 2000), the data 
are insufficient for these conclusions and Ku may also simply localize to telomeres 
through its ability to interact with DNA ends (Walker et al. 2001) including DNA ends 
containing telomeric DNA (Bianchi and de Lange 1999). 
How the protection of telomere ends might be achieved molecularly is suggested 
by the structure of Oxytricha TEBP, which shows how the very 3' end of chromosomes 
can be hidden in a deep hydrophobic protein pocket (Horvath et al. 1998). A tantalizing 
possibility of a second way of hiding the very end comes from a finding that telomeres in 
evolutionarily distant species end with a t-loop (Griffith et al. 1999; Murti and Prescott 
1999; Munoz-Jordan et al. 2001)(Figure i-4). Observation of the chromosome termini 
from human and mouse cells using electron microscopy revealed that the telomere loops 
back forming a large duplex lariat called the t-loop (Griffith et al. 1999). The t-loop is 
stabilized by the strand-invasion of the 3' telomeric overhang into the double-stranded 
telomeric DNA. Such architectural remodeling of a telomere in effect masks the very 
end, thus eliminating the need for its direct protection by a TEBP-like protein. T-loops 
were also found at the chromosome ends in T. brucei (Munoz-Jordan et al. 2001), as 
well as at the ends of micronuclear polytene chromosomes of O. fallax (Murti and 
Prescott 1999). Thus Oxytricha, and possibly other organisms might use both the t-loop 
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directed protection, as well as the TEBP like protection of their termini, possibly at 
different times in the cell cycle (Baumann and Cech 2001; de Lange 2001). 
No matter what the basis of telomere protection, there is ample evidence that 
lack of protection can have disastrous effects on the survival of the organism. Generally, 
when telomere function is compromised, cells grow very poorly and unless they find an 
alternative way of maintaining their telomeres, they undergo a terminal arrest or die. A 
few examples from recent literature illustrate this point. 
A number of studies have explored what happens in the ciliate Tetrahymena 
when the RNA template is mutated resulting in incorporation of altered sequences into 
the telomere (Yu et al. 1990; Kirk et al. 1997). As discussed earlier, such changes may 
result in telomere length deregulation, presumably because changes in telomere 
sequence preclude or modify the binding of telomere protein necessary for length 
regulation. By the same token, some changes were severe enough to alter telomeric 
protection and lead to the appearance of large cells with abnormal nuclei and in many 
cases complete cessation of growth of certain strains (Yu et al. 1990). In particular, 
changing the telomeric sequence from GGGGTT to GGGGTTTT leads to a severe 
anaphase block with appearance of the telomere associations (Kirk et al. 1997). 
Although the cause of the growth arrest was misinterpreted at the time to mean that the 
telomere function was necessary for correct chromosome segregation, and not for 
protection of ends from fusions, the outcomes of telomere dysfunction were deadly for 
the organism. 
Lack of telomere function in S. cerevisiae also has deleterious effects for cell 
survival. All of the Ever Shorter Telomeres (est) mutants (Lundblad and Szostak 1989; 
Lendvay et al. 1996) as well as the mutant lacking the RNA template (tld) (Singer and 
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Gottschling 1994) cease to grow and die when their telomeres become too short to 
support proper telomere function. Cultures only survive when telomeric DNA is restored 
through recombination dependent processes (Lundblad and Blackburn 1993). When 
this independent process is not available in rad52 mutants (Lundblad and Blackburn 
1993), or double mutants of rad50 and rad51 (Le et al. 1999), lack of telomere 
maintenance is completely lethal. 
The outcome of lack of telomere function in human cells will be explored in detail 
in Chapter 2 of this thesis but generally the result depends on the cell type. Some cells 
respond with permanent growth arrest, and others with apoptosis. When telomerase is 
inhibited in human tumor cell lines by expression of a dominant negative allele of 
telomerase (Hahn et al. 1999; Zhang et al. 1999) cells cease to grow and appear to 
undergo apoptosis. This phenotype is observed after an expected lag phase during 
which telomeres shorten. Since the replicative potential of cells expressing the dominant 
negative allele of hTERT is thwarted, such cells, as expected, do not give rise to tumors 
in nude mice (Hahn et al. 1999). A more recent study using a chemical inhibitor of 
telomerase led to a similar conclusion but instead of apoptosis, a cell cycle arrest with 
characteristics of senescence was seen (K. Damm, personal communication). 
A mouse strain lacking the telomerase RNA gene is a good illustration of the 
consequences of telomere dysfunction at the organismal level. As discussed earlier, 
telomere dysfunction in mTERC -/- animals commences only after the mice have been 
bred for a number of generations. The development of chromosomal fusions, a marker 
of telomere deprotection, coincides with the appearance of adverse effects that include 
sterility due to abnormal spermatogenesis resulting in cell death in the testis (Hemann et 
al. 2001), decreased proliferative capacity of the hematopoietic tissues (Lee et al. 1998), 
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shortened life-span, and a reduced capacity to heal skin lesions or to respond to blood 
cell depletion (Rudolph et al. 1999). Additionally, the rate of spontaneous tumor 
formation rises in the late generations of mTERC -/- mice, suggesting that the instability 
that is triggered by telomere dysfunction might contribute to tumorigenesis (Rudolph et 
al. 1999). 
Human telomeric proteins 
In recent years we have seen an enormous surge in our knowledge of the protein 
components of mammalian telomeres. The first two human telomeric proteins, TRF1 
and TRF2 and their interacting partners will be described in detail below. The presence 
of these proteins on telomeres is firmly established. Ku70, Ku80, and DNA-PKcs as 
noted above, have a protective function at telomeres. Recently chromatin IP analysis 
has revealed that all three proteins were somewhat enriched on the telomeric DNA as 
compared to bulk DNA as detected with an Alu repeat probe (d'Adda di Fagagna et al. 
2001). It is unclear at this point, whether the association of Ku proteins with telomeres is 
constant or whether they bind at specific times. Human Potl, an ortholog of Potlp from 
S.pombe has been described (Baumann and Cech 2001) but there is no data yet on the 
localization or function of Potl in human cells. Finally, there is data to suggest that 
WRN and BLM proteins, both orthologs of Sgsl RecQ helicase in S. cerevisiae can be 
present at telomeres. BLM has been reported to colocalize with a subfraction of the 
telomeres in human cells (Yankiwski et al. 2000), although the significance of such 
infrequent colocalization is unclear. WRN protein can be found mainly in the nucleoli of 
cells (Marciniak et al. 1998), but in cells that maintain their telomere length through an 
alternative mechanism described before (ALT), WRN can also reside in ALT associated 
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PML (AA-PML) bodies, where it colocalizes with PML, Rad52, TRF1, and TRF2 
(Johnson et al. 2001). By analogy to Sgsl in S. cerevisiae, WRN could play a role in 
telomere maintenance by the alternative pathways. The only indication that WRN 
protein might also play a role in regulating length in non-ALT cells comes from the 
finding that telomere shortening is accelerated in cells from Werner Syndrome patients 
(Schulzetal. 1996). 
TRF1 and TRF2 
TRF1 was identified in cell extracts as an activity that specifically bound to 
human TTAGGG repeats (Zhong et al. 1992; Chong et al. 1995). Biochemical 
characterization revealed a homodimeric protein (Bianchi et al. 1997) that uses two Myb-
type helix turn helix motifs to bind to variably spaced sites of the sequence 5'-
YTAGGGTTR-3' (Bianchi 1999). TRF1 is widely expressed and due to its binding 
activity, specifically localizes to telomeres at all stages of the cell cycle (Chong et al. 
1995). Electron microscopy studies of TRF1 binding to arrays of TTAGGG repeats have 
shown that the protein is able to pair two duplex tracts of telomeric DNA (Griffith et al. 
1998). Such architectural activity has been proposed to aid TRF1 in telomere length 
regulation. As will be discussed further in Chapter 3, TRF1 influences telomere length in 
vivo through regulating the elongation pathway of telomere length maintenance 
(Karlseder and de Lange; van Steensel and de Lange 1997) 
Three proteins interact with TRF1 at telomeres. Tankyrasel (Smith et al. 1998), 
Tankyrase2 (Kaminker et al. 2001), and TIN2 (Kim et al. 1999) were discovered in 
separate yeast-two-hybrid screens using TRF1 as bait. Tankyrasel, a poly (ADP-
fibose) polymerase (PARP), binds to an acidic N-terminus of TRF1 and modifies it using 
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its catalytic activity. This modification alters TRFVs ability to bind to telomeric DNA in 
vivo and in vitro thus indirectly influencing telomere length (Smith et al. 1998; Smith and 
de Lange 2000). The biochemical role of TIN2 is less well defined but its influence on 
telomere length is also consistent with the regulation of TRFl's presence on the 
telomere (Ye and de Lange; Kim et al. 1999). 
Early human cDNA sequencing efforts uncovered a cDNA fragment encoding a 
Myb domain that had striking similarities to that found in TRF1 (Bilaud et al. 1996). 
Cloning of the full-length cDNA revealed a protein, which due to its similarity to TRF1 
and ability to bind TTAGGG repeats was named TTAGGG repeat binding factor 2 
(TRF2) (Bilaud et al. 1997; Broccoli et al. 1997). As shown in Figure i-2, the highest 
conservation between TRF1 and TRF2 is found in the Myb domains (58%). This level of 
conservation is in agreement with the fact that both proteins recognize the same 
sequence in vitro (Bianchi et al.; Broccoli et al. 1997) as well as with the localization of 
TRF2 to telomeric DNA in vivo (Broccoli et al. 1997), and Figure i-3. 
The second most conserved domain in TRF1 and TRF2 is the TRF homology 
domain (TRFH) (Broccoli et al. 1997; Li et al. 2000). This part of the protein is 
responsible for homotypic interactions (Bianchi et al. 1997) as well as interactions with 
other proteins (TIN2 (Kim et al. 1999) for TRF1, and hRapl (Li et al. 2000) for TRF2). 
Although the sequence identity between TRF1 and 2 is only 29% within TRFH, crystal 
structures of these domains can be superimposed (Fairall et al. 2001). Despite this 
overall architectural conservation, the structure reveals slight differences between the 
dimer interfaces of TRF1 and 2 that include changes in the length of the interacting 
helices, differences in the side chain amino acids and in the hydrogen bonding pattern. 
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Figure i-2. Schematic of domain structure of TRF1 andTRF2 (adapted from Broccoli et al., 
1997; Griffith et al., 1999). Not drawn to scale. Identities are shown in black, similarities in 
grey. TRF homology (TRFH) domain is used in homodimerization as well as in interactions with 
other factors specific for each protein. Myb domain is used in DNA binding. 
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Figure i-3. Localization of TRF2 to telomeres of human chromosomes. Indirect 
immunofluorescence with 647 antibody (raised against full length TRF2 protein) on a 
metaphase spread of HeLal.2.11 cells. 
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These findings explain why TRF1 and 2 fail to heterodimerize (Broccoli et al. 1997; Zhu 
et al. 2000). 
Electron microscopic studies directly implicate TRF2 in t-loop formation. 
Baculovirus-derived TRF2 is able to induce invasion of the 3' single-stranded TTAGGG 
repeats into duplex telomeric DNA, forming t-loops in vitro (Griffith et al. 1999). A single-
stranded overhang of six nucleotides of a G strand (TTAGGG) is sufficient for in vitro t-
loop formation by TRF2 and it needs to be adjacent to the double-stranded telomeric 
DNA so that the double- to single-stranded transition is composed of TTAGGG 
sequence (Stansel et al. 2001). When the t-loop is formed, TRF2 can be visualized at its 
base where the invasion of the single-strand overhang is thought to occur (Griffith et al. 
1999; Stansel et al. 2001). Based on these findings and the earlier studies of the 
biochemical activities of TRF1, a model for t-loop formation has been proposed (Griffith 
et al. 1999; Stansel et al. 2001) and Figure i-4. In this model, TRF1 pairs the telomeric 
sequences and TRF2 aids in the invasion by the single-stranded overhang into the 
telomeric repeats. Besides creating the t-loops, telomeric proteins might also stabilize 
these structures. 
TRF2, like TRF1 has multiple binding partners. Rapl, an ortholog of S. 
cerevisiae's Rapl (discussed earlier) has been identified in a yeast-two-hybrid screen 
with TRF2 as bait. Like the yeast Raplp, hRapl is implicated in telomere length 
regulation although its mode of action is not yet understood (Li et al. 2000). However, 
unlike the yeast protein, hRapl does not bind to DNA directly and uses TRF2 as an 
anchor. Further analysis of known telomeric proteins in S. pombe revealed that Tazl is 
an ortholog of the human TRF proteins (Li et al. 2000). This suggests that the telomeric 




TRF1 I pairing of duplex D N A by T R F 1 
^ ™ " .tf̂^̂ K̂ "̂P"»», 
TRF2 binding of T R F 2 close to the junction 






invasion of 3' overhang 
Figure i-4. Schematic of t-loop formation. Adapted from (Griffith et al.,1999; Steensel et al. 
2001). 
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cerevisiae's telomeric complex. It also suggests that the ancestral telomeres had both 
Rapl like molecules and a TRF-like molecules, and the budding yeast lost the TRF like 
component. 
Immunoprecipitation with antibodies against TRF2 from human cells revealed 
that a small portion of the Rad50/Mre11/Nbs repair complex associates with TRF2 in 
vivo (Zhu et al. 2000). Immunofluorescence and cell cycle experiments showed that 
Rad50 and Mrel 1 reside at telomeres during all stages of the cell cycle, whether as 
Nbsl joins the complex only in S-phase. Genetic studies have implicated the Mrel 1 
complex in homologous recombination and in telomere maintenance in yeast (reviewed 
in (Haber 1998)and (de Lange and Petrini 2001)). Studies in mammalian systems have 
been hindered by the lethality of the organisms lacking the complex. However, NBS1, a 
component of the Mre11 complex, is mutated in patients with Nijmegen breakage 
syndrome (NBS) (Carney et al. 1998; Varon et al. 1998) and Mre11 itself is mutated in 
an Ataxia-Telangiectasia-like disorder (A-TLD) (Stewart et al. 1999). NBS and ATLD are 
characterized by chromosomal instability, increased sensitivity to ionizing radiation, and 
radioresistant DNA synthesis (RDS) (Carney et al. 1998; Stewart et al. 1999). These 
findings implicate the Mre11 complex in detection and signaling of DNA damage 
(reviewed in Petrini 1999). In agreement, the complex rapidly localizes to the sites of 
damage (Nelms et al. 1998). Moreover, Nbs is a substrate for phosphorylation by ATM 
(Gatei et al. 2000; Lim et al. 2000; Wu et al. 2000; Zhao et al. 2000) and it is necessary 
for the ATM dependent S phase checkpoint (Lim et al. 2000). Currently the functional 
consequences of the telomeric localization of the Mrel 1 complex are unknown although 
it has been suggested that the complex could generate the 3' G-overhangs or could 
40 
participate in formation, stabilization and/or resolution of t-loops (Zhu et al. 2000; de 
Lange and Petrini 2001) 
The experimental part of this thesis concentrates on TRF2. Its function has been 
explored using an ex vivo primary cell culture system, in which a number of different cell 
types were used in order to gain a better understanding of the protein. First, I describe 
in detail the role of TRF2 in protection of chromosome ends. Then, I show that the 
removal of TRF2 from the telomeres leads to the rapid induction of senescence in 
primary cells. This will be followed by description of TRF2 as an essential regulator of 
telomere length, mainly, if not exclusively involved in determining the shortening rate of 
telomeres. Chapter 4 describes telomere loss and growth arrest phenotypes associated 
with a truncation allele of TRF2 that lacks its N-terminal basic domain, and suggests that 
this domain is important for the proper function of TRF2. In Chapter 5 an additional 
phenotype of loss of TRF2 function, whole genome reduplication and aberrant 
centrosome duplication, as well as the finding of TRF2 at centrosomes will be discussed. 
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C h a p t e r 1 
T h e role o f T R F 2 in t e l o m e r e e n d protection 
Introduction 
Telomeres confer protection onto chromosome ends. Early cytological studies 
revealed that ends devoid of telomeres are spontaneously repaired by fusion with other 
broken ends (McClintock 1938). Telomeric DNA seems to be a necessary component of 
the protected terminus. In human somatic cells, which naturally lack, or have a very low 
level of telomerase, telomeres shorten by 50-200 bp per division (Cooke and Smith 
1986; Harley et al. 1990; Hastie et al. 1990). Once a certain, still ill-defined- length 
setting is reached, telomeres lose their ability to protect and become fusogenic, 
resulting in the formation of dicentric chromosomes (Wolman 1964; Thompson and 
Holliday 1975; Benn 1976). 
End-to-end fusions also arise in tumors where in many cases their appearance 
has been correlated with short telomere length ((Counter et al. 1992; Saltman et al. 
1993), reviewed in de Lange 1995). As pointed out previously (de Lange 1995), 
resolution of dicentric chromosomes can lead to loss of heterozygosity (LOH), gene 
amplification and chromosomal rearrangements, events that are hallmarks of many 
cancer cells. However, most human cancer cells are characterized by high level of 
telomerase activity (reviewed in Shay and Bacchetti 1997), hence telomere-directed 
chromosomal abnormalities might be important at the early stages of the tumor 
development. 
In the past four years, the mouse strain lacking the telomerase RNA (mTERC 
KO) became a very fruitful model system for studying telomere dysfunction and its 
consequences for tumorigenesis. Cells derived from mice null for telomerase exhibit 
end-to-end fusions (Blasco et al. 1997). In mice, as in humans, telomeres become 
fusogenic only after they become short, which in a mouse can take 4 to 6 generations of 
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growth without telomerase (Blasco et al. 1997; Herrera et al. 1999). It has been 
proposed that lack of telomeres in the aging mice of the late generation mTERC KO 
could be responsible for the increased rate of spontaneous cancers seen in these 
animals (Rudolph et al. 1999). The majority of tumors in such mice originated from 
highly proliferative cells that were expected to divide extensively during the animal's life, 
leading to increased attrition of their telomeres. In agreement, the tumor cells were 
found to display a 3-18 fold increase in chromosome fusions (Rudolph et al. 1999). 
Recent studies (Artandi et al. 2000) further substantiate the notion that lack of telomeres 
leads to increased genomic instability and enhanced tumorigenesis (reviewed in 
DePinho 2000). 
A number of different repair pathways participate in the maintenance of general 
stability of the genome (reviewed in Hoeijmakers 2001). Two of these pathways, 
homologous recombination (HR) and non-homologous end joining (NHEJ) are pertinent 
to the repair of double-stranded DNA breaks. Engagement of both of the pathways at 
telomeres should be avoided. HR involving telomeric repeats might lead to poorly-
regulated telomere lengthening (Dunham et al. 2000). NHEJ activity at telomeres could 
lead to formation of end-to-end fusions. 
The core of NHEJ pathway consists of five proteins (Ku80, Ku70, DNA-PKcs, 
DNA Ligase IV [Lig4], and XRCC4) that work in concert to repair site specific breaks, 
which occur during a physiological event of V(D)J recombination in the immune system, 
as well as random breaks occurring in the genome (reviewed in Critchlow and Jackson 
1998). Surprisingly, lack of Ku70, Ku80 or DNA-PKcs in mouse cells leads to a mild 
telomere deprotection phenotype (Bailey et al. 1999; Samper et al. 2000; Goytisolo et al. 
2001). The function of the DNA-PK complex in telomere protection seems to be 
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independent of its function in NHEJ, since deletion of the other two components of the 
pathway- Lig4 or XRCC4, which together are thought to act in the ligation step of the 
repair reaction (Lieber 1999), do not show telomere end-to-end fusions ((Ferguson et al. 
2000; Gao et al. 2000), this chapter). 
The molecular mechanism of protection by telomeric DNA has been proposed to 
involve formation of the t-loop (Griffith et al. 1999), a large, lasso-like structure in which 
the telomeric G-overhang is tucked into the double-stranded telomeric DNA. Although 
repetitive arrays like the telomeric DNA might be imagined to spontaneously form t-
loops, it has been shown that the telomeric proteins aid in t-loop formation and/or 
stabilization. In particular, TTAGGG repeat binding factor 2 (TRF2) is capable of 
generating t-loops in vitro when supplied with a substrate with duplex TTAGGG repeats 
ending with the telomeric 3' single-stranded overhang (Griffith et al. 1999; Stansel et al. 
2001). Electron microscopic analysis of in vitro formed t-loops revealed that TRF2 can 
be visualized at the base of the t-loop where the invasion of the single strand is thought 
to occur Griffith et al. 1999; Stansel et al. 2001). 
TRF2 is one of two proteins that directly bind to the mammalian telomeric DNA 
(Bilaud et al. 1997; Broccoli et al. 1997). It binds DNA as a homodimer using two Myb 
related helix-turn-helix domains brought together by the dimerization of the TRF2 
polypeptide through a TRF homology (TRFH) domain (Broccoli et al. 1997; Fairall et al. 
2001). Another distinct domain of TRF2 is its N-terminus, which is highly basic (pi of 9) 
(Broccoli et al. 1997). TRF2 resides at all telomeres throughout the cell cycle (Broccoli 
etal. 1997). 
This chapter focuses on the role of TRF2 in telomere protection. Experiments 
described in this section show that loss of TRF2 from telomeres leads to telomere 
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deprotection, which manifests itself in formation of end-to-end fusions, visible as 
dicentric chromosomes in metaphase cells and chromosome bridges in anaphase cells. 
The fusions are covalent and are formed through Ligase 4 action on chromosome ends 
that most likely have lost the single-stranded G-overhangs. Breakage of end-to-end 
fusions in subsequent divisions can lead to translocations, which are markers of 
genomic instability. The mechanism of protection by TRF2 is suggested by the 
decrease in the frequency of t-loops in cells without functional TRF2. Unregulated 
dissolution of the t-loops is proposed to constitute a necessary event leading to fusion 
formation after TRF2 inhibition. Furthermore, these findings suggest that short 
telomeres in senescent or tumor cells become deprotected because they fail to recruit 
sufficient amount of TRF2 to support t-loop formation. 
Results 
To study the function of TRF2 at human telomeres, a dominant negative allele of 
TRF2 was expressed in a number of different cell types. The design of the dominant 
negative allele was guided by the knowledge that TRF2, like TRF1 is a dimeric protein 
(Bianchi et al. 1997; Broccoli et al. 1997), which preferably uses two Myb domains to 
efficiently bind the telomeric DNA (Bianchi et al. 1999). A protein containing the 
dimerization domain but lacking the Myb domain should be able to interact with the 
endogenous protein and preclude it from binding to telomeres. Additionally, a highly 
basic N-terminal domain of TRF2 was removed and replaced with a myc tag to facilitate 
discrimination between the dominant negative allele and the endogenous protein. Thus, 
the dominant negative allele of TRF2 used in these studies lacks the Myb domain and 
the basic domain of the protein and is designated TRF2ABAM (Figure 1-1). The full length 
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Figure 1-1. Schematic of TRF2 alleles used in these studies. In some experiments, 
constructs with a N-terminal FLAG or M Y C tag were used. Untagged FL TRF2 included the 
endogenous methionine as the first amino acid. Untagged deletion alleles included a 
methionine in front of amino acid 45 and ended with amino acid 453 or 500, as indicated. 
In N-terminally tagged FL TRF2, the tag was fused in-frame with the 2nd amino acid of 
the protein, and in tagged TRF2AB and TRF2ABAM alleles, the tag was fused to amino 
acid 45. Asterisk indicates a segment of TRF2 that is recognized by antibody 508. 
Antibody 647, raised against a full length protein, recognizes all of the alleles used in this 
study. 
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an N-terminal tag, as indicated in the text. The protein lacking only the basic domain 
(TRF2AB) will be discussed separately (Chapter 4) since this allele is able to localize to 
telomeres and phenotypes associated with its expression are different from an inhibition 
of telomeric TRF2 by dominant negative TRF2. 
Two different systems were employed to overexpress TRF2 alleles (Figure 1-2). 
One of them made use of retroviral vectors, which when transfected into a packaging 
cell line produced replication-deficient retroviral particles that were subsequently used 
for infection of human and mouse primary fibroblasts. A timeline of experiments 
following retroviral infection is shown in Figure 1-2 (top). Cells were infected three times 
in 5-hour intervals and the selection was started on the following day. Puromycin or 
hygromycin were the most commonly used markers for infection of the TRF2 alleles. 
Selection produced a pure population of expressing cells within 3 and 5 days for 
puromycin and hygromycin, respectively. Expression of the alleles was confirmed by 
immunofluorescence with appropriate antibodies and by western analysis. 
A second system used in these studies is an inducible expression system in the 
HTC75 cell line, a Tetracyclin-inducible derivative of HT1080 human fibrosarcoma cell 
line previously used to study the function of TRF1 in telomere length regulation (van 
Steensel and de Lange 1997). An untagged full length TRF2 or a FLAG-tagged 
TRF24BAM were placed under control of a Tetracyclin-controlled promoter and were stably 
transfected into the HTC75 cells. Subsequently, single cell clones were isolated and 
named P clones (FLTRF2) or T clones (TRF2ABAM). A control cell line expressing no 
exogenous protein was also created and named B27. As opposed to the retroviral 
system described above, selection of stable clones gave rise to clonal populations of 
cells, requiring analysis of a number of clones of each type. The 
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Retroviral delivery system (primary fibroblasts) 
-10 12 3 4 5 15(days) 
I 1 1 1 1 1 V-ys 1 
A | day of selection/experiments _ 
start selection 
infection (3x) 
Tetracyclin-inducible system (HTC75 cells) 
-10 1 2 3 4 5 15(days) 
! 1 1 1 1 1 h # 1 
A | day of expression/experiments^ 
induction 
plating of uninduced cells 
Figure 1-2. Timeline of experiments using the retroviral delivery system and the 
Tetracyclin-inducible system. Alleles of TRF2 shown in Figure 1-1 were delivered using 
retroviral vectors or were stably transfected and induced by removal of doxycyclin (Tetracyclin 
derivative) from the media. Expression of all alleles was confirmed using immunofluorescence 
and western blotting. 
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Tetracyclin-inducible system was set up such that removal of doxycyclin from the 
medium resulted in a relief of repression and appearance of expression of the alleles. 
For clarity, "induced" will mean that the indicated allele was expressed and "non-
induced" that it was not expressed. Expression of the alleles reached its highest levels 
within one day after induction (van Steensel et al. 1998) and this was the day that was 
designated to be the first day of expression (Figure 1-1, bottom). 
In order to test the effects of expression of a FLTRF2 and TRF2ABAM allele on 
endogenous TRF1 and TRF2, a subclone of human Helal cells (Saltman et al. 1993), 
HeLal.2.11 with particularly long telomeres of 15-40 kbp (Griffith et al. 1999), were 
infected with a myc-tagged FLTRF2 and myc-tagged TRF2ABAM (Figure 1-3). One day 
after infection the cells were fixed and immunostained with an antibody recognizing the 
myc tag (9E10), an endogenous and transduced FLTRF2 (508), and TRF1 (371). 
Antibody 508 was raised against a peptide present in the basic domain and it recognizes 
the full-length TRF2 but not TRF2ABAM or TRF2AB (van Steensel et al. 1998). FLTRF2, 
when overexpressed, gave high nucleoplasm^ staining with overlaid punctate staining 
that co-localized with TRF1 (Figure 1-3, B, top panel), suggesting that some of the 
expressed TRF2 localizes to telomeres. Moreover, the TRF1 staining pattern did not 
change with FLTRF2 expression, indicating that presence of TRF1 on telomeres was 
largely unperturbed. A diminished level of TRF1 on telomeres has been noticed in cells 
that expressed the FLTRF2 at a very high level (van Steensel et al. 1998), suggesting 
that a very high load of telomeric TRF2, as sometimes achieved in transient transfection 
experiments, might be able to displace some of the TRF1 from telomeres. TRF2ABAM, 
when overexpressed, gave a diffuse nucleoplasm^ staining and efficiently removed the 
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endogenous TRF2 when the myc-tagged TRF2ABAM was expressed (Figure 1-3, A, 
bottom panel). Telomeric TRF1 did not seem to be affected by TRF2ABAM expression 
(Figure 1-3, B, bottom panel). 
Expression of TRF2 ABAM in the HTC75 cells and in human primary fibroblasts led 
to appearance of frequent anaphase bridges and lagging chromosomes (Figure 1-4). 
Such anaphase abnormalities were very rare in any other cell line analyzed, including 
non-induced HTC75 T cell lines (van Steensel et al. 1998), IMR90 cells that did not 
express any exogenous proteins (vector in Figure 1-4, A, Table 1-1), or FLTRF2 
expressing cells (Table 1-1). Quantification of the frequency of anaphase bridges in the 
HTC75 T4 cell line on the 4th day of induction revealed a very low frequency of anaphase 
bridges and lagging chromosomes (less than 0.1 events per anaphase) when 
expression of TRF2ABAM was not induced. The frequency of bridges and lagging 
chromosomes increased to 0.7 abnormalities per anaphase with induction of TRF2ABAM 
(van Steensel et al. 1998). Similarly, IMR90 cells infected with a control virus or 
FLTRF2, showed only 0.2 fusions per anaphase (Table 1-2) and the expression of the 
TRF2ABAM allele induced frequent anaphase bridges (1.5 chromosome fusions per 
anaphase) when scored on day 7 of selection. 
Anaphase bridges can arise from abnormal chromosomes with more than one 
centromere being pulled in opposite directions by the mitotic spindle. If this is the origin 
of anaphase bridges when TRF2 is inhibited, chromosome fusions in TRF2ABAM-
expressing cells should be also visible as dicentric chromosomes in metaphase spreads. 
Indeed, when TRF2ABAM was expressed in IMR90 cells (Figure 1-5) or in HTC75 T cell 
lines (Figure 1-6 and (van Steensel et al. 1998)) multiple end-to-end fusions are visible. 





Figure 1-4. Anaphase bridges in TRF2ABAMexpressing IMR90 human primary fibroblasts 
and HTC75 fibrosarcoma cells. A. Anaphases of IMR90 cells infected with a vector control 
virus carrying no exogenous TRF2 (vector) or TRF2ABAM (TRF2ABAM) on day 7 of selection. B. 
Anaphases of HTC75-T19 cell line expressing TRF2ABAM (TRF2ABAM). Expression of 
TRF2ABAM was induced for 6 days. DNA was stained with DAPI. The arrow points to a lagging 
chromosome. 
54 
Table 1-1. Induction of fusions in anaphase and metaphase IMR90 primary fibroblasts infected 
with control vector, full length TRF2, and TRF2ABAM. All alleles had a N-terminal myc tag. 50 
anaphase cells were analyzed for all infections. Scoring of events was done on day 7 of selection 
and was done on coded samples. Pieces and breaks were also scored in this experiment (see 
Table 4-2). 
Fraction of Number of Fraction of 
Fusions3 per anaphases metaphases Fusions per metaphases 



















a including bridges and lagging chromosomes 
b0.4 lagging chromosomes per anaphase, 1.1 bridges per anaphase 
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Table 1-2. Induction of fusions in metaphase cells expressing no exogenous protein or 
TRF2ABAM. The HTC75 T4 and T19 cells were grown under conditions resulting in repression or 
induction of the dominant negative allele of TRF2, TRF2ABAM. The HTC75 B27 cell line which does 
not express any exogenous protein was used as a control. Metaphase spreads were prepared 
on day 4 of induction and number of fusions was assessed in 50 metaphase spreads. 
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Figure 1-5. Telomere fusions in metaphases of TRF2ABAM-expressing IMR90 human 
primary fibroblasts. Metaphase spreads of IMR90 cells expressing TRF2ABAM prepared on 
day 7 of selection. Chromosomes were stained with DAPI. Many likely chromatid and 












Figure 1-6. Telomere length analysis in IMR90 primary fibroblasts expressing TRF2ABAM. 
Southern blot of telomeric restriction fragments from cells carrying no exogenous TRF2 (vector) 
or TRF2ABAM (TRF2ABAM). Genomic DNA was isolated from cells on the indicated days of 
selection, digested with Hinfl and Rsal, fractionated on a 0.7% agarose gel, and hybridized with 
a TTAGGG repeat probe. The molecular weights of marker DNAs are indicated in kb. 
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(chromosome fusions). However, sister chromatids were never observed to form fusions. 
Quantification of the fusions in 50 metaphases of HTC75 T4 and T19 cell lines induced 
to express TRF2ABAM for 4 days, and IMR90 TRF2ABAM cells on the 7th day of selection 
(Table 1-1 and 1-2) revealed a greater than 6 fold increase in fusion frequency when 
compared to cells that do not express exogenous TRF2 or express the FLTRF2 allele. 
In mice lacking a telomerase RNA subunit, telomeres gradually shorten and 
eventually metaphase spreads reveal the presence of chromosome end-to-end fusions 
(Blasco et al. 1997). When such spreads are further analyzed by performing 
fluorescence in-situ hybridization with a telomeric probe, sites of fusions show no 
telomeric signal, suggesting that the fusions formed between chromosomes that have 
lost telomeric DNA. To ask if end-to-end fusions induced by the presence of TRF2ABAM 
could be due to generalized loss of the telomeric DNA, telomere length was compared 
between wt IMR90 cells and IMR90 cells expressing TRF2ABAM (Figure 1-6). The 
analysis revealed no differences in telomere length between these cells (but see below 
for the description of telomere length in HTC75 T4 cells). Furthermore, when peptide 
nucleic acid (PNA) telomeric probe was employed to perform fluorescent in-situ 
hybridization (FISH) on the metaphases harboring fusions, telomeric signal was always 
found at the sites of fusion (Figure 1-7). The signal often appeared to be much brighter 
at the site of fusion than on the adjacent sister chromatids, consistent with preservation 
of both telomeric repeat arrays at the fusion site. 
As opposed to IMR90 cells in which Southern blot with a telomeric probe 
revealed no changes in hybridization pattern when TRF2ABAM was expressed, the HTC75 
T cell lines revealed a new class of DNA that was hybridizing with a telomeric probe. 
This new class of TTAGGG positive DNA first appeared faintly on the 4th day of induction 
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Figure 1-7. T T A G G G repeats at the sites of fusions in a metaphase of TRF2ABAM-
expressing HTC75 cells. Peptide neucleic acid (PNA) fluorescence in-situ hybridization with a 
telomeric probe on chromosomes of HTC75-T4 cells induced to express TRF2ABAM for 6 days. 
Telomeric DNA was visualized using a fluorescently labled PNA (CCCTAAA)3 probe. DNA was 
counterstained with DAPI. Arrows point to sites of fusion. 
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T 4 (TRF2ABAM) 





Figure 1 -8. Time course of changes in telomere structure with expression of TRF2ABAM in 
HTC75 T4 cell line. Southern blot of telomeric restriction fragments from HTC75 T4 cells 
induced to express TRF2ABAM Genomic DNA was isolated from cells on the indicated days 
after induction, digested with Hinfl and Rsal, and hybridized with a TTAGGG repeat probe after 
fractionation on a native 0.7% agarose gel. The molecular weights of marker DNAs are 
indicated in kb. The arrow points to a new high molecular weight DNA that appears after 
induction of TRF2ABAM but not in control cell line (not shown). The mean length of the new 
species is around 10 kb and mean length of the telomeres before induction is about 5 kb. 
This experiment was performed by Bas van Steensel (van Steensel, Smogorzewska, and 
de Lange, 1998). 
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of TRF2ABAM (Figure 1-8 and van Steensel et al. 1998). The strength of hybridization to 
this new class of telomeric DNA increased with time. However, the median size of this 
new class of telomeric DNA remained stable with time and in all cell lines examined it 
was twice the median size of the original telomeres (van Steensel et al. 1998). Further 
molecular analysis showed that the higher molecular weight telomeric DNA represented 
the fused telomeres, since that DNA was resistant to an exonucleolytic activity of Bal31 
(van Steensel et al. 1998). The Southern blot visualizing the new class of TTAGGG 
repeat fragments (Figure 1-8) was performed on the DNA that has been extensively 
treated with proteinase K, hence, it was concluded that the fusions arose from joining of 
the deprotected chromosome ends at the DNA level and are not formed by a 
proteinaceous connection. 
Two types of joining events involving telomeric DNA might be imagined. One 
would be a covalent joining of the deprotected ends where the DNA would be ligated 
together, and the other would be a non-covalent, but very stable interactions at the 
termini. For example, TTAGGG repeats present in the single-stranded G-overhangs of 
human telomeres readily form G-G base-paired structures in vitro (for review see 
Henderson 1995) and this type of interaction could be responsible for the end-to-end 
fusions. To address whether the telomere fusions induced by TRF2 removal were 
covalent, the fusions were analyzed under denaturing alkaline conditions. 
DNA was isolated from HTC75 T4, T19, and T22 cell lines with or without 
induction of TRF2ABAM (Figure 1-9). Protein free genomic DNA was isolated, digested 
with Hinfl and Rsal, and size-fractionated on native (Figure 1-9, A) or alkaline (Fig. 1-9, 
B and C) agarose gels. Comparison of the pattern of TTAGGG repeat containing 
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Figure 1-9. Visualization of fusions in HTC75 cells expressing TRF2ABAM under native and 
denaturing conditions. Southern blot of telomeric restriction fragments from HTC75 T4, T19, 
and T22 cell lines resolved under native (A) and denaturing (B and C) conditions. Three 
independent cell lines (T4, T19, and T22) were grown under conditions resulting in repression (-) 
or induction (+) of the dominant negative allele of TRF2, TRF2ABAM. Protein-free genomic DNA 
was isolated, digested with Hinfl and Rsal and fractionated on a native 0.7% agarose gel (A), or 
treated with 0.05 N NaOH and fractionated on an alkaline 0.5% agarose gel (B and C). The 
native gel (A) and one half of the denaturing gel (B) were blotted onto a nylon membrane and 
hybridized with the TTAGGG repeat probe. The other half of the denaturing gel (C) was 
hybridized in-situ without blotting onto a membrane. The molecular weights marker were 
prepared by digesting a TTAGGG repeat bearing 2.6 kb pTH5 plasmid with Hindlll and self 
religation of the cut plasmid. Markers are in the first lane in each gel and their size is indicated in 
kb. 
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expected, showed the larger class of TTAGGG repeat containing fragments when TRF2 
was inhibited (Figure 1-9, left). This new class of larger TTAGGG repeat-bearing 
restriction fragments was also detectable when the DNA was fully denatured by 
incubation in NaOH and fractionated on an alkaline gel (compare Figure 1-9 A and B). 
To verify that this treatment denatured telomeric DNA fully, a DNA ladder generated by 
ligating the Hindlll linearized TTAGGG repeat bearing plasmid (pTH5; de Lange et al. 
1990) was used as a marker. This DNA was fractionated on an alkaline gel and 
hybridized in situ to a TTAGGG repeat probe without additional denaturation. As 
expected this control DNA hybridized to the probe showing that it was denatured (Figure 
1-9, C). As a further control, the genomic DNAs were analyzed in parallel by 
fractionation on an alkaline gel followed by either blotting onto a membrane (involving an 
additional denaturation step) (Figure 1-9, B) or in-gel hybridization (not involving 
additional denaturation) (Figure 1-9, C). Since both protocols gave similar pattern and 
intensity of hybridization signals, it is likely that the alkaline gel procedure had fully 
denatured the genomic DNA. 
These experiments demonstrated that the telomeric fusions induced by the 
removal of TRF2 are formed by a covalent linkage of chromosome ends. Given the 
presence of long G-overhangs at the end of all chromosomes (Makarov et al. 1997) such 
ligation is unexpected. To assess the state of G-overhangs in cells expressing TRF2ABAM 
allele, a G-overhang assay (Makarov et al. 1997) was performed. HTC75 T4 cells were 
induced and the DNA was isolated at different days of induction. After digestion with 
Rsal and Hinfl, equal amounts of DNA were hybridized in solution with a radiolabled 
(CCCTAA)4 probe under non denaturing conditions (50°C). The reactions were 
fractionated under native conditions (Figure 1-10) and the resulting signal from the 
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Figure 1-10. T i m e course of disappearance of G-strand overhang signal in cell expressing 
TRF2ABAM. G-strand overhang assay (Makarov et al., 1997) performed on genomic D N A 
isolated from H T C 7 5 T 4 cells. H T C 7 5 T 4 cells were grown under conditions resulting in 
repression or induction of the dominant negative allele of T R F 2 , TRF2ABAM. D N A w a s isolated 
from cells on the indicated days after induction, digested with Hinfl and Rsal, and hybridized 
without denaturing with a radiolabled (CCCTAA)4 visualizing only the single-stranded telomeric 
D N A (Top). Loss of G-strand overhangs w a s quantified after induction of TRF2ABAM in two 
independent experiments performed with the T 4 clone (bottom). The data were derived from two 
experiments similar to those shown and the average value w a s plotted. 
This experiment was performed by Bas van Steensel (van Steensel, Smogorzewska, and 
de Lange, 1998). 
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hybridization of the single-stranded probe to the G-overhang was quantified (Figure 1-
10). With induction of TRF2ABAM, G-overhang signal diminished to reach a minimum level 
of about 50% of the signal in TRF2ABAM non-expressing cells. The specificity of the signal 
was confirmed by treating the DNA with Mung Bean nuclease prior to hybridization with 
the (CCCTAA)4 probe. Mung Bean nuclease removes the overhang without degrading 
the double-stranded telomeric DNA, which resulted in a loss of hybridization signal in the 
G-overhang assay, but not in a Southern blot performed on the Mung Bean nuclease-
treated samples (data not shown, performed by Bas van Steensel). Furthermore, when 
a (TTAGGG)4 probe was used for the hybridization, G-overhangs were not visualized 
(data not shown, performed by Bas van Steensel). 
Loss of the hybridization signal in the G-overhang assay on DNA from TRF2ABAM-
expressing cells could not be fully accounted for by formation of fusions, since only 10-
20% of telomeres appeared to be fused at the time when the overhang signal was 
diminished to 50% (van Steensel et al. 1998). It is impossible to discern from the G-
overhang assay how much of the G-overhang is lost at an individual telomere. For 
instance, all of the telomeres may have lost half of the G-overhang or half of the 
telomeres lost the entire overhang. However, the detection of covalent fusions suggests 
that at least some of the chromosomes lost all of the G-overhangs preceding their 
fusion. 
Under normal growth conditions the G-overhangs are thought to invade the 
double-stranded telomeric repeats, forming t-loops. Disappearance of the G-overhang 
upon induction of TRF2ABAM suggested that t-loop formation may be diminished when 
TRF2 is absent from telomeres. This would parallel the in vitro findings, in which TRF2 
was shown to aid in formation and/or stabilization of t-loops (Griffith et al. 1999; Stansel 
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et al. 2001). To test the hypothesis that removal of TRF2 from telomeres would lead to 
dissolution of t-loops, electron microscopic analysis was performed on DNA from cells 
expressing no exogenous protein, FLTRF2 and TRF2ABAM (Figure 1-11, table 1-3). For 
these experiments IMR90 cells were first infected with SV40 Tag to allow continuous 
division while expressing TRF2ABAM (see Chapter 2). Subsequently, a second infection 
was performed with a control vector (pLPC) or with TRF2 alleles (pLPC TRF2 and pLPC 
TRF2ABAM). Nuclei were prepared from about 2x108 cells per cell type and the DNA was 
cross-linked by exposing the nuclei to 365 nm UV light in the presence of 4'-
aminomethyltrioxsalen (AMT). Further analysis was done by Jack Griffith using a 
modification of a procedure previously used to discover t-loops at the ends of 
chromosomes (Griffith et al. 1999). An example of a t-loop from IMR90 cells infected 
with a vector control is shown in Figure 1-11. Preliminary analysis showed that a 
number of t-loops visible in samples obtained from TRF2ABAM-expressing cells was 
diminished when compared to control or FLTRF2-expressing cells and dropped to 40% 
of the control levels. In this experiment only 65% of cells used for the analysis 
expressed TRF2ABAM as assessed by immunofluorescence staining. This means that the 
TRF2ABAM-expressing sample contained a substantial fraction of cells that no longer 
expressed the dominant negative allele of TRF2, resulting in an underestimate of the 
effect of TRF2ABAM on the t-loop frequency 
The above experiments suggest that removal of TRF2 from telomeres results in 
the loss of at least some of the t-loops, loss of the G-overhang and a covalent fusion of 
deprotected telomeres. To ask whether the non-homologous-end-joining (NHEJ) 
pathways are responsible for formation of end-to-end fusions after inhibition of TRF2, 
mouse embryonic fibroblasts (MEFs) lacking Ligase IV (Lig4) (Frank et al. 2000) were 
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Figure 1-11 A t-loop from IMR90 cells expressing SV40 large T antigen but no exogenous 
TRF2 allele. An electron micrograph of a telomeric DNA fragment isolated from IMR90 cells 
expressing SV40 large T antigen. Nuclei of logarithmically growing cells were prepared and 
their DNA was crosslinked using 4'-aminomethyltrioxsalen (AMT). DNA was digested with Mbol 
and Alul and after fractionation over a Biogel A5M column, fractions containing telomeric DNA 
were spread for EM analysis as described in materials and methods. 
Collection of cells was done with the help of Jan Karlseder. All preparation and analysis 
following crosslinking including the E M analysis was performed by Jack Griffith, 
University of North Carolina, Chapel Hill. 
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Table 1-3. T-loop frequency in IMR90 primary fibroblasts expressing SV40 Large T antigen 
infected with control vector, full length TRF2, and TRF2ABAM On average 2x108 cells per 
experiment were harvested and their D N A was crosslinked using 4'-aminomethyltrioxsalen 
(AMT). D N A was digested with Mbol and Alul and after fractionation over a Biogel A 5 M column, 
fractions containing telomeric D N A were spread for E M analysis (as descried in materials and 
methods). 
E M analysis was performend by Jack Griffith, University of North Carolina, Chapel Hill. 
% cells # t-loops/ Relative t-loop 
Viral vector expressing Molecules t-loops 1000 frequency per 











































n.a- not applicable 
n.d- not determined 
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used to investigate fusion formation after expression of TRF2ABAM. Lig4 has been shown 
to be necessary for the NHEJ in human cells (Grawunder et al. 1998). Mice that are 
devoid of Lig4 or that lack a Lig4 accessory factor (XRCC4) die during embryonic 
development and cells recovered from the embryos are unable to perform NHEJ 
resulting in their sensitivity to irradiation ((Barnes et al. 1998; Frank et al. 1998; Gao et 
al. 1998; Frank et al. 2000), reviewed in Sekiguchi et al. 1999). Because MEFs lacking 
Lig4 grow extremely poorly, Lig4 MEFs that also lacked p53 were used for the analysis 
(Frank et al. 2000). Lack of p53 rescues the organismal lethality of the Lig4 KO as well 
as allows for faster and continuous growth of the population, while not influencing the 
primary NHEJ defect of these MEFs in non-homologous end joining pathway (Ferguson 
et al. 2000; Frank et al. 2000). For the analysis of fusions, Lig4+/+p53-/- and Lig4-/-p53-
/- MEFs obtained from the same litter were infected with the pLPC control or the 
TRF2ABAM-expressing virus. Chromosomal abnormalities in 30 metaphase spreads of 
each type were assessed on coded samples. To aid in distinguishing between end-to-
end fusions that are formed due to TRF2ABAM expression and fusions that form between 
broken chromosomes that are expected to be present in Lig4 null cells, PNA FISH was 
performed to visualize telomeric DNA. Metaphases from Lig4+/+p53-/- cells infected with 
a control vector (Table 1-4) showed presence of some breaks and fragments and low 
level of chromosome fusions without the telomeric DNA, but no chromosome fusions 
with telomeric signal. Expression of TRF2ABAM led to appearance of the expected 
telomere fusions (Figure 1-12). Such fusions were never seen when TRF2ABAM was 
expressed in MEFs that were devoid of Lig4, despite the fact that these cells showed a 
general increase in chromosomal abnormalities. Abnormalities in Lig4-/-p53-/- cells 
included breaks, fragments, and chromosome fusions without telomeric signal (Figure 1-























Figure 1-12. Chromosomal abnormalities observed in mouse embryonic fibroblasts 
expressing TRF2ABAM. Peptide nucleic acid (PNA) fluorescence in-situ hybridization with a 
telomeric probe on chromosomes from mouse cells infected with TRF2ABAM . Metaphase 
spreads of Llg4+/+ p53-/- and Lig4-/- p53 -/- cells expressing TRF2ABAM were prepared on the 
third day of selection. DNA was counterstained with DAPI and chromosomes were false-
colored in red. Llg4+/+ p53-/- MEFs expressing TRF2ABAM showed all abnormalities 
documented in B to L. Lig4-/- p53 -/- expressing TRF2ABAM cells showed no abnormalities of 
the type illustrated in I to L, and short arm chromatid fusion shown in H was seen independent 
of presence or absence of TRF2ABAM (also see Table 1-2). (A) Normal chromosome (B) 
Fragments without telomeric signal (C) Fragment with telomeric signals (D) Chromosome with 
telomeric signal missing from the long arms (E) Break (F) Long arm chromosome fusion 
without telomeric signal (G) Short arm chromosome fusion without telomeric signal (H) Short 
arm chromatid fusion with telomeric signal (I) Two-chromosome ring chromosome with 
telomeric signal at the fusion sites (J) Long arm chromosome fusion with telomeric signal (K) 
Short arm chromosome fusion with telomeric signal (L) Long arm chromatid fusion with 
telomeric signal (arrow) and short arm chromosome fusion with telomeric signal (as in panel K). 
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Table 1-4. C h r o m o s o m a l abnormalities in 3 0 m e t a p h a s e spreads of primary Lig4+/+p53-/- and 
Lig4-/-p53-/- m o u s e embryonic fibroblasts infected with control vector ( p L P C p u r o ) or 
p L P C T R F 2 A B A M Peptide nucleic acid fluorescence in-situ hybridization w a s performed on 
metaphase spreads from cells on the 3rd day of selection. Abnormalities were scored on coded 





























































* Including fragments with and without telomeric signal, as well as c h r o m o s o m e s with missing 
telomeric signal at two chromatids (see examples Figure 1-11, panels B-E) 
t All were short arm chromatid fusions (see example Figure 1-11 2 H ) 
§ Average n u m b e r of c h r o m o s o m e s per cell: 6 4 (Lig4+/+p53-/-, vector), 64(Lig4+/+p53-/-, 
TRF2ABAM), 71 (Lig4-/-p53-/-, vector), and 7 4 (Lig4-/-p53-/-, TRF2ABAM) 
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fusion with a telomeric signal at the site of fusion in Lig4-/-p537- MEFs was of the 
chromatid type (Figure 12-H) and only at the short arm of the mouse chromosome. 
Formation of this type of fusion was also independent of TRF2ABAM expression, because 
examples of such fusions were seen in all cells examined, even when they were infected 
with a vector control (Table 1-4). Taken together, the main conclusion of this experiment 
is that ligase 4 and hence non-homologus end joining, is necessary for the fusion 
formation after inhibition of TRF2. 
As shown above, end-to-end fusions formed after expression of the dominant 
negative TRF2 allele can be visualized as anaphase bridges, representing dicentric 
chromosomes being pulled apart to opposite spindle poles. Resolution of such bridges 
may give rise to broken chromosomes, giving rise to chromosome translocations. To 
ask whether lack of TRF2 presence on telomeres can cause genomic instability, 
multiplex fluorescence in situ hybridization (M-FISH) was employed in collaboration with 
Dr. Anna Jauch at Institute fur Humangenetik in Heidelberg (Speicher et al. 1996; Eils et 
al. 1998). This technique relies on hybridization of metaphase spreads with a set of 
fluorescent probes representing individual chromosomes. Each chromosome is 
recognized by computer-assisted decoding of its unique hybridization color, enabling 
detection of translocated chromosome segments. M-FISH analysis performed on 35 
metaphase spreads of normal human primary fibroblasts revealed two breaks in the 
centromere region of chromosome 10 and 2 [del(10p) and del(2p), see Table 1-5] but no 
translocations. In contrast, cells expressing TRF2ABAM showed a high number of 
chromosome translocations (Table 1-5). Many of them were end-to-end chromosome 
fusions (also known as telomere associations) (Figure 1-13, C, indicated by the 
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Figure 1-13. Chromosomal abnormalities in metaphase spreads of IMR90 fibroblasts 
expressing TRF2ABAM. Multiplex fluorescence in situ hybridization (M-FISH) on metaphase 
spreads of cells expressing TRF2ABAM. Spreads were prepared on day 6 of selection, after 12-
hour colcemid treatment. A. and B. Examples of full metaphase spreads. C. Examples of 
translocation (top row), likely telomere associations (indicated by *), and other chromosomal 
abnormalities 
(Experiments done in collaboration with Heidi Holtgreve-Grez and Anna Jauch (Institute 
fur Humangenetik, Heidelberg, Germany) 
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Table 1-5. Chromosomal abnormalities in metaphase spreads of IMR90 fibroblasts infected with 
control vector (pLPC puro), full length TRF2 (FL TRF2) or the dominant negative allele of TRF2 
(pLPCTRF2ABAM), as assessed by M-FISH. Metaphase spreads were prepared on day 6 of 
selection after a 12 hour colcemid treatment. Chromatid fusions are not scored by this method. 
All alleles were untagged. 
(Experiments done in collaboration with Heidi Holtgreve-Grez, Anna Jauch (Institute fur 
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complete chromosomes were also seen (Figure 1-12, A, B, and C, top row). The 
existence of such translocations suggest that removal of TRF2 can lead to genomic 
instability even in the otherwise normal human fibroblasts. Chromosomal abnormalities 
are generally underdetected by M-FISH, since chromatid fusions are not scored (unless 
they give rise to true translocations) and terminal deletions that should be formed during 
translocations involving telomeric DNA are not well visualized, given that they result in 
loss and not gain of the chromosome DNA. 
Discussion 
This chapter provided evidence that the maintenance of protection at human 
telomeres is highly dependent on TRF2, one of the two TTAGGG binding factors present 
in all mammalian cells tested to date. Removal of TRF2 from telomeres by 
overexpression of the dominant negative (TRF2ABAM) allele leads to telomere 
deprotection which can be deduced from the presence of end-to-end fusions in 
metaphase and in anaphase cells. 
The striking finding that telomeric DNA is present at sites of fusions when TRF2 
is removed, shows that the telomeric DNA itself is insufficient to provide protection to 
chromosome ends and that it must act in concert with TRF2 and possibly other proteins 
to confer protection. A strong requirement for the TTAGGG repeats has been noted 
during the de novo telomere formation in human cells (Hanish et al. 1994). In other 
experiments, addition of non-TTAGGG repeats by a mutant telomerase resulted in 
telomere dysfunction leading to the formation of end-to-end fusions (Guiducci et al. 
2001) and the decline in growth potential of cells harboring mutated telomeric sequence 
(Guiducci et al. 2001; Kim et al. 2001). Based on the results presented in this chapter, it 
is likely that the acquisition of TRF2 by the transfected telomere seed allows for the 
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Figure 1-14. Model of c h r o m o s o m a l events following inhibition of T R F 2 . T w o alternative 
pathways from t-looped state to deprotected and fusogenic state are shown. (Left) Expression 
of TRF2ABAM leads to dissolution of t-loops. G-overhangs become deprotected and degraded. 
(Right) Expression of TRF2ABAM leads to lack of re-establishment of t-loops on chromosome 
ends that were replicated by leading strand synthesis. For example, T R F 2 could be necessary 
for the formation of G-overhangs. Both pathways converge w h e n the telomeres lacking the G-
overhang are repaired by the non homologous end joining (NHEJ) pathway employing ligase 4 
in the covalent ligation of D N A strands. Breakage of a dicentric chromosome formed by the 
end-to-end fusion leads to formation of a translocation and a deletion. 
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development of the fully functional new telomere. Conversely, inability of the non-
TTAGGG repeats synthesized by the mutated telomerase to recruit TRF2, can be now 
proposed to lead to telomere deprotection seen in these cells. 
The mechanism of how TRF2 and telomeric DNA collaborate to ensure the 
protected state has been proposed to involve formation of the t-loop (Griffith et al. 1999). 
In preliminary experiments described here, t-loop formation was significantly reduced in 
cells that express TRF2ABAM, but normal when cells expressed a full length TRF2 
(FLTRF2). In light of this finding, two different scenarios for telomere fusions can be 
envisioned (Figure 1-14). In one scenario, expression of TRF2ABAM could lead to the 
dissolution of t-loops. T-loop opening would then make the G-overhang susceptible to 
degradation (Figure 1-14, left) resulting in the formation of a suitable substrate for 
ligation by the NHEJ pathway. Alternatively, cells expressing TRF2ABAM could be unable 
to re-establish t-loops on chromosome ends after replication. For example, TRF2 could 
be necessary for the formation of G-overhangs after replication by leading strand 
synthesis. Such a role for TRF2 would not be unexpected since it interacts with the 
Mrel 1 complex, which has been proposed to act in the formation of the overhang (de 
Lange and Petrini 2001). As in the first scenario, a telomere remaining devoid of an 
overhang would then be a substrate for the NHEJ. 
The above proposals are not mutually exclusive; however, a recent study by 
Bailey and colleagues (Bailey et al. 2001) substantiates parts of the second proposal. In 
these studies end-to-end fusions in HTC75 cells expressing TRF2ABAM were analyzed 
using chromosome orientation-FISH (CO-FISH), a technique to differentiate between 
chromatids formed by leading and lagging DNA synthesis. The conclusion reached from 
these studies was that all of the chromatid fusions seen in the HTC75 T lines were due 
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to fusion of two chromatids synthesized using leading strand synthesis ("leading to 
leading" chromatid fusions). 
Based on these studies, one might assume that TRF2 is responsible for 
protection of only half of the chromatids- those that are formed by the leading strand 
synthesis. Such interpretation would not be prudent at this point since there are many 
caveats to these experiments. The dominant negative effect of the TRF2ABAM construct 
might never be complete in these experiments. The fact that the dominant negative 
effect is often not complete is stressed by the fact that many of the metaphases of the 
TRF2ABAM-expressing cells did not show any abnormalities, while others showed as many 
as 30 aberrations (van Steensel et al. 1998). There might be also variability of the 
dominant negative effect within each cell so that some telomeric TRF2 might be resistant 
to stripping by the dominant negative allele. In this case only the most vulnerable sites 
might reveal themselves in forms of fusions. Chromatids that were replicated by the 
leading strand synthesis might represent such vulnerable sites. Finally, one example 
(Figure 1-5 top panel, three-chromosome fusion on the right of the picture) possibly 
demonstrates that a leading to lagging chromosome fusion could occur. The caveat here 
is that without the CO-FISH on this very spread one will never know if one of these 
fusions represent a true lagging-to leading chromatid fusion. 
In general, further studies of how t-loops are resolved and re-established during 
the cell cycle, and how and when the G-overhang is formed on the chromatids replicated 
by the leading strand synthesis, will aid in an understanding of the details of telomere 
protection by TRF2. Study of the cells that lack any TRF2 will also be needed to confirm 
and further develop the details presented in this chapter. The dominant negative 
approach of TRF2 inhibition has added to the knowledge about the mechanism of 
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control vector (pLPC puro), full length TRF2 (FL TRF2) or the dominant negative allele of TRF2 
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complete chromosomes were also seen (Figure 1-12, A, B, and C, top row). The 
existence of such translocations suggest that removal of TRF2 can lead to genomic 
instability even in the otherwise normal human fibroblasts. Chromosomal abnormalities 
are generally underdetected by M-FISH, since chromatid fusions are not scored (unless 
they give rise to true translocations) and terminal deletions that should be formed during 
translocations involving telomeric DNA are not well visualized, given that they result in 
loss and not gain of the chromosome DNA. 
Discussion 
This chapter provided evidence that the maintenance of protection at human 
telomeres is highly dependent on TRF2, one of the two TTAGGG binding factors present 
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during the de novo telomere formation in human cells (Hanish et al. 1994). In other 
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Figure 1-14. Model of chromosomal events following inhibition of TRF2. Two alternative 
pathways from t-looped state to deprotected and fusogenic state are shown. (Left) Expression 
of TRF2ABAM leads to dissolution of t-loops. G-overhangs become deprotected and degraded. 
(Right) Expression of TRF2ABAM leads to lack of re-establishment of t-loops on chromosome 
ends that were replicated by leading strand synthesis. For example, T R F 2 could be necessary 
for the formation of G-overhangs. Both pathways converge when the telomeres lacking the G-
overhang are repaired by the non homologous end joining (NHEJ) pathway employing ligase 4 
in the covalent ligation of D N A strands. Breakage of a dicentric chromosome formed by the 
end-to-end fusion leads to formation of a translocation and a deletion. 
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development of the fully functional new telomere. Conversely, inability of the non-
TTAGGG repeats synthesized by the mutated telomerase to recruit TRF2, can be now 
proposed to lead to telomere deprotection seen in these cells. 
The mechanism of how TRF2 and telomeric DNA collaborate to ensure the 
protected state has been proposed to involve formation of the t-loop (Griffith et al. 1999). 
In preliminary experiments described here, t-loop formation was significantly reduced in 
cells that express TRF2ABAM, but normal when cells expressed a full length TRF2 
(FLTRF2). In light of this finding, two different scenarios for telomere fusions can be 
envisioned (Figure 1-14). In one scenario, expression of TRF2ABAM could lead to the 
dissolution of t-loops. T-loop opening would then make the G-overhang susceptible to 
degradation (Figure 1-14, left) resulting in the formation of a suitable substrate for 
ligation by the NHEJ pathway. Alternatively, cells expressing TRF2ABAM could be unable 
to re-establish t-loops on chromosome ends after replication. For example, TRF2 could 
be necessary for the formation of G-overhangs after replication by leading strand 
synthesis. Such a role for TRF2 would not be unexpected since it interacts with the 
Mrel 1 complex, which has been proposed to act in the formation of the overhang (de 
Lange and Petrini 2001). As in the first scenario, a telomere remaining devoid of an 
overhang would then be a substrate for the NHEJ. 
The above proposals are not mutually exclusive; however, a recent study by 
Bailey and colleagues (Bailey et al. 2001) substantiates parts of the second proposal. In 
these studies end-to-end fusions in HTC75 cells expressing TRF2ABAM were analyzed 
using chromosome orientation-FISH (CO-FISH), a technique to differentiate between 
chromatids formed by leading and lagging DNA synthesis. The conclusion reached from 
these studies was that all of the chromatid fusions seen in the HTC75 T lines were due 
78 
to fusion of two chromatids synthesized using leading strand synthesis ("leading to 
leading" chromatid fusions). 
Based on these studies, one might assume that TRF2 is responsible for 
protection of only half of the chromatids- those that are formed by the leading strand 
synthesis. Such interpretation would not be prudent at this point since there are many 
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to stripping by the dominant negative allele. In this case only the most vulnerable sites 
might reveal themselves in forms of fusions. Chromatids that were replicated by the 
leading strand synthesis might represent such vulnerable sites. Finally, one example 
(Figure 1-5 top panel, three-chromosome fusion on the right of the picture) possibly 
demonstrates that a leading to lagging chromosome fusion could occur. The caveat here 
is that without the CO-FISH on this very spread one will never know if one of these 
fusions represent a true lagging-to leading chromatid fusion. 
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the cell cycle, and how and when the G-overhang is formed on the chromatids replicated 
by the leading strand synthesis, will aid in an understanding of the details of telomere 
protection by TRF2. Study of the cells that lack any TRF2 will also be needed to confirm 
and further develop the details presented in this chapter. The dominant negative 
approach of TRF2 inhibition has added to the knowledge about the mechanism of 
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telomere protection; however, this approach depended on the overexpression of 
TRF2ABAM. It is formally possible that the phenotype is caused by the dominant negative 
allele not only removing TRF2 from telomeres but also non-specifically titrating other 
proteins. To control for effect of overexpression, a FLTRF2 was overexpressed and the 
overexpressing cells were noted not to have phenotypes associated with deprotection; 
however, FLTRF2 when overexpressed might suppress some of the phenotypes by 
increased telomeric localization. Two approaches might be useful in addressing this 
problem. First of all, using the information from the crystal structure of the TRFH 
domain, a dominant negative allele containing a much smaller portion of the molecule 
might be created, decreasing its ability to titrate other proteins. Secondly, a mouse KO 
of TRF2 will be very informative. Based on the phenotypes observed after expression of 
the dominant negative allele of TRF2, it is likely that the mouse deficient in TRF2 would 
not be able to develop, thus the KO needs to be of the conditional type. 
Another point that needs to be addressed is the discrepancy in fusion types 
visualized in studies in HTC75 T cell lines (Bailey et al. 2001) and studies presented in 
this chapter. Chromosome fusions (those in which two sister chromatids of one 
chromosome are joined with two sister chromatids of a second chromosomes, (see 
Figure 1-15) were often observed and are shown in Figures 1-5, 1-12, and 1-13. Even in 
the HTC75 T lines, such fusions were clearly visualized (van Steensel et al. 1998). 
However, Bailey et al. (Bailey et al. 2001) have noted that they only observed chromatid 
fusions (Figure 1-15), but never chromosome fusions. Chromosome fusions can form in 
two ways; both arms can fuse in S or G2 stage of the cell cycle, or a single chromatid 
fusion, which was not broken during metaphase to anaphase transition can be 
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Figure 1-15. Types of fusions following inhibition of TRF2 A. Chromatid fusion, B. 
Chromosome fusion, C. Schematic of events leading to formation of a chromosome fusion 
through a replication of a chromatid fusion, which was not severed during the metaphase to 
anaphase transition (M-A). 
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duplicated in a subsequent S phase (Figure 1-15). Chromosome fusions formed through 
the second process should have been visualized in the studies of Bailey et al. The 
reason why they were not observed probably stems from the fact that the experiments in 
that study were done soon after expression of the TRF2ABAM (day 5). Also, the procedure 
used in that study, included contact inhibition of the cells during the first days of 
expression and release from this inhibition followed by collection of cells after 24 hours 
of growth (personal communication). Therefore, only fusion events in the first cell cycle 
after inhibition of TRF2 were being studied. Inhibition of TRF2 leads to covalent joining 
of telomeric DNA, since, as shown, the fused DNA is resistant to alkaline conditions. 
The lack of telomeric fusions in TRF2ABAM-expressing MEFs lacking NHEJ activity 
revealed a requirement for this pathway in the end-to-end fusion formation. Ligase IV, in 
particular, was required for formation of fusions after inhibition of TRF2. The 
requirement for DNA-PK was not assessed since the results would be confounded by 
the fact that all three components of DNA-PK themselves play some, although small, 
role in telomere protection (Bailey et al. 1999; Samper et al. 2000; Goytisolo et al. 2001). 
Participation of the NHEJ pathway in the repair of deprotected chromosomes validates a 
long-standing presumption that unprotected telomeres can behave like double stranded 
breaks. Such a conclusion has also been reached in S. pombe (Godhino Ferreira and 
Promisel Cooper 2001). Nitrogen starvation of cells lacking Tazl, or a combination of 
tazl- and rad22- leads to telomere deprotection in this yeast. Telomeres can be shown 
to fuse to each other and fusion is dependent on the NHEJ since it does not occur when 
Ku70 or Lig4 are mutated (Godhino Ferreira and Promisel Cooper 2001). 
This repair of telomeres through NHEJ pathway is not a desired event. M-FISH 
analysis of metaphase spreads from cells expressing TRF2ABAM, not only confirmed 
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presence of chromosome end-to-end fusions, but also showed that abnormalities 
resulting from such fusions may persist as translocations. Translocations, as 
demonstrated in these experiments can even occur in a setting of wild type primary 
human fibroblasts, which generally are very sensitive to damage (Di Leonardo et al. 
1994), Chapter 2. This experiment shows that telomere deprotection can induce 
genomic instability in human cells. 
The findings presented in this chapter might also shed light on what defines a 
critically short telomere, a telomere that is too short to function. Critically short 
telomeres are usually described in the setting of somatic cells at the end of their 
replicative life-span, or tumor cells that have not (yet) reactivated telomerase. Cells that 
have critically short telomeres harbor dicentric chromosomes (reviewed in de Lange 
1995). Hence, some of the telomeres in the population had reached a length that could 
no longer support proper protection. Since the protected state is proposed to be a t-
looped state and TRF2 is thought to aid in formation and/or stabilization of t-loops, the 
critical length would be the length of the DNA that can no longer recruit sufficient TRF2 
to form a proper t-loop. Several experiments could be performed to check the validity of 
this hypothesis. First of all, senescent human primary fibroblasts should have a 
decreased frequency of t-loops. Similarly, tumors with critically short telomeres and 
frequent telomere fusions may also be expected to have fewer t-loops, but tumors that 
have reactivated telomerase and show no sign of deprotection should have normal 
levels of t-loops, even if such tumors still harbor very short telomeres. Finally, adding 
TRF2 to cells with critically short telomeres might aid in their protection by facilitating t-
loops formation even on very short telomeres. 
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Other proteins, besides TRF2 might also participate in telomere protection in 
human cells. One candidate is Potl, a single-strand TTAGGG DNA binding protein 
recently identified in the human database (Baumann and Cech 2001). Lack of Potl in S. 
pombe leads to rapid degradation of both strands of telomeric DNA. It will be very 
interesting to compare results after removal of human Potl from telomeres with the 
outcome of removal of telomeric TRF2 described in this chapter. 
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C h a p t e r 2 
TRF2AB*M induces s e n e s c e n c e t h r o u g h t h e p 5 3 
a n a t h e R b p a t h w a y s 
Introduction 
The first description of the limited replicative capacity of human fibroblasts has 
been reported 40 years ago by Hayflick and Moorhead (Hayflick and Moorhead 1961), 
and the point at which human fibroblasts cease to divide when cultured in vitro is 
referred to as the Hayflick limit or senescence (from Latin senescere- to grow old). The 
limited life-span of human fibroblasts is a consequence of the accumulated number of 
cell divisions and not the calendar time spent in culture (Dell'Orco et al. 1973; Goldstein 
and Singal 1974), suggesting that the counting of cell divisions by a mitotic clock is 
responsible for the scheduling of senescence entry. 
It has been proposed that in vivo, senescent cells might be contributing to a 
number of age-related diseases (Stanulis-Praeger 1987; Dimri et al. 1995) however, the 
best evolutionary reason for the existence of a limit to the number of divisions of human 
cells is its tumor suppressive potential (reviewed in de Lange 1998). Most of the known 
tumor cells are immortal, suggesting that senescence represents one of the obstacles 
that need to be overcome during tumorigenesis. 
The indication that telomeres might determine the timing of entry into 
senescence came from the findings that telomeres shorten in most human somatic cells 
(Harley et al. 1990; Hastie et al. 1990). It has been proposed that lack of telomere 
maintenance stems from the deficiency in telomerase activity in cells (Cooke and Smith 
1986). Indeed, telomerase activity is repressed in most normal human tissues (Kim et al. 
1994). Activity can be found only in ovaries and testis (Wright et al. 1996), where it 
assures immortality of the germline, and highly proliferative tissues including 
hematopoietic cells (Broccoli et al. 1995; Counter et al. 1995). 
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However, the formal proof that telomere shortening leads to senescence was 
provided by experiments in which the catalytic subunit of telomerase was expressed in 
telomerase-negative primary human cells (Bodnar et al. 1998; Vaziri and Benchimol 
1998). Telomerase-expressing cells exhibited elongated telomeres and divided well 
beyond the scheduled senescence timepoint. Importantly, although not surprisingly, 
ectopic expression of telomerase did not change the karyotype, the growth 
requirements, or the cell cycle checkpoint responses of the cells (Morales et al. 1999). 
The above experiments have established the causal relationship between 
telomere shortening and senescence. However, it is not understood, what exactly is the 
trigger for senescence. Lack of telomere maintenance leads to attrition of telomeres, 
until they reach a certain length setting, commonly referred to as the "critical telomere 
length". At that stage, telomeres lose their ability to protect the chromosome ends and 
become fusogenic, resulting in the formation of dicentric chromosomes as observed in 
senescent cells (Thompson and Holliday 1975; Benn 1976). It is unclear what is the 
length of the "critically short" telomeres. It is difficult to imagine how loss of just a few 
kbp from a telomere of 10 kbp could lead to such a critical difference in telomere 
function. The high median telomere length in senescent cells might suggest that it is not 
the telomere length alone that determines the senescence entry. Alternatively, it is 
possible that some of the telomeres in each senescent cell are much shorter than the 
median size, and that those telomeres are responsible for the signaling into senescence. 
The main effectors of the senescence entry seem to be the p53 and Rb 
pathways (reviewed in (Shay et al. 1991) and (Sedivy 1998)). Expression of SV40 Tag, 
which neutralizes the activity of p53 and Rb (reviewed in Pipas and Levine 2001) or 
simultaneous expression of HPV16 E6 and E7 (Shay et al. 1991) suppresses 
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senescence and allows for additional divisions (see Figure 2-1 for a schematic). 
However, the cells do not become automatically immortal since they have not stabilized 
their telomeres. After about 20 to 30 divisions (Ide et al. 1984; Neufeld et al. 1987; Shay 
and Wright 1989) they enter a state of crisis, in which there is no net gain in cell growth 
resulting from equal rates of cell division and cell death. 
Viral oncogenes, although useful in the initial dissection of the requirements for 
the induction of senescence are not perfect for such studies since they have pleiotropic 
effects. Mouse cells are also not ideal to study senescence since their replicative life-
span in culture is not determined by telomere length (reviewed in Sherr and DePinho 
2000). A knockout approach in human cells has been used to assess the role of p21, an 
inhibitor of cyclin-dependent kinases (Brown et al. 1997), resulting in the proposal that 
p21 is one of the main effectors of the senescence program. However, it is not excluded 
that other genes were also altered during the long culture period required for this 
experiment. A more defined system is needed to study the pathways that lead to 
senescence induction in human primary fibroblasts. 
Inhibition of TRF2, one of the two proteins able to directly bind to human 
telomeres, leads to dissolution of t-loops, loss of the G-overhangs and eventually repair 
of the deprotected ends resulting in formation of end-to-end fusions (See Chapter 1). In 
many cells, inhibition of TRF2 leads to induction of apoptosis (Karlseder et al. 1999). 
Cells can undergo apoptosis even before they enter the first S phase after TRF2ABAM is 
expressed. This points out that the signal resulting in cell apoptosis appears to come 
from the deprotected telomeres and not from the secondary damage that ensues after 
the inhibition (e.g. dicentrics ruptured in mitosis). Apoptosis is mediated by 
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Figure 2-1. Schematic of experimental strategies to inhibit p53 and Rb pathways. p53 
and Rb can be simultaneously inactivated using SV40 Tag antigen (reviewed in [Pipas and 
Levine,2001]) or they can be individually inactivated by HPV16 E6 and E7 proteins (reviewed in 
[zur Hausen, 2000]). p53 can also be inhibited by overexpression of a dominant negative allele 
of p53 (Serrano et al., 1997). 
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the A T M kinase and p53 since cells that are deficient in either of these proteins fail to 
undergo programmed cell death. 
Human primary fibroblasts are another exception to the apoptotic response. To 
further study the cellular outcomes of inhibition of TRF2 in primary human fibroblasts 
that naturally undergo a telomere-directed senescence, retroviral infection was used to 
deliver TRF2ABAM, the dominant negative allele of TRF2. Removal of TRF2 from 
telomeres in primary human fibroblasts resulted in rapid induction of a permanent growth 
arrest with characteristics of senescence. Strikingly, simultaneous elimination of the p53 
and Rb pathways by expression of SV40 Tag bypassed the arrest. These findings 
suggest that critically short telomeres existing in pre-senescent human primary cells are 
unable to recruit sufficient TRF2 to achieve proper protection, which results in signaling 
into arrest through the DNA damage checkpoint pathways. 
R e s u l t s 
As shown in the previous chapter, removal of TRF2 from telomeres by 
overexpression of a dominant negative TRF2 allele (TRF2ABAM) leads to telomere 
deprotection. To study the influence of inhibition of TRF2 on the growth of human 
primary fibroblasts, IMR90 cells were infected with a TRF2ABAM retrovirus, a control virus 
carrying no exogenous protein, or a FLTRF2 virus. All experiments followed the timeline 
presented in Figure 1-2 (Chapter 1) and all the TRF2 alleles were untagged. In growth 
studies, in which the cells were plated at the same density on day 4 of selection and 
counted on day 5 and every-other day until day 15 of selection, TRF2ABAM-expressing 
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Figure 2-2. Effects of expression of T R F 2 and TRF2ABAM on growth of h u m a n primary 
fibroblasts. A. Representative growth curve of cells expressing no exogenous protein (vector), 
FLTRF2 (FLTRF2) or TRF2ABAM (TRF2ABAM). At later time points, T R F 2 expressing cells grow 
as fast as vector control cells. O n the 4th day of selection, cells were plated in duplicate at 
3x104 cells per well in a six-well plate. O n the indicated days cells from 2 wells were washed, 
trypsinized and counted in duplicate using a Coulter counter. B. % of cells in S-phase as 
measured by 1 hour bromo-deoxyuridine (BrdU) incorporation on day 5, 10 and 15. All 
numbers are normalized to the level of BrdU incorporation in vector control cells using the 
formula: (fraction of BrdU-positive cells in TRF2ABAM-expressing cells/ fraction of BrdU-positive 
cells in vector control cells) x100%. For example if 3 0 % of cells infected with vector control 
were positive for BrdU and 1 5 % of TRF2ABAM-expressing cells were positive, the plotted number 
would be 5 0 % . Average values and S D s derived from 5 experiments for vector and TRF2ABAM, 
and 4 experiments for T R F 2 are shown. 
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Within 10 days of the growth assays, the control cells gained 4.4 population doublings 
(PDs), FLTRF2-expressing cells gained 3.9 PDs, but TRF2ABAM-expressing cells gained 
only 1.5 PDs. When the growth curve was continued for an extended time, the FLTRF2-
expressing cells reached the growth rates of the control cells. However, TRF2ABAM-
expressing cells continued to be very sparse. Growth assays were also performed in 
HS68 and WI38 cells with similar results. Between day 5 and 11 of selection control HS 
68 cells gained 3.4 PDs, FLTRF2-expressing HS68 cells, 3.7 PDs and TRF2ABAM-
expressing HS68 cells only 1.9 PDs. During the same period, control WI38 cells gained 
1.8 PDs, FLTRF2-expressing WI38 cells, 2.1 PDs and TRF2ABAM-expressing WI38 cells 
only 0.7 PDs. 
Lack of gain in number of population doublings can be due to rapid division 
followed by death of the produced cells, or alternatively can be due to the cessation of 
cellular division. To differentiate between these two possibilities, a BrdU incorporation 
assay was performed to assess the number of actively cycling cells. Cells on day 4, 9, 
and 14 of selection were plated in equal numbers and incorporation of BrdU into the 
newly synthesized DNA was assessed during a 1-hour interval on the following day. A 
rapid decline in percentage of cells in S phase in the TRF2ABAM population was 
documented when compared to control or FLTRF2-expressing cells (Figure 2-2, B). In 5 
experiments, the % of S phase cells among TRF2ABAM-expressing cells on day 15 
averaged only 17% (+/- 7%) of the control cells found in S phase. The declining 
numbers of cells in S phase specifically among TRF2ABAM-expressing cells led to the 
conclusion that TRF2 inhibition causes cell cycle arrest. Similar results were obtained in 
other primary cell lines including WI38, and BJ hTERT fibroblasts (Table 2-1). 
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Table 2-1. Effects of expression of T R F 2 and TRF2ABAM on growth of human primary fibroblasts. 
Relative % of cells in S-phase as measured by 1 hour bromo-deoxyuridine (BrdU) incorporation 
on day 5, 10 and 15. All numbers are normalized to the level of BrdU incorporation in vector 
control cells as explained in Figure 2-2. 
Relative % of cells in S-phase 
Celli line 
Wi38 






























*BrdU in BJ hTERT cells was assessed on day 4 
§ BrdU in BJ hTERT cells was assessed on day 9 
n.d- not determined 
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The morphology of TRF2ABAM-expressing cells was also suggestive of a growth 
arrest. With time, cells became enlarged and flat, and often harbored multilobed nuclei 
(Figure 2-3). These cells were strikingly similar to primary IMR90 fibroblasts at the end 
of their natural replicative life-span. Positive staining for p-galactosidase at pH6 (so 
called senescence associated p-galactosidase activity SA-p-gal) has been described to 
be one of the markers of senescent cells (Dimri et al. 1995). The SA-p-gal staining 
intensity of TRF2ABAM-expressing cells was high, although not as intense as in senescent 
cells stained under the same conditions (Figure 2-3,). In contrast, FLTRF2-expressing 
cells or control cells did not exhibit staining for SA-p-gal. However, all cells were positive 
when control staining was performed at pH 4, which revealed the lysosomal activity of P-
galactosidase. 
To define the cell cycle phase of the arrest, a Fluorescence Activated Cell 
Sorting (FACS) analysis was performed on day 15 of the selection and revealed that 
cells were accumulating in broad 2n and 4n peaks when stained with propidium iodide 
(Figure 2-4). This pattern of growth arrest has also been seen in senescent cells. 
Because of the striking similarities between the phenotype of senescent cells and 
cells expressing TRF2ABAM, their protein expression profiles were compared. This 
analysis has also included IMR90 cells treated with y-rays. It has been reported that 
primary human cells irradiated with y rays, a treatment leading to formation of double 
stranded breaks (DSB), undergo a permanent growth arrest that resembles senescence 
(Di Leonardo et al. 1994). To directly compare results of irradiation and expression of 
TRF2ABAM, the irradiated cells were maintained for 15 days after treatment. The three 
conditions, expression of TRF2ABAM, senescence and irradiation, resulted in a very similar 
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vector F L T R F 2 
Figure 2-3. Cell morphology and SA-p-activity in control, TRF2, TRF2ABAM infected IMR90 
cells and IMR90 cells undergoing replicative senescence. Cells infected with TRF2 alleles 
were plated at low density and stained for p-galactosidase activity on day 16 of selection. Note 
the differences in cell size and staining. At pH 4, which assesses the lysosomal activity, and 
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Figure 2-4. Effects of expression of TRF2 and TRF2ABAM on cell cycle profile in human 
primary fibroblasts- comparison with senescent and irradiated cells. FACS analysis of 
control, TRF2, TRF2ABAM, senescent fibroblasts, and fibroblasts treated with 10 Gy IR. A. 
Control, TRF2, TRF2ABAM cells were analyzed on day 15 of selection, senescent cells were 
analysed when the cells completely ceased dividing B. The irradiated cells were maintained for 
1,5, or 15 days with feeding before analysis. 50000 events were collected per sample and the 
data are presented without gating. C. Same cells as in A. and B. except 10000 events above 
"4n" were collected. Note different scales that were used to normalize for different cell numbers 
in M1 and M 2 regions. An approximate % of 2n cells is given. 
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pattern of protein expression, including increased levels of p53 and its transcriptional 
target p21, accumulation of p16 and a switch from the hyper- to hypo-phosphorylated 
state of Rb (Figure 2-5). The Rb protein was almost not detectable in the senescent 
cells and after irradiation, and it was greatly reduced in TRF2ABAM-expressing cells. 
Consistent with consequence of the cell cycle arrest, cyclin A (Figure 2-5) and cyclin B 
(Figure 4-8) levels were very low. 
In order to test the role of the p53 and Rb pathways in the induction of 
senescence by TRF2ABAM, viral oncoproteins were used (see Figure 2-1). Young 
fibroblasts were first infected with SV40 Tag or with pBabeNeo control virus and 
subsequently with control, TRF2, or TRF2ABAM carrying viruses. Comparison of BrdU 
labeling in these cells showed that the cell cycle arrest induced by TRF2ABAM was 
eliminated in IMR90 cells expressing SV40 Tag (IMR90-SV40Tag) (Figure 2-6, B). On 
day 15 of selection, the fraction of cells in S phase in TRF2ABAM-expressing cells was 
close to that in control cells (88% [+/- 9]). However, the growth curves of these cells 
revealed that the population of TRF2ABAM-expressing SV40 Tag cells did not grow as fast 
as the control populations also expressing the SV40 T antigen (Figure 2-6, C). At day 
10 of the growth assay, the control cells gained 4.9 PDs, FLTRF2-expressing cells 
gained 5.1 PDs, and TRF2ABAM-expressing cells gained 3.7 PDs. Since cells lacking the 
SV40 Tag but expressing TRF2ABAM only gained 1.5 PDs, SV40 Tag clearly has a strong 
suppressive effect on TRF2ABAM-induced arrest. 
The morphology of the TRF2ABAM-expressing IMR90-SV40T cells was non-
senescent (Figure 2-7), they did not stain for SA-p-galactosidase, and the only difference 
between these and control Tag cells was the presence of many refractile cells detached 
from the plate (Figure 2-7). Such cells are presumed to be unable to divide, explaining 
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Figure 2-5. Effects of expression of TRF2 and TRF2ABAM on protein profiles in human 
primary fibroblasts- comparison with senescent and irradiated cells. Western blot 
analysis of cell cycle regulatory proteins in control, TRF2, TRF2ABAM, senescent fibroblasts, and 
cells treated with 10 Gy IR from a 137Cs source. Control, TRF2, TRF2ABAM cells were collected 
on day 15 of selection, senescent cells were collected when the cells completely ceased 
dividing and the irradiated cells were left in tissue culture for 15 days with feeding before 
preparation of a lysate. Lysates from the five cell types represented the same number of cells. 
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Figure 2-6. Effects of expression of TRF2 and TRF2ABAM on growth of human primary 
fibroblasts that also express S V 4 0 Tag. A. Western blot showing expression of S V 4 0 Tag 
and of T R F 2 alleles in young I M R 9 0 cells infected with p B a b e S V 4 0 Tag or a p B a b e N e o 
control. Endogenous T R F 2 is not detectable under these conditions. T h e I M R 9 0 S V 4 0 Tag 
cells were used for experiments s h o w n in panels B and C. B. Relative % of cells in S-phase as 
measured by 1 hour BrdU incorporation on day 5, 10 and 15. All numbers are normalized to the 
level of BrdU incorporation in vector control cells as explained in Figure 2-2. M e a n values and 
and S D s derived from 3 experiments are shown. C. Representative growth curve of cells 
expressing no exogenous protein (vector), F L T R F 2 (FLTRF2) or TRF2ABAM (TRF2ABAM). O n the 
4th day of selection, cells were plated in duplicate at 3x104 cells per well in a six-well plate. O n 
the indicated days cells from 2 wells were washed, trypsinized and counted in duplicate using a 
Coulter counter. 
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Figure 2-7. Comparison of cellular morphology of cells with or without SV40 large T 
antigen, expressing no exogenous protein or TRF2ABAM Micrographs showing cell 
morphology on day 13 of selection. Young IMR90 were first infected with SV40 Tag or a Neo 
marker alone and were confirmed to express the large T antigen by immunofluorescence and 
western blotting (see Figure 2-5). Subsequently these cells were infected with a vector control 
or a TRF2ABAM carrying virus. On the 4th day of selection, cells were plated at 3x104 cells per 
well in a six-well plate for the growth curve shown in Figure 2-5. Photographs were taken on 
day 13 of selection. Note that in SV40 Tag cells expressing TRF2ABAM, the cell density is 
similar to SV40 T antigen cells infected with a vector control but the latter culture has many 
floating cells that are round and refractile . 
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the discrepancy between the hindered population growth and the normal levels of the 
BrdU labeling in TRF2ABAM-expressing cells. 
To further analyze the requirements for p53 and Rb in the induction of 
senescence by TRF2ABAM, these pathways were separately inhibited by expression of 
HPV16E6 or HPV16E7 respectively. The expression of E7 was verified by 
immunoblotting (Figure 2-8, A). Since the available antibodies against E6 do not seem 
to recognize the protein in western blots, loss of p53 protein acted as a surrogate marker 
for the presence of E6 (Figure 2-8, A). As expected from the results of the Tag 
experiments, simultaneous expression of E6 and E7 abrogated the arrest caused by the 
TRF2 inhibition in primary human cells (Figure 2-8, B), but separate repression of the 
p53 and the Rb pathways led only to a limited suppression of the growth arrest. 
Additionally, expression of p53175H, a dominant negative allele of p53 (Serrano et al. 
1997) could not overcome the arrest (Figure 2-8, B), even though it was expressed at 
very high levels. These experiments suggested that signaling through either one of the 
pathways is sufficient to induce and maintain the arrest after TRF2 inhibition. 
Signaling from the unprotected telomere to growth arrest might be expected to 
involve the PI-3 kinases that have been implicated in DNA damage signaling. Based on 
the previous experiments, in which the induction of apoptosis by telomere deprotection 
depended on the ATM gene product (Karlseder et al. 1999), it was pertinent to test 
whether the arrest induced by TRF2ABAM expression also required the ATM kinase. Three 
different primary fibroblast lines from patients affected with Ataxia Telangiectasia and 
one control line from a heterozygous parent of one of the affected patients were 
analyzed for the ability to undergo growth arrest after inhibition of TRF2. The ATM 
status of the cell lines was confirmed by immunoblot analysis with an antibody directed 
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Figure 2-8. Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that co-express H P V 1 6 E6, H P V 1 6 E7, HPV 1 6 E6 and E7, p53175H, or pBabe Neo. A. 
Western blot confirming presence or absence of HP V 1 6 E7 or p53 in cells that were infected 
with viruses carrying H P V 1 6 E6, H P V 1 6 E7, both H P V 1 6 E6 and H P V 1 6 E7, or p53DN 
(p53175H). Lack of p53 acts as a surrogate marker of expression of H P V 1 6 E6. B. Relative % 
of cells in S-phase as measured by 1 hour BrdU incorporation on day 5, 10 and 15 of selection 
after infection with TRF2ABAM. All numbers are normalized to the level of BrdU incorporation in 
vector cells as explained in Figure 2-2. 
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against the ATM kinase (Figure 2-9, A). The AT status did not influence the percentage 
of cells that were in S phase (Figure 2-9, B) nor the morphology of the cells after 
expression of TRF2ABAM, suggesting that the ATM kinase is dispensable for the induction 
of the arrest but not excluding the possibility that ATM, when present, can be involved in 
signaling from unprotected telomeres in primary fibroblasts. 
One possibility is that ATM signals to p53 and that in its absence inhibition of 
TRF2 induces senescence via the Rb pathway. The prediction would be that p53 is not 
upregulated in AT cells expressing TRF2ABAM. However, western blot analysis showed 
increased levels of p53 in TRF2ABAM-expressing AT cells (Figure 2-9, C). This indicates 
that ATM is not solely responsible for p53 activation in this setting. Furthermore, 
suppression of Rb in AT cells by expression of HPV16E7 (Figure 2-10, A) led to only 
minimal suppression of the growth arrest caused by TRF2ABAM expression (Figure 2-10, 
B). However, parallel experiments in which HPV16E7 was expressed in cells that 
already expressed p53175H (dominant negative allele of p53 (Serrano et al. 1997)) also 
led to a minimal suppression of the growth arrest caused by TRF2ABAM expression. This 
might indicate that inhibition of the endogenous p53 with p53175H and HPV16E6 proteins 
are not equivalent, and makes the lack of full suppression of growth arrest caused by 
TRF2abam expressjon jn AT cells expressing HPV16E7 hard to interpret. 
Telomere directed senescence does not seem to occur in mouse cells (reviewed 
in Sherr and DePinho 2000); however, telomere dysfunction can have deleterious effects 
as shown by studies using the mTERC KO mice (Lee et al. 1998; Rudolph et al. 1999; 
Hemann et al. 2001) or inhibition of TRF2 in MEFs (Karlseder et al. 1999). In both 
settings, cells undergo apoptosis, appearance of which can be temporarily inhibited 
(Chin etal. 1999; Hemann etal. 2001), or completely suppressed (Karlseder et al. 1999) 
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Figure 2-9. Effects of expression of TRF2ABAM o n growth of h u m a n primary fibroblasts 
that express or lack e n d o g e n o u s A T M protein. A. Western blot confirming presence or 
absence of A T M in primary fibroblasts obtained from individuals affected with Ataxia 
Telengiectasia (AG04405, AG02496, AG03058A), fibroblasts from heterozygous mother of the 
individual w h o donated the A G O 3 0 5 8 A cells (AG03057) or wt primary fibroblasts (IMR90). B. 
Relative % of cells in S-phase as measured by 5 hour BrdU incorporation on day 5, 10 and 15 
of selection after infection with TRF2ABAM- All numbers are normalized to the level of BrdU 
incorporation in vector cells as explained in Figure 2-2. C. Western blots in the A G 0 2 4 9 6 cells 
after expression of T R F 2 alleles on day 15 of selection. Note that the loading is in different 
order than in previous westerns. Also, the loading is not equal (best visualized on cyclin D 
western). Lysates m a d e from ~5700 FL TRF2-expressing cells, ~17500 control cells, ~ 10000 
TRF2ABAM-expressing cells, and ~10000 TRF2AB-expressing cells were loaded. 
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Figure 2-10 Effects of expression of TRF2ABAM on growth of human primary fibroblasts 
that lack ATM and express HPV E7 or Neo control A. Western blot confirming presence or 
absence of HPV16 E7 in two AT cell lines (AG02496 and AG04405). Loading control is a cross-
reacting band observed with the antibody against E7 antibody. B. Relative % of cells in S-
phase as measured by 5 hour BrdU incorporation on day 5, 10 and 15 of selection after 
infection with TRF2ABAM. All numbers are normalized to the level of BrdU incorporation in vector 
cells as explained in Figure 2-2. 
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Figure 2-11. Effects of expression of TRF2ABAM on growth of wt primary MEFs and MEFs 
deficient in p53 protein. Relative % of cells in S-phase as measured by 1 hour BrdU 
incorporation on day 5, 10 and 15 of selection after infection with TRF2ABAM. All numbers are 
normalized to the level of BrdU incorporation in vector cells as explained in Figure 2-2. 
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by the lack of p53 protein. To determine if primary MEFs, like human cells, undergo 
growth arrest after inhibition of TRF2, they were infected with a control virus or TRF2ABAM 
virus. Indeed, the primary MEFs arrested very efficiently after inhibition of TRF2 (Figure 
2-11). The arrest was dependent on p53 protein because MEFs deficient in p53 did not 
undergo arrest (Figure 2-11) despite having clear markers of telomere dysfunction (see 
Figure 1-12). These data suggest that lack of TRF2 on telomeres is sensed by the DNA 
damage checkpoint, and that lack of p53 alone suppresses the TRF2ABAM-induced arrest 
in mouse cells. 
D i s c u s s i o n 
The data presented in this chapter show that the presence of TRF2 on telomeres 
is required for continuous growth of human primary fibroblasts. This finding parallels the 
conclusion that inhibition of TRF2 is incompatible with cell survival and leads to 
apoptosis in certain cells (Karlseder et al. 1999). Senescence can be viewed as a 
different terminal phenotype assuring that cells with chromosomes that are not properly 
protected, no longer divide. 
Telomeres devoid of TRF2 become deprotected and it was surmised that the 
state of being deprotected results from the inability of the telomere to fold into a t-loop 
(see Chapter 1). An unfolded telomere on a chromosomal level leads to telomere fusion 
through the NHEJ pathway, which suggests that it is recognized as a double stranded 
break (DSB). Here it is shown that chromosome ends that are without TRF2, and 
thought to be in a non t-looped state, can activate checkpoint pathways resulting in 
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Figure 2-12. A model of parallels between events leading to growth arrest in replicative 
senescence and after inhibition of TRF2 in human primary fibroblasts. Inhibition of TRF2 
(right) leads to t-loop opening and signaling to p53 and Rb pathways resulting in growth arrest. 
Telomere shortening due to the "end replication problem" (left) eventually is proposed to lead to 
loss of sufficient TRF2 from the telomere, resulting in opening of t-loops and downstream 
events that activate p53 and Rb pathways bringing about the arrest. 
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arrest induced by inhibition of T R F 2 and naturally occurring senescence suggests the 
possibility that the inability of short telomeres in pre-senescent cells to fold into a t-loop 
leads to activation of the senescence program (Figure 2-12). If this hypothesis is 
correct, senescent cells should have greatly diminished levels of t-loops, a prediction 
that is currently being tested 
The similarity of protein expression in cells at the end of their replicative life-span 
and cells expressing TRF2ABAM led to the conclusion that the same pathways are 
activated in both states. In testing the necessity for signaling through the p53 and Rb 
pathways, it was found that expression of TRF2ABAM in the presence of the SV40 Tag 
overcomes senescence but that the population seems to enter a state similar to crisis. 
An analogy can be drawn between inhibition of TRF2 in the presence of Tag and life-
span extension of wt primary fibroblasts in which both p53 and Rb are inhibited by 
expression of Tag, or simultaneous expression of HPV16E6 and E7 proteins. In such 
cells, the signal to halt proliferation is presumably disregarded, resulting in suppression 
of senescence and continued growth despite considerable telomere dysfunction, 
evidenced by frequent dicentrics and other chromosomal abnormalities present in these 
cells (Ray et al. 1992). After 20-30 population doublings of additional growth, such 
cultures enter crisis, a state in which cell numbers do not increase because cell division 
is offset by cell death. The cause of crisis is unclear and may stem from loss of 
essential subtelomeric genes that are normally protected by telomeres. The crisis-like 
state induced by TRF2ABAM in SV40Tag expressing cells occurs without loss of telomeric 
DNA, making it unlikely that subtelomeric genes were lost. Perhaps, a more plausible 
explanation for crisis is the cumulative genome damage caused by cells that divide with 
unstable chromosomes. 
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There are many remaining questions about the induction of senescence. A very 
important question is what the upstream signals are that activate the p53 pathway. 
ATM, even though clearly involved in signaling from DSB (Rotman and Shiloh 1998), is 
not essential for the induction or the maintenance of the arrest after inhibition of TRF2. 
This is in agreement with findings that fibroblasts from patients afflicted with A-T undergo 
replicative senescence (Vaziri et al. 1997). p53 is also induced in senescent A-T cells, 
suggesting that other pathways are also responsible for signaling to p53. Similarly, in a 
mouse model of A-T, gamma irradiation leads to a partial G1 cell cycle arrest (Xu and 
Baltimore 1996), which is completely removed when p53 is also mutated (Xu et al. 
1998). 
Two other PI-3 kinases, ATR and DNA-PK are candidates for the signaling from 
damaged DNA, and thus potential candidates for the sensors of unprotected telomere. 
ATR is able to phosphorylate p53 in vitro and in vivo (Lakin et al. 1999; Tibbetts et al. 
1999) and its inhibition leads to hypersensitivity to damaging agents (Cliby et al. 1998). 
DNA-PK also phosphorylates p53 in vitro (Lees-Miller et al. 1990; Shieh et al. 1997); 
however, recent analysis of DNA-PKcs deficient mice suggests that DNA-PK is not 
essential for signaling after general genome damage (Jhappan et al. 2000). It will be 
important to test the requirements for ATR and DNA-PK in induction of arrest after the 
inhibition of TRF2. 
p53 can also be regulated by p14ARF (Kamijo et al. 1997; Stott et al. 1998). Semi 
quantitative RT-PCR has shown increased levels of p14ARF message in senescent cells, 
and overexpression of the protein can result in growth arrest of human primary 
fibroblasts (Dimri et al. 2000). It remains to be determined if TRF2 inhibition also can 
result in increased levels of p14ARF. 
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Rb hypophosphorylation in replicative senescence and after inhibition of TRF2 
seems to result from p16 upregulation. When present, p16 inhibits the Cdk4 and Cdk6-
cyclin D complexes, leading to inhibition of Rb phosphorylation; however, events leading 
to increase in p16 expression are much less well defined than events leading to p53 
stabilization. With ongoing divisions, p16 mRNA as well as p16 protein accumulate in 
human fibroblasts (Hara et al. 1996). This accumulation seems to be at least partially 
dependent on the increase in the transcriptional factor Ets1 (Ohtani et al. 2001), 
although other pathways of p16 regulation are also expected to operate in human cells, 
based on the finding that mouse cells deficient in Bmi-1, a transcriptional repressor 
belonging to the Polycomb group, p16 levels are increased (Jacobs et al. 1999). 
Again, at this point it is not known how p16 is induced in cells in which TRF2 was 
inhibited. It might be informative to use some of the mouse KO and overexpression 
model systems to confirm the involvement of the discussed proteins in growth response 
to telomere deprotection. 
It is also of interest to point out that growth arrest in human primary fibroblasts 
can be induced by DSBs resulting from irradiation ((Di Leonardo et al. 1994) and Figure 
2-5), as well as by an inappropriate mitogenic stimulus originating from expression of 
oncogenic Ras (Serrano et al. 1997; Zhu et al. 1998). Under these conditions, the 
pattern of protein expression is very similar to the pattern of expression after inhibition of 
TRF2, suggesting a common pathway that is engaged in implementation and/or 
maintenance of the arrest. 
One of the important questions in the senescence field pertains to the signal that 
induces the growth arrest when telomeres reach the critical length. Some suggest that 
progressive telomere shortening might change expression of genes that would 
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eventually lead to growth arrest (Baur et al. 2001); however, as of yet, no candidate 
genes were found to be localized in the subtelomeric regions of human cells. Others 
propose that there is a telomere specific checkpoint that examines the telomere status 
and dictates the arrest. Finally, the critically short telomere might signal as a double 
stranded break inducing common DNA damage response pathways. The data 
presented in this chapter support the last model of how senescence signals into arrest. 
Additionally, based on the data presented in Chapter 1, it can be further proposed, that 
the signal to these pathways is brought on by the unfolding of the t-loop as a 
consequence of insufficient TRF2 being recruited to the critically short telomere or 
telomeres. 
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C h a p t e r 3 
T R F 2 a n d t e l o m e r e length regulation 
Introduction 
Human cells that lack telomerase generally do not maintain telomere length. 
They can activate a poorly understood alternative lengthening pathway (ALT) (Bryan et 
al. 1995), which has been proposed to rely on homologous recombination (Dunham et 
al. 2000). However, activation of ALT is a very rare event even in tumor cells, and all 
human primary cells lacking telomerase do not maintain their telomeres, which results in 
loss of 50 to 200 bp of telomeric DNA from each telomere per division (Cooke and Smith 
1986; Harley et al. 1990; Hastie et al. 1990). Shortening originates from the inability of 
the DNA polymerases to fully replicate some of the termini, but also from nucleolytic 
activities that may participate in the formation of the G-overhangs. Eventually, lack of 
telomere maintenance leads to deprotection of telomeres (discussed in Chapter 1) and 
senescence (discussed in Chapter 2). 
Expression of hTERT, a catalytic subunit of telomerase restores telomerase 
activity as well as stabilizes telomere length in most primary cells tested to date (Bodnar 
et al. 1998; Vaziri and Benchimol 1998). This is in agreement with findings that 
telomerase activity in human cells is regulated at the level of expression of the catalytic 
subunit (hTERT) and hTERT expressing cells usually have detectable telomerase 
activity (Kilian et al. 1997; Meyerson et al. 1997; Nakamura et al. 1997). Tissues that 
express hTERT at a very low level but have no discernable telomerase activity in 
extracts have been proposed to produce a telomerase variant that is able to act as a 
dominant negative allele poisoning the wt activity (Colgin et al. 2000). 
Although existence of the functional telomerase enzyme in the cell is often a 
requirement for telomere maintenance, its presence does not automatically lead to 
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telomere elongation. A number of findings suggest that telomere length is regulated in 
cis at each telomere. Despite high telomerase activity in the germline (Mantell and 
Greider 1994; Prowse and Greider 1995; Wright et al. 1996), telomere length is species 
specific. (Kipling and Cooke 1990, Zhu et al. 1998). While expressing high telomerase 
activity, many tumor cell lines maintain their telomeres at a stable length (Counter et al. 
1992; Counter et al. 1994; van Steensel and de Lange 1997). Finally, new telomeres 
that are synthesized after transfection of telomeric DNA (so called "telomeric seeds") into 
the cultured cells are elongated to match the length of the other telomeres in those cells 
(Barnett et al. 1993; Hanish et al. 1994; Sprung et al. 1999). To achieve such control, the 
length of each telomere has to be monitored and regulated separately. 
Telomere length control studies in human cells have shown that the TTAGGG 
binding factor 1 (TRF1) is a negative regulator of telomerase-directed elongation 
(Karlseder and de Lange; van Steensel and de Lange 1997). Removal of TRF1 from 
telomeres by overexpression of a dominant negative allele of TRF1 in cells that also 
express telomerase leads to telomere elongation (van Steensel and de Lange 1997). 
Overexpression of TRF1 in the same cell line causes telomeres to shorten (van Steensel 
and de Lange 1997). Under conditions of inhibition or overexpression of TRF1, the 
telomere length stabilizes at a new length setting, which can be maintained for many 
population doublings (Smogorzewska et al. 2000). Based on these findings it was 
proposed that TRF1 acts in cis and regulates length of each individual telomere (van 
Steensel and de Lange 1997). According to the model, a large amount of TRF1 is 
recruited to long telomeres. This blocks telomerase from adding more repeats and 
telomeres gradually shorten. When they reach a length at which they no longer can 
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recruit enough TRF1 to cause inhibition, telomerase again is able to add more repeats. 
Through multiple cycles of such changes, telomeres achieve length equilibrium. 
To establish that TRF1 affects telomere length through regulating the telomerase 
pathway, TRF1 or its dominant negative allele were introduced into primary human cells. 
Because these cells lack telomerase, their telomeres naturally shorten with cell divisions. 
This characteristic shortening rate did not change when any of the TRF1 alleles were 
added and confirmed that TRF1 acts through modulating the telomerase pathway 
(Karlseder and de Lange, unpublished). 
TRF1 is regulated by one of its interacting proteins. Tankyrasel, a poly (ADP-
ribose) polymerase (PARP), binds to an acidic N-terminus of TRF1 and modifies it using 
its catalytic activity (Smith et al. 1998). Upon this modification TRF1 loses its affinity for 
the telomeric DNA, which can be demonstrated both in vitro and in vivo (Smith et al. 
1998; Smith and de Lange 2000). In agreement with its ability to inhibit TRF1, 
expression of tankyrase leads to telomere elongation (Smith and de Lange 2000), and 
the effect requires the PARP activity of tankyrase since an allele lacking the PARP 
domain does not affect telomere length. Taken together, these experiments suggest 
that tankyrase acts through TRF1 to modulate telomere length. However, the ultimate 
experiment showing that tankyrase acts only through regulating TRF1 by creation of a 
TRF1 allele that cannot be modified by tankyrase has not been done yet. 
TRF1 has a second binding partner, TIN2 (Kim et al. 1999), which also 
participates in telomere length regulation (Kim et al. 1999). Expression of a number of 
truncation alleles of this protein leads to telomere elongation that is dependent on 
telomerase. Since TIN2 exists in a complex with TRF1 (Kim et al. 1999) and tankyrase 
(Ye and de Lange, unpublished), it is likely that the proteins act in the same pathway. 
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This chapter defines TRF2, the second T T A G G G repeat binding factor, as a 
regulator of telomere length. Overexpresion of TRF2 leads to telomere shortening in 
telomerase positive but also in telomerase negative cells showing that TRF2 can 
influence the shortening activities at the telomere. At this point, it is impossible to 
discern whether TRF2 can also influence the telomerase pathway, but the fact that it 
interacts with Rapl, which when overexpressed causes mild telomere elongation, 
suggests that TRF2 might endow the telomere with both the positive regulators of 
shortening and negative regulators of elongation. 
Results 
One of the indications that both TRF1 and TRF2 might influence telomere length 
comes from the observations that long telomeres seem to accumulate much more TRF1 
and TRF2 than short telomeres. Immunofluorescent staining of telomeric proteins was 
performed in HeLal.2.11, a HeLa subclone with very long telomeres (15-40kbp), and 
Helall, a subclone with considerably shorter telomeres (3-6.5 kbp) (Saltman et al. 1993) 
(Figure 3-1). Telomere staining of TRF2 was generally less visible than staining of 
TRF1, and staining with aTRF2 antibodies always resulted in a higher nucleoplasm^ 
signal than staining with aTRF1 antibodies. Although quantification of the signal was not 
feasible, the punctate pattern of staining against both proteins was reproducibly much 
more prominent in HeLal.2.11 than HeLall (Figure 3-1, B, pictures were taken at the 
same exposure time and are reproduced without any adjustments). Many cells in HeLall 
population had almost no punctate staining visible above the overall nucleoplasms 
staining. These results indicate that the length of the telomere tract influences 
accumulation of telomeric proteins at the chromosome termini. However, this apparent 
differential presence of TRF1 and TRF2 on short and long telomeres does not seem to 
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correlate with the expression levels of these proteins since TRF1 levels were 
comparable in Helal.2.11 and HeLall cells, and levels of TRF2 in Helal.2.11 were slightly 
lower than in HeLall (Figure 3-1, A). It needs to be noted that another study found a two 
fold difference in the TRF1 levels between HeLa cells with short and long telomeres, and 
much smaller difference for TRF2 (Okabe et al 2000). This group has also calculated 
that the number of molecules of TRF1 present in the cell per each kb of TTAGGG 
repeats is higher in cells with shorter telomeres than with longer telomeres. This inverse 
correlation was weaker for TRF2 (Okabe et al 2000). 
To gain understanding of how TRF2 influences telomere length, a previously 
established Tetracyclin-inducible expression system was used ((van Steensel and de 
Lange 1997), and see Chapter 1 for a more detailed description). An untagged full 
length TRF2 was placed under the control of a Tetracyclin-controlled promoter and was 
stably transfected into the HTC75 cells, a derivative of HT1080 human fibrosarcoma cell 
line characterized by high telomerase activity and stable telomere length (van Steensel 
and de Lange 1997). A number of clonal lines were established by Bas van Steensel 
and were called P lines. In short term experiments induction of TRF2 had no effect on 
growth ((van Steensel et al. 1998), Chapters 1 and 2). To study the influence of TRF2 
on telomere dynamics, cells induced and non-induced for expression of TRF2 were 
grown in parallel for 124 population doublings (PDs). Telomere length was assessed 
periodically by Southern blot hybridization with a telomeric probe. Out of the four clonal 
cell lines examined, one (P4) showed erratic changes in telomere length that did not 
correlate with presence or absence of TRF2. This cell line was not studied further. 
Three other cell lines (P7, P12, and P33), when grown without induction, maintained 
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Figure 3-1. Immunofluorescent analysis of TRF1 and TRF2 staining in cells with long and 
short telomeres. A. Western blot showing expression of TRF1 and TRF2 in buffer C extracts 
from two HeLa cell lines with different telomere lengths. TRF1 was detected with antibody 371; 
TRF2 was detected with antibody 647. Cyclin D is used as a loading control. In the first two 
lanes, loading was based on cell numbers and the second two lanes were normalized based on 
protein amounts (30 \ig). B. Indirect immunofluorescence staining for TRF1 and TRF2 in two 
HeLa cell lines with the indicated telomere lengths. All samples were processed identically and 
in parallel and images are presented without any adjustment. For each combination of cell line 
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pattern of telomere length changes, which generally was comprised of an initial period of 
telomere shortening, followed by telomere re-growth (Figure 3-2). In the P7 cell line, 
initially telomeres shortened at 82 bp per PD (calculated from telomere lengths between 
PDO and PD28). Unexpectedly, this trend of shortening halted around PD 48 and within 
the next 30 PDs telomeres regained their original length, which appeared to be stably 
maintained until the end of the experiment. Similar changes in telomere length were 
observed in P33 cell line, in which the initial shortening (47 bp/PD, calculated for PDO to 
PD 40) was followed by elongation, which started around PD72 and was not completed 
by the end of the experiment. P12 cell line also showed initial telomere shortening (51 
bp/PD, calculated from telomere lengths at PDO and PD8), but telomeres started 
elongating soon after that and reached a length setting that was longer than the original 
length setting in this cell line. Such telomere behavior was very different from the one 
observed in TRF1 studies where TRF1 overexpression led to telomere shortening and 
eventual stabilization of telomere length at the lower setting (van Steensel and de Lange 
1997). However, these complex telomere changes were consistently seen in three 
different cell lines, which led to a conclusion that TRF2 was the causative agent of such 
unexpected changes. 
Changes in telomere dynamics seen in the above experiments could be 
explained if the initial high expression of the exogenous TRF2 subsided with time. The 
initial telomere shortening determined by TRF2 would then also stop, leading to telomere 
elongation. In order to test this hypothesis TRF2 levels were analyzed at different time 
points during the experiment (Figure 3-3). Western blots have shown very high levels of 
TRF2 at the start of the experiment in all three lines. With time, the levels decreased 
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Figure 3-3. TRF2 expression in P7, P12 and P33 HTC75 cells at various times during 
growth. A. Immunoblot analysis of TRF2 levels in P7, P12 and P33 cells grown under induced 
and non-induced conditions. Buffer C extracts were prepared at indicated population doublings 
(PDs), and TRF2 was detected with antibody 508. Endogenous TRF2 is below detection limit 
under these conditions. B. Immunofluorescence with antibody 508 in non-induced and induced 
P12 cells at PD2, and induced P12 cells at PD12. Note that at PD 12 the level of expression is 
invisioble in two cells, very low in other two, and high in one. C. % expressing P12 cells at 
different PDs. All expressing cells were counted, so that 3 out of the 5 cells in right panel of B. 
would be counted as being positive for expression. 
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experiment (Figure 3-3 A). As documented by immunofluorescence, this decline in 
expression was due to a decrease in numbers of cells that expressed exogenous TRF2 
as well as decrease in levels of TRF2 in the expressing cells (Figure 3-3 B). The 
changes in expression roughly coincided with the switch from the shortening to 
elongation states. P12 line exhibited this switch at a very early time point (before PD 
28). Loss of expression in this cell line also occurred very early and by PD 48 none of 
the cells in the population expressed TRF2 as determined by IF (Figure 3-3, C). 
Exogenous TRF2 in the P7 cell line, on the other hand, expressed robustly at PD 48 and 
telomeres were still shortening at that time. However, at PD 76, only 20% of cells were 
expressing TRF2 in that cell line and telomeres in the population were already 
elongating. Overall, this correlation further stresses that telomere changes in the HTC75 
cell line were being influenced by TRF2. However, it is curious that whereas TRF1 could 
be stably maintained for 300 PDs (Smogorzewska et al. 2000), TRF2 expression was 
being extinguished during these experiments. This finding might suggest that presence 
of TRF2, or the short telomere state that is achieved when TRF2 is being 
overexpressed, or the combination of both is detrimental for the cell. While the 
deleterious nature of TRF2 overexpression could not be fully addressed in this system 
because of the asynchrony of TRF2 loss, it has been noted that the morphology of cells 
in the population, which was about to lose TRF2 expression, differed from uninduced 
cells, and many cells appeared to have multilobulated nuclei (Figure 3-4). 
To further understand the events that led to the initial telomere shortening in 
HTC75 cells, the ability of TRF2 to influence telomerase activity and expression of the 
telomerase subunits was examined. Telomeric repeat amplification protocol (TRAP) 
assay was performed on extracts from HTC75 cells induced or not induced to express a 
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Figure 3-4. Cell morphology of P12 HTC75 cells at PD 14. DAPI staining of P12 HTC75 
cells uninduced or induced to express TRF2. Note the presence of multilobulated nuclei and 
DAPI positive material joining two interphase cells (indicated as * in the lower panel) in cells 
expressing TRF2. 
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Figure 3-5. Effects of expression of TRF2, TRF2ABAM and TRF2AB on telomerase activity. 
Telomeric repeat amplification protocol (TRAP) assay in HTC75 grown in the presence or 
absence of doxycyclin (- and + induction respectively). 0.5 ug total protein of buffer C extract as 
assayed by Bradford assay (BioRad) was used per reaction. RNase digestions were done in 
parallel to the untreated reactions by addition of 0.2 ,ug DNase-free RNAse. Buffer C was used 
instead of extract in the "no extract" control (last lane on the right). 
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full length T R F 2 and the two truncation alleles (TRF2ABAM and TRF2AB). To assure that 
only telomerase activity was being assayed, RNAse was included in parallel reactions. 
Additionally, one reaction was performed without any extract to control for any 
contamination during the polymerase chain reaction. Telomerase activity appeared to 
be comparable in all cells examined (Figure 3-5). This parallels findings that TRF1 or 
any of the truncation alleles of TRF1 also did not change the in vitro telomerase activity, 
showing that neither TRF1 nor TRF2 modulate the global activity of telomerase, but are 
more likely to act in cis at each telomere. Furthermore, expression of TRF2 did not 
influence expression of the telomerase subunits, hTERT or hTR, as shown using the 
RNAse protection assay on total RNA from HTC75 P lines induced or not induced to 
express TRF2 (Figure 3-6). 
The many parallels between telomere behavior upon overexpression of TRF1 
and TRF2 might suggest that the two proteins act in concert to modulate the telomerase 
pathway of telomere length maintenance. However, there remains a possibility that 
TRF2, unlike TRF1, influences the shortening activities at the telomere. In an attempt to 
address this issue, TRF2 was induced in the HTC75 cell lines previously infected with a 
dominant negative allele of hTERT (hTERTD710A) (Hahn et al. 1999). Expression of 
hTERTD710A in three HTC75 cell lines examined (P7, P12, P33) inhibited, although not 
fully abolished the endogenous telomerase activity (Figure 3-7). Nevertheless, telomere 
shortening expected after inhibition of telomerase was seen in all three cell lines (Figure 
3-8, A, indicated as "- induction" in the blots, black squares in the graphs). Parallel 
induction of TRF2 in these cells led to an increased rate of telomere shortening (Figure 
3-8, A, indicated as "+ induction" in the blots, red diamonds in the graphs). One 
interpretation of this finding would be that TRF2 is capable of influencing the shortening 
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Figure 3-6. Effects of induction of TRF2 on expression levels of hTERT and hTR RNA. 
RNase protection assay on total RNA in B27, P12, P7, P33 HTC75 cells grown in the presence 
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Figure 3-7. Effects of expression of the dominant negative hTERT in P7, P12, P33 HTC75 
cells on telomerase activity. Telomeric repeat amplification protocol (TRAP) assay in non-
induced P7, P12, and P33 HTC75 expressing the dominant negative hTERT allele 
(hTERTD710A> (Hahn et al., 1999). The TRAPeze telomerase detection kit (Intergen) was used 
for this assay. Activity was in a linear range. A signifies heat treatment which was done in 
parallel to the untreated reactions by incubation of the extract at 85°C for 10 minutes prior to 
telomerase extension. C is a positive control, and the "no extract" lane contains product of 
reaction performed with lysis buffer supplied with the kit instead of the extract. S-IC is an 
internal control during a PCR step 
126 
P 7 P12 
induction £ 
P33 
+ + + 
PD 
CO g m 2 













c « 4̂  
2 



















P12 P 3 3 • non-induced 
• induced 
• pBabe control vector 
* , A pBabe hTERT DN 
population doubling 
P7 P12 
population doublings population doublings 
P33 
induction - + - + - + 
— « . — »»,*»-*» ^ TRF2 
Figure 3-8. Telomere dynamics analysis in HTC75 cells co-expressing the dominant 
negative hTERT( DNhTERT) and TRF2. A. Southern blot of telomeric restriction fragments 
from P7, P12, and P33 HTC75 cells carrying DNhTERT (hTERTD71°A) grown in the presence or 
absence of doxycyclin, resulting in repression (-) or induction (+) of TRF2. The molecular 
weights of marker DNAs are indicated in kb. Length changes were quantified and plotted as 
median telomere length (Y axis) against population doublings (PDs) (X axis). B. Immunoblot 
analysis of TRF2 levels in P7, P12, and P33 HTC75 cells carrying DN hTERT grown under 
induced and non-induced conditions. TRF2 was detected with antibody 647. 
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activities at the telomere. According to this interpretation, an increased rate of telomere 
shortening in the cell lines expressing both hTERTD710A and TRF2 results from the 
additive effect of inhibition of telomerase pathway by hTERTD710A and stimulation of the 
shortening pathway by TRF2. Although this interpretation is attractive, the 
overexpressed TRF2 in these experiments might have still been able to modulate the 
residual activity of telomerase at the shortening telomeres. Therefore, to further study 
the effects of TRF2 on the shortening rate, TRF2 was expressed in human primary 
fibroblasts, which naturally lack any telomerase activity. 
IMR90, primary lung fibroblasts were infected with an untagged full length TRF2 
allele and telomere length was observed in short term experiments. Already by the 5th 
day of selection telomere shortening was evident in cells expressing TRF2 but not in 
cells expressing vector control (Figure 3-9, left panel). A long-term expression of TRF2 
in IMR90 cells that also expressed a SV40 Tag led to a steady decrease in telomere 
length, and the rate of shortening remained increased throughout the experiment when 
compared to rate of shortening in cells expressing vector control (Figure 3-9, right 
panel). Moreover, TRF2 expression was not lost from the FLTRF2 infected cells during 
this experiment. Similar results were obtained in long-term expression of TRF2 in 
IMR90 cells that did not express SV40 Tag (Karlseder and de Lange, unpublished). In 
those studies, quantification of telomere shortening revealed that telomeres shortened at 
a rate of 110 bp/PD in cells infected with a control vector or any of the TRF1 alleles, but 
at a rate of 165-180 bp/PD in cells expressing TRF2 (Karlseder and de Lange). These 
results unequivocally demonstrate that although TRF2 is a negative regulator of 
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Figure 3-9. Telomere length analysis in IMR90 primary fibroblasts infected with control 
virus or with FLTRF2. Southern blot of telomeric restriction fragments from cells carrying no 
exogenous T R F 2 (vector) or T R F 2 (TRF2). O n the left, a short term experiment is shown in wt 
IMR90 cells. O n the right, a longer term experiment is shown in IMR90 expressing Tag. Similar 
results are obtained in long term experiments when T ag is absent (Jan Karlseder and Titia de 
Lange, unpublished). Genomic D N A w a s isolated from cells on the indicated days of selection, 
digested with Hinfl and Rsal, and hybridized with a T T A G G G repeat probe. The molecular 
weights of marker D N A s are indicated in kb. 
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However, these findings do not exclude the possibility that besides being a positive 
regulator of telomere shortening, TRF2 might also influence the telomerase pathway. 
Addressing this question is difficult given current experimental methods. In an attempt to 
show that the telomerase pathway of telomere length regulation can be affected by 
TRF2, TRF2ABAM, the dominant negative allele of TRF2, was expressed in the BJ primary 
cells expressing hTERT (Bodnar et al. 1998). As shown in Chapter 2, expression of 
TRF2ABAM leads to growth arrest even in telomerase positive lines. To circumvent the 
arrest, SV40 Tag was also expressed in hTERT BJ cells. The expectation was that 
removal of TRF2 from the telomeres under conditions permitting cell growth would allow 
telomerase to elongate the exposed telomere ends. Indeed, the telomeres appeared to 
be slightly longer in cells expressing TRF2ABAM (Figure3-10, top panel lane 6 and 7). 
However, the pattern of this elongation was reminiscent of the appearance of end-to-end 
fusions after inhibition of TRF2 (see Chapter 1). To test if this apparent telomere 
elongation in TRF2ABAM-expressing cells is due to fusion formation, the genomic DNA 
extracted from these cells was fractionated on an agarose gel and without denaturation 
hybridized in situ to a (CCCTAA)4 probe. Under these conditions only the telomeres with 
G-overhangs are detected and DNA of fused telomeres should not be revealed. As 
shown in Figure 3-10, lower left panel, telomeres from vector control cells and cells 
expressing TRF2ABAM appeared to be of similar length when hybridization was performed 
under native conditions. When the same gel was denatured, the higher molecular 
weight telomeric DNA reappeared in TRF2ABAM-expressing cells. These results showed 
that the apparent increase in telomere length in TRF2ABAM-expressing cells seen in 
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Figure 3-10. Telomere length analysis in B J h T E R T fibroblasts infected with control virus 
or TRF2ABAM. A. Southern blot of telomeric restriction fragments from cells carrying no 
exogenous T R F 2 (vector) or TRF2ABAM (TRF2ABAM). Genomic D N A w a s isolated from cells on 
the indicated days of selection, digested with Hinfl and Rsal, and hybridized with a T T A G G G 
repeat probe. The molecular weights of marker D N A s are indicated in kb. The arrow points to 
a higher molecular weight telomeric D N A present only in lanes 6 and 7. B. In gel hybridization 
of telomeric restriction fragments with an end-labeled telomeric probe under non-denaturing 
conditions (left) and denaturing conditions (right). Under the non-denaturing conditions only the 
D N A which has G overhangs is revealed, and under denaturing conditions, all telomeric D N A is 
visualized. Arrow points to a higher molecular weight telomeric D N A visualized only under 
denaturing conditions. 
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This suggests that a telomere devoid of TRF2 cannot be elongated by telomerase but it 
still does not exclude that TRF2 affects the telomerase-pathway. 
Discussion 
This chapter has identified TRF2 as a regulator of telomere length. The ability of TRF2 
to cause telomere shortening in human cells lacking telomerase led to the conclusion 
that TRF2 can positively regulate the rate of telomere shortening. The mechanism of 
such regulation was not addressed in these experiments and a number of possibilities 
can be proposed. TRF2 could influence the shortening rate by affecting the replication 
through the terminus. For example, the last primer on the lagging strand could be 
placed farther from the tip when more TRF2 was present on the telomere. Secondly, 
TRF2 might be able to regulate nucleases involved in telomere shortening. Expressing 
more TRF2 might place more of the nuclease activity on telomeres leading to faster 
shortening. TRF2 might physically be able to interact with a nuclease or might positively 
regulate it. However, if TRF2 were to physically be in a complex with such a nuclease, 
this proposal assumes that there would be an excess of nucleases in the cell that could 
be brought to the telomeres by the overexpressed TRF2. Another possibility pertinent to 
regulation of the putative telomeric nuclease is to propose that TRF2 interacts with an 
inhibitor of shortening and that expression of TRF2 in the nucleoplasm titrates away this 
activity from telomeres, leading to the decreased presence of this inhibitor on the 
telomeres, increased nuclease activity and telomere shortening. These proposals are 
testable especially in light of a putative nuclease, the Mre11 complex localizing to 
telomeres (Zhu et al. 2000, Lombard and Guarente 2000). 
TRF2 expression in primary human cells led to persistent and continuous 
telomere shortening. Eventually cells senesced (Karlseder and de Lange, unpublished) 
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and although the dynamics of senescence with overexpressed TRF2 will not be 
discussed here, these findings shed light on the reasons why telomerase positive 
HTC75 cells induced to express TRF2 might have lost expression of the allele (Figure 3-
2 and Figure 3-3). It seems that the telomerase activity present in the HTC75 cells was 
unable to compensate for the loss of telomeres caused by the shortening activities 
stimulated by the overexpression of TRF2. Evidently, the shortening activities are 
dominant in this setting. With time telomeres become critically short and probably 
become non functional. Although presence of fusions was not noted m the P lines when 
the telomeres were short, such an event could have been missed because of the 
asynchrony of the telomere shortening and emergence of cells that have lest expression. 
However, the HTC75 P cell lines were noted to have an altered morphology at the time 
when cells had short telomeres. The multilobulated nuclei of cells could have 
represented events of cells trying to undergo anaphase with a large number of fusions. 
aborting such event and returning to a G1 like state resulting in a dumbbell shaped ceil 
or a phenotype that has been described as a "cut" phenotype in yeast. If the HTC75 
cells were unable to select for the non-expressing cells when their telomeres were very 
short, the population probably would have ceased to grow. 
The findings presented here stress the differences in how TRF1 and TRF2 
regulate telomere length. Although the two proteins are pa.-alogs and are able to interact 
with the same DNA sequence, they act in two different pathways to regulate telomere 
length. This ability of TRF1 and TRF2 to impinge on different pathways must s'ium from 
their capacity to interact with different partners. As pointed out earlier, two of the TP-F1 
binding proteins- tankyrasel and TIN2 are also involved in telomere length regulation. It 
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will be interesting to see what are the other functions of TRF1, since studies to date 
suggest that the complex is devoted exclusively to telomere length regulation. 
So far, TRF2 has not been shown to have the ability to regulate telomere 
elongation. It would be surprising if TRF2 did not have such capacity since Rapl, which 
seems to exists in a 1:1 complex with TRF2 (Zhu et al. 2000) behaves as a negative 
regulator of telomere elongation (Li et al. 2000). A protein that anchors a regulator of 
telomere elongation should be itself functioning as such. However, if TRF2 can 
influence the telomerase pathway it would do so in cis at each telomere. 
Overexpression of any of the alleles had no influence on the telomerase activity as 
assayed by TRAP assay. Expression of a full length TRF2 also did not affect the 
presence of hTERT or hTR RNA messages. 
Although expression of the dominant negative allele of TRF2 in telomerase 
positive cells failed to show that TRF2 acts as a regulator of telomere elongation, it did 
suggest that a telomere devoid of TRF2 is inert with regards to its interaction with 
telomerase. Without TRF2, the chromosome end might no longer be seen as a 
telomere. Such an end does not get degraded and it does not seem to get elongated. It 
now behaves like a break (see Chapter 1) and as such it might be initially protected and 
then repaired by the NHEJ pathway. This also suggests that the presence of TRF2 is 
necessary for the proper elongation of the telomere. 
Parenthetically, it is useful to note that IMR90 Tag control infected cells show a 
prominent band that is likely to represent telomere fusions (Figure 3-9, right panel, 
vector). This band is not observed in cells that also express TRF2, consistent with the 
ability of TRF2 to protect telomeres from the NHEJ pathway (Chapter 1). 
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C h a p t e r 4 
C h r o m o s o m e a n d t e l o m e r e b r e a k a g e in cells 
expressing TRF2AB 
Introduction 
Besides being present at the telomeres, TTAGGG repeats are found at interstitial 
sites in many species (Meyne et al. 1990). In human cells, there are a number of 
interstitial sites containing telomeric repeats (Ijdo et al. 1991; Azzalin et al. 1997). The 
origin of all of them is not yet known; however, at least one of them, consisting of a long 
stretch of degenerate TTAGGG repeats in head to head orientation, most likely arose 
from fusion of ancestral ape chromosomes (Ijdo et al. 1991). It has been proposed that 
the interstitial sites can be the sites of recombination, breakage, and fragility (Hastie and 
Allshire 1989). Supporting such a proposal, a number of studies in hamster cells have 
correlated the presence of interstitial sites with instability (Slijepcevic et al. 1997; Day et 
al. 1998). In human cells, interstitial repeats participate in rearrangements including 
jumping translocations, (Park et al. 1992; Jewett et al. 1998) and might represent fragile 
sites (Boutouil et al. 1996), although it is not understood what the requirements are for 
an interstitial site to become recombinogenic. 
A recent study focused on a more defined interstitial site engineered in a way 
that allows for efficient scoring of rearrangements at that site (Kilburn et al. 2001). A 
stretch of 800 bp TTAGGG repeats were placed within an intron of the adenosine 
phosphoribosyltransferase gene (APRT). Interstitial placement of the TTAGGG repeats 
did not influence homologous recombination at this site; however, local rearrangements 
involving the interstitial telomeric sequence increased 30 fold. The rearrangements 
included deletions, insertions and translocations (Kilburn et al. 2001). 
The study described above has defined the interstitial 800 bp of telomeric DNA 
as destabilizing element in human chromosomes. However, it did not give insight in to 
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the mechanism underlying the destabilizing behavior. One possibility is that TTAGGG 
repeat DNA is able to form structures that somehow are destabilizing when present at 
interstitial sites. A second possibility can now be proposed based on the finding that 
both TTAGGG binding proteins, TRF1 and TRF2, are found to bind interstitial 
(TTAGGG)n sites (Smogorzewska et al. 2000). BHK-21, a Syrian hamster cell line and 
CHO-K1, a Chineses hamster cell line, but not AHL-1, an Armenian hamster cell line, 
contain very large blocks of pericentromeric satellite sequences that contain TTAGGG 
and related repeats (Meyne et al. 1990; Ashley and Ward 1993). Indirect 
immunofluorescence against the basic domain of human TRF2 showed that the 
endogenous hamster TRF2 was binding at the interstitial sites (Smogorzewska et al. 
2000). TRF1 is much less conserved between the species (Broccoli et al. 1997; Smith 
and de Lange 1997), and antibodies against human or mouse TRF1 do not cross-react 
with the hamster TRF1; however, a transfected human TRF1 was also able to bind to 
the Syrian and Chinese hamster interstitial sites (Smogorzewska et al. 2000, Krutilina et 
al. 2001). It is possible that an interstitial site bound by a telomeric protein might be 
inappropriately processed to give a break. This proposal can now be directly tested by 
examining the frequency of rearrangements in cells expressing different alleles of TRF1 
and TRF2 (also see discussion). 
One of the striking differences between TRF1 and TRF2 are their N terminal 
domains. The acidic domain in TRF1 is functionally important, as suggested by its 
interaction with tankyrase. So far no protein has been found to interact with the basic 
domain of TRF2. The only known direct interaction of TRF2 is with Rapl and it maps to 
the TRF homology domain of TRF2. It is not yet known if the Mrel 1 complex interacts 
directly with TRF2 or whether the interaction occurs via Rapl. This chapter explores the 
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function of the basic domain of TRF2 by studying the truncation allele of TRF2, TRF2AB. 
It is shown that TRF2AB localizes to telomeres very efficiently where it replaces the 
endogenous TRF2 but not TRF1 from the telomeres. Expression of TRF2AB leads to 
rapid telomere loss that is distinct from the telomere shortening in the presence of 
increased levels of TRF2 (see Chapter 3). Large portions of telomeric DNA seem to be 
lost from single chromatids. The loss of telomeric DNA is also visible on telomere blots 
and seems to be caused by loss of the duplex DNA and not a specific strand of the 
telomeric DNA. Besides the telomere length phenotype, cells expressing TRF2AB are 
found to have chromatid gaps and breaks, which leads to the appearance of 
chromosome pieces in anaphase cells and micronuclei in interphase cells. Primary 
human cells undergo a senescent-like growth arrest when they express TRF2AB. This 
growth arrest is very similar to the arrest seen with TRF2ABAM-expressing cells although 
the kinetics of the arrest are somewhat slower. TRF2AB-induced arrest, just like the 
arrest following expression of TRF2ABAM or replicative senescence can be abrogated by 
expression of the SV40 Tag. It is not clear at this point what the primary source of the 
arrest is, although the prevalence of telomeres lacking any telomeric signal suggests 
that chromosomes become deprotected. Additionally, the presence of breaks might also 
lead to signaling into growth arrest. 
Results 
The function of the basic domain of TRF2 was indirectly studied by expression of 
an allele lacking this domain (TRF2AB) in a number of different cell lines. The effect of 
TRF2AB on the endogenous TRF1 and TRF2 was shown by expression of the tagged 
TRF2AB allele in HeLal.2.11, a subclone of HeLa cells that is characterized by very long 
telomeres. Immunofluorescent staining against the tagged protein revealed that when 
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overexpressed, TRF2AB gives high nucleoplasm^ signal with overlaid punctate staining 
(Figure 4-1 A and B). The punctate pattern of TRF2AB staining colocalized with that of 
TRF1 (Figure 4-1 B) showing that, like in vitro (Broccoli et al. 1997, van Breugel M. and 
de Lange T., unpublished, Stansel R, Griffith J. D., unpublished), TRF2AB was able to 
bind to telomeric DNA in vivo. TRF2AB expression did not seem to affect the presence of 
TRF1 on telomeres. However, fluorescent staining against the basic domain of the 
endogenous protein with antibody 508 in cells expressing TRF2AB, showed no punctate 
pattern, suggesting that the endogenous TRF2 was being replaced at the telomeres by 
the overexpressed TRF2AB allele. Similar finding of a decreased amount of the 
endogenous TRF2 on telomeres were obtained in chromatin immunoprecipitation 
experiments performed on cells expressing TRF2AB (Loayza D. and de Lange T, 
unpublished results). 
In an attempt to characterize the phenotype of cells expressing the TRF2AB allele, 
fluorescent in situ hybridization (FISH) with a peptide nucleic acid (PNA) telomeric probe 
was performed on cells infected with a vector control or the non-tagged TRF2AB allele. 
BJ human primary fibroblasts expressing hTERT were particularly suitable for these 
studies, since their telomeres are very long (median around 15 kbp) and rather 
homogenous in length. These cells were also expressing SV40 Tag; however, its 
expression did not influence any of the phenotypes presented here. Telomere signals 
visualized by PNA FISH on metaphase spreads of cells infected with a vector control on 
day 6 after selection were usually very high, and as expected, telomeric staining on 
sister chromatids was typically equal in intensity (Figure 4-2, top). Parallel experiments 
performed with cells expressing TRF2AB revealed an overall less bright telomere staining 
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Figure 4-1. Effects of expression of myc tagged TRF2AB on endogenous TRF1 and 2 
protein localization to telomeres. Indirect immunofluorescence of HeLa 1.2.11 cells infected 
with myc tagged TRF2AB. Analysis was performed one day after infection on non-selected 
cells. Staining with an antibody against a myc tag (9E10) reveals infected cells. TRF2 is 
visualized with antibody 508 (A), and TRF1 with antibody 371 (B). Antibody 508 was raised 
against a peptide (GRRASRSSGRARRGRHEPGLGGPAEAG) present in the basic domain of 
TRF2 and it recognizes FLTRF2 but does not recognize TRF2AB. DNA was counterstained with 
DAPI. 
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Figure 4-2 Telomeric staining in BJ hTERT SV40 T ag cells expressing TRF2AB. Peptide 
nucleic acid (PNA) fluorescence in-situ hybridization with a telomeric probe on spreads of BJ 
hTERT Tag cells infected with vector control (vector) or with TRF2AB (TRF2AB). Spreads were 
prepared on the 6th day of selection. DNA was counterstained with DAPI. Overall the telomeric 
signal in TRF2AB expressing cells was weaker (not shown here due to enhancement of the 
signal for the reproduction purposes). As shown at the lower right (arrows), many chromatids in 
the TRF2AB expressing cells had very low or had no telomeric signal. Scoring 20 metaphases 
of vector cells revealed 9 single chromatids with no telomeric signal. In 21 spreads of cells 
expressing TRF2AB, 102 chromatids had no telomeric signal. 
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(data not shown, but see telomere blots below). Furthermore, many chromatids lacked 
any telomeric signal (Figure 4-2, bottom). In 21 spreads of cells expressing TRF2AB, 102 
chromatids had no telomeric signal which corresponds to an 11 fold increase of such 
events over control cells in which 20 metaphases revealed only 9 single chromatids with 
no telomeric signal. Further analysis revealed that telomere signals on many chromatids 
of TRF2AB-expressing cells were substantially lower from the signals on the surrounding 
chromosomes. Curiously, often only one of the sister chromatids showed no signal. 
When two chromatids had very low signal, they frequently were on the opposite arms 
(Figure 4-2, top chromosome on the right). It is not clear yet if the distribution of lost 
signals represents a stochastic event or whether telomeres of specific chromatids are 
being lost (see discussion). Results of overall diminution of telomere signal and loss of 
some of the chromatid signals were first observed when TRF2AB was expressed in 
mouse cells (Wang R. and de Lange T., unpublished). 
Non-chromosomal telomeric signals were not seen on the spreads that revealed 
chromosomes without the telomeric signal, suggesting that the events of telomere DNA 
diminution were most likely not due to sudden separation of the telomere from the 
chromosome but rather a degradative process. However, telomere length changes after 
induction of TRF2AB were very different from the gradual telomere shortening that was 
observed in cells expressing FLTRF2. Southern blot telomere length analysis of the 
cells used in the experiments described above revealed that as opposed to slow and 
constant telomere shortening seen in FLTRF2-expressing cells (Figure 4-3, also see 
Chapter 3), TRF2AB-expressing cells showed overall loss of the signal intensity. The 
telomeric hybridization signal also became more heterogenous with appearance of some 
signal in the lower molecular weight range. Loss of hybridization did not depend on the 
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Figure 4-3. Telomere length analysis in BJhTERT SV40 Tag, BJhTERT, and HS68 
fibroblasts infected with control virus, FLTRF2, and TRF2AB Southern blot of telomeric 
restriction fragments from cells carrying no exogenous TRF2 (vector), FLTRF2 (FLTRF2), and 
TRF2AB (TRF2AB). Genomic DNA was isolated from cells on the indicated days of selection, 
digested with Hinfl and Rsal, fractionated on a 0.7% agarose gel, and hybridized with a 
TTAGGG repeat probe. Lane #1 of the gel shown in C. was overloded, the rest of lanes had 
equal loading as confirmed by ethidium bromide staining. The molecular weights of marker 
DNAs are indicated in kb. A. Telomere length analysis of BJhTERT SV40 Tag cells. Note the 
loss of the signal intensity and the increase in the heterogeneity of telomeric signal in TRF2AB 
expressing cells at day 8 and 10. By day 29, most of the population of TRF2AB cells have lost 
expression of the allele. The signal loss was not quantified in this experiment. Loss of intensity 
did not depend on presence of hTERT similar results were obtained with wt primary BJ cells 
(see fig 4-4). B. Telomere length analysis of BJhTERT cells. The signal in each lane was 
integrated, normalized to signal in lane #1 and is presented below each lane. The number was 
calculated as (signal in lane x/signal in lane 1)x100%. C. Telomere length analysis in HS68 
cells. Because the first lane was overloaded, lane #2 was used to normalize the signal in all 
other lanes. 
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presence of hTERT or SV40 Tag because similar results were obtained with wt primary 
BJ cells (see Figure 4-4) as well as with BJhTERT cells not expressing SV40 Tag. The 
effect of telomere signal loss was also noted in HS68 primary human fibroblasts (Figure 
4-3, C), although the effect was much harder to visualize on the blots of these cells since 
their starting telomere length was considerably shorter and appeared more 
heterogenous on standard telomere blots. TRF2AB-expressing HS68 cells on day 13 of 
the selection have lost about 35 % of the telomeric signal (Figure 4-3, C) 
Findings of decreased hybridization intensity in cells expressing TRF2AB 
corroborate that chromosomes lose telomeric signal when TRF2AB is overexpressed. 
Interestingly, this loss appears to occur very fast, possibly within the first few divisions 
after TRF2AB expression. When PNA FISH was performed on the metaphase spreads of 
the non-selected population of BJ hTERT cells on the third day of TRF2AB expression, 
many cells showed decreased telomere staining and some chromatids already showed 
no telomeric signals. Also, Southern blots with DNA from cells on day 4 of selection 
already showed the decreased hybridization and increased heterogeneity of the 
telomere signal (Figure 4-3, C). It is possible that any additional decrease in telomere 
length might have been due to replication of the already shortened telomeres. 
Overexpression of TRF2AB was deleterious to the cells because by day 29 most 
BJhTERT SV40 Tag cells lost expression of the allele (see Figure 4-8 for the description 
of the growth phenotype). After TRF2AB expression was lost, telomere length of the 
population returned to normal length (Figure 4-3, day 29). 
To ask if one of the telomeric strands was preferentially degraded in TRF2AB-
expressing cells, an in-gel G-overhang assay was performed on DNA collected from 
primary BJ cells (this time not expressing SV40Tag or hTERT) expressing control vector, 
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FLTRF2, TRF2AB and TRF2ABAM. To visualize only G -overhang containing telomeres, 
the gel was hybridized under non-denaturating condition with a (CCCTAA)4 probe 
(Figure 4-4, native). Subsequently, the gel was denatured and hybridized with the same 
probe to visualize all telomeric DNA (Figure 4-4, denatured). Although the TRF2AB-
expressing cells showed the expected loss and smearing down of the telomeric signal, 
the ratio of the G-overhang signal to total telomere signal did not appear to change, 
suggesting that the G-overhangs in TRF2AB-expressing cells were unaltered. Similar 
experiments using a (TTAGGG)4 probe, which recognizes the C strand telomeric DNA 
led to a conclusion that no single-stranded C strand telomeric DNA was produced during 
the degradation process induced by the TRF2AB expression (Figure 4-5). These findings 
were further corroborated by experiments in which telomeric DNA from the same lines 
was run under alkaline conditions to separate the two strands of telomeric DNA. 
Hybridization with the (CCCTAA)4 or the (TTAGGG)4 probe resulted in the same pattern 
of hybridization, indicating that both of the telomeric strands were being degraded to a 
similar extent (Figure 4-6). 
Telomere length data obtained from FISH analysis and from telomere blots have 
suggested that some of the chromosome ends might have completely lost their telomeric 
DNA. This conclusion cannot be made with full confidence since due to limits of 
detection, lack of FISH signal might not represent complete telomere loss. However, 
chromosomes that lack telomeres should become fusogenic. Examination of anaphase 
cells of IMR90 cells induced to express TRF2AB indeed showed an increased level of 
fusion formation (Figure 4-7, top, Table 4-1). On the seventh day of the selection there 
were 0.6 fusions per anaphase in TRF2AB-expressing cells compared to 0.2 fusions per 
anaphase in control, and 0.3 fusions per anaphase in FLTRF2-expressing cells. As 
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Figure 4-4. Telomere length analysis in primary BJ fibroblasts infected with control virus, 
FLTRF2, TRF2AB, and TRF2ABAM. In gel hybridization of telomeric restriction fragments with an 
end-labeled (CCCTAA)4 telomeric probe under non-denaturing conditions (left) and denaturing 
conditions (right). Genomic DNA was isolated from cells carrying no exogenous TRF2 (vector), 
FLTRF2 (FLTRF2), TRF2AB (TRF2AB), and TRF2ABAM (TRF2ABAM ) on the indicated days of 
selection, digested with Mbol and Alul and fractionated on a 0.7% agarose gel. Equal loading 
was confirmed by ethidium bromide staining. The gel was first hybridized under non-denaturing 
conditions (native). Subsequently, the same gel was denatured and hybridized with the same 













Figure 4-5. Telomere length analysis in primary BJ fibroblasts infected with control virus, 
FLTRF2, TRF2AB, and TRF2ABAM. In gel hybridization of telomeric restriction fragments with an 
end-labeled (TTAGGG)4 telomeric probe under non-denaturing conditions (left) and denaturing 
conditions (right). Genomic DNA was isolated from cells carrying no exogenous TRF2 (vector), 
FLTRF2 (FLTRF2), TRF2AB (TRF2AB), and TRF2ABAM (TRF2ABAM ) on the indicated days of 
selection, digested with Mbol and Alul and fractionated on a 0.7% agarose gel. Equal loading 
was confirmed by ethidium bromide staining. The gel was first hybridized under non-denaturing 
conditions (native). Subsequently, the same gel was denatured and hybridized with the same 
probe (denaturing). The molecular weights of marker DNAs are indicated in kb. 
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Figure 4-6. Comparison between the C and the G strand length in BJhTERT SV40 Tag 
fibroblasts infected with control virus, FLTRF2, and TRF2AB. Southern blot of telomeric 
restriction fragments fractionated under denaturing conditions. Genomic DNA was isolated from 
cells on the indicated days of selection, digested with Mbol and Alul, fractionated on a 0.7% 
alkaline agarose gel, blotted onto a nylon membrane and hybridized first with a (CCCTAA)4 
probe and subsequently with a (TTAGGG)4 probe. Equal loading was not confirmed due to 
the alkaline conditions of the electrophoresis. The molecular weights marker were prepared by 
digesting a TTAGGG repeat bearing 2.6 kb pTH5 plasmid with Hindlll and self religation of the 
cut plasmid. Their size is indicated in kb . 
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Figure 4-7. Chromosomal abnormalities in TRF2AB expressing cells. A. Anaphase of 
IMR90 cells infected with TRF2AB, stained with DAPI on day 7 of selection. Arrow points to two 
pieces of DAPI positive material between the two future daughter cells. Two anaphase bridges 
are also visible. B. Partial metaphase spreads (top) and single chromosomes (bottom) of 
IMR90 cells expressing TRF2AB showing chromatid breaks and gaps (arrow heads) and a 
possible fusion most likely formed after a chromatid break (asterisk). Chromosomes were 
stained with DAPI. 
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Table 4-1. No induction of fusions in metaphase and anaphase HTC75 cells expressing TRF2AB. 
HTC75 S13 cells were grown under conditions resulting in repression or induction of the N-
terminal truncation of TRF2, TRF2AB HTC75 B27 cell line, which does not express any 
exogenous protein, was used as a control. Metaphase spreads were prepared on day 4 of 






















described in Chapter 1, 1.5 fusions per anaphase were seen in TRF2ABAM"expressing 
cells. There were also more fusions visible on metaphase spreads of TRF2AB-
expressing cells than in control, or FLTRF2-expressing cells; however, FLTRF2 also had 
considerably higher numbers of fusions than control cells (Table4-2, see discussion). 
Contrary to finding of fusions in primary cells, examination of anaphase HTC75 cells 
induced to express TRF2AB did not show increased fusion formation on the 4th day of 
induction ((van Steensel et al. 1998), Table 4-2). However, the 4th day might be too 
early to see fusions (also see discussion). 
Another abnormality was noted in anaphases of TRF2AB-expressing cells. 
Besides the fusions discussed above, small DAPI-positive pieces were seen between 
the cells. This has been seen in the HTC75 TRF2AB-expressing cells (van Steensel et al. 
1998), as well as in primary cells infected with TRF2AB (Figure 4-7,A). 20 small 
chromosome pieces were seen when 100 anaphases of TRF2AB-expressing IMR90 cells 
were scored (Table 4-1). 2 pieces per 100 anaphases were seen in cells infected with 
all other TRF2 alleles examined. The presence of pieces in anaphase cells correlated 
with their presence in metaphase spreads (Table 4-2). Additionally, metaphases 
revealed the presence of chromosome breaks (Figure 4-7, B and Table 4-1). Breaks 
were of the chromatid type and they would be able to give rise to fusions. One such 
fusion has been observed in cells expressing TRF2AB (Figure 4-7 B, bottom right panel) 
A different way of assessing chromosome breakage is to look for its products. 
Pieces seen in the anaphase cells might represent broken fragments that contained no 
centromere and were left behind by the spindle when the cell was dividing. In telophase 
such fragments may get incorporated into one of the newly formed nuclei. Alternatively, 
they may reform their own nuclear envelope and persist next to a main nucleus as a 
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Table 4-2. Induction of abnormalities in metaphase and anaphase IMR90 cells expressing no 
exogenous protein, FLTRF2, TRF2AB, TRF2ABAM. IMR90 cells infected with a vector control 
(pLPC), FLTRF2 (pLPCTRF2), TRF2AB (pLPCTRF2AB), or TRF2ABAM (pLPCTRF2ABAM) on day 7 of 
selection were scored on coded samples for the presence of abnormalities in metaphase and 
anaphase cells. All alleles were myc-tagged. Numbers in parentheses specify the fraction of 
metaphases or anaphases that had the indicated abnormality. 































§ 108 metaphases were scored for pLPC control, 115 for pLPCTRF2, 113 for pLPCTRF2AB, 57 for 
pLPCTRF2ABAM. 
* including bridges and lagging chromosomes 
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micronucleus. Primary BJ cells have very low level of micronuclei. Only 3 % of control 
cells had a micronucleus (Table 4-3). This number stayed low when FLTRF2 was 
expressed (2%) but increased to 33% when TRF2AB was expressed. Micronuclei were 
also frequent in TRF2ABAM-expressing cells although not as prominent as in cells 
expressing TRF2AB. Micronuclei formed in TRF2ABAM might be due to the breakage of the 
anaphase bridges that are formed frequently in these cells. 
Experiments described above indicate that TRF2AB expression led to dramatic 
changes in the genome. Telomere degradation and chromosome breakage were 
observed when TRF2AB was expressed in a variety of cells. Therefore it is not surprising 
that primary cells expressing TRF2AB grow poorly. IMR90 cells expressing TRF2AB 
behaved similarly to TRF2ABAM-expressing cells in all growth assays (discussed in 
Chapter 2); however, the growth arrest was never complete in the population. TRF2AB 
expressing cells grew very slowly, although slightly better than TRF2ABAM-expressing cells 
(Figure 4-8, A). BrdU incorporation on day 15 in cells expressing TRF2AB was only 40% 
of incorporation in control cells. This number was again significantly higher than in 
TRF2ABAM-expressing cells. The morphology of the arresting cells in the TRF2AB-
expressing population at day 15 was very similar to TRF2ABAM-expressing cells, with cells 
becoming large and flat and becoming positive for the senescence-associated p-
galactosidase activity (SA P-gal). However, the degree of the morphological change, as 
well as the intensity of the SA p-gal staining was again decreased when compared to 
TRF2ABAM-expressing cells. The protein expression profile on day 15 has confirmed the 
above findings. Although p53 and p16 were induced to the same level as in TRF2ABAM-
expressing cells, TRF2AB-expressing cells showed some Rb hyperphosphorylation, as 
well as some cyclin A expression, suggesting that some of the cells in the population 
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Table 4-3. Micronuclei in primary BJ cells expressing no exogenous protein, FLTRF2, TRF2AB, 
TRF2abam pnmary BJ1 cells were infected with a vector control (pLPC), FLTRF2 (pLPCTRF2), 
TRF2AB (pLPCTRF2AB), or TRF2ABAM (pLPCTRF2ABAM). On day 6 of selection, DAPI stained 
anaphase nuclei were scored. Most of the events comprised of a single micronucleus abutting 
the interphase nucleus. 
Cell line % cells with micronuclei 
pLPC 3 % 
pLPC TRF2 2 % 
pLPCTRF2AB 3 3 % 'o 
pLPCTRF2ABAM 1 7 % 
*300 interphase cells were scored for pLPC, pLPCTRF2, and pLPCTRF2ABAM, 602 interphase 
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Figure 4-8. Effects of expression of TRF2AB on growth characteristics, protein expression 
profile and SA p-gal staining of young IMR90 cells- comparison with cells expressing 
TRF2ABAM (also see chapter 2). A. Representative growth curve of vector control, TRF2, 
TRF2AB or TRF2ABAM expressing IMR90 cells. On the 4th day of selection, cells were plated in 
duplicate at 3x104 cells per well in a six-well plate. On the indicated days cells from 2 wells 
were washed, trypsinized and counted in duplicate using a Coulter counter. B. % of cells in S-
phase as measured by 1 hour bromo-deoxyuridine (BrdU) incorporation on day 5, 10 and 15. 
All numbers are normalized to the level of BrdU incorporation in vector control cells as 
explained in Figure 2-2. C. Western blot analysis of cell cycle regulatory proteins in control, 
TRF2, TRF2AB, and TRF2ABAM expressing cells. Cells were collected on day 14 of selection. D. 
Senescence associated 6-galactosidase activity. Cells infected with TRF2 alleles were plated at 
low density and stained for p-galactosidase activity at pH 6 on day 14 of selection. E. 
Representative growth curve of IMR90 cells expressing SV40 large T antigen and vector 
control, TRF2, TRF2AB or TRF2ABAM F. % of IMR90 cells expressing SV40 large T antigen 
and TRF2 alleles in S-phase as measured by 1 hour BrdU incorporation on day 5,10 and 15. 
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were actively cycling. To determine if the SV40 Tag is able to rescue cells from the 
TRF2AB-induced growth arrest, TRF2AB was expressed in cells already expressing SV40 
Tag. Just like in TRF2ABAM-expressing cells, the BrdU levels were restored to levels of 
control cells, but the growth curves showed that the TRF2AB-expressing populations 
grew poorly. 
Discussion 
This chapter has explored the function of the basic domain of TRF2 by studying 
the phenotypes associated with expression of the N-terminal truncation of TRF2, 
TRF2AB. By binding to telomeres, the TRF2AB allele appears to displace the full-length 
protein (Figure 4-1). This is in agreement with the finding that in vitro TRF2AB has a 
slightly higher affinity for telomeric repeats than FLTRF2 (van Breugel and Titia de 
Lange, unpublished data). In vitro TRF2AB forms higher-order oligomers to a greater 
extent than the TRF2 (van Breugel and Titia de Lange, unpublished data), which might 
increase the affinity for DNA by bringing more myb domains in the vicinity of multiple 
binding sites on the telomeric DNA. 
One of the phenotypes observed after expression of TRF2AB is loss, or a 
significant reduction of telomere signal from many chromosome ends. Often only one of 
the sister chromatids on a mitotic chromosome had a decreased signal. Such a finding 
suggests that many of the events leading to appearance of shorter telomeres had to 
occur in S or G2 phase immediately preceding mitosis. One of the many possible 
scenarios of how TRF2AB expression could lead to telomere loss on one chromatid is 
shown in Figure 4-9 (left column). It is proposed here that the presence of TRF2AB 
creates a nick in one strand of the DNA. The site of the nick suggested in the model is 
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Figure 4-9 Model of telomere loss and break formation upon induction of TRF2AB. 
Presence of TFRF2AB creates a nick (at any place in the loop not necessarily where indicated in 
the schematic). The nick is processed during the S phase and creates a shortened telomere on 
one chromatid and a normal telomere on the opposite chromatid. The telomeric DNA that has 
been severed gets degraded. Similarly, if a t-loop is made by an invasion of the overhang into 
the interstitial site, a break forms on one chromatid, but not on the other. Formation of t-loops 
involving the interstitial TTAGGG sites are not necessary for this model. TFRF2AB through 
binding at the interstitial sites might bring the necessary factors for the fragmentation to occur. 
Also, multiple nicks might be formed due to TFRF2AB expression, leading to a faster 
degradation of the telomere. 
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site. The nick is processed into a break during D N A replication and eventually the 
telomere piece that has been formed is degraded. How TRF2AB would lead to the 
creation of a nick is not specified in the model, but one possibility is that the basic 
domain interacts with an inhibitor of a nuclease present at telomeres. At some point in 
the cell cycle such a nuclease might be needed for the resolution of the t-loop. Lack of a 
basic domain would repress the inhibition leading to increased activity of the nuclease. 
The biochemical activity of the nuclease would specify whether a nick, a break, or a 
complete degradation of one or both strands would be expected. It is proposed here 
that the nuclease makes a nick, since such a proposal would be in agreement with the 
frequent finding of decreased telomeric DNA only at one of the sister chromatids. 
However, other reasons for the presence of decreased signals on only one of the 
chromatids can be proposed. It is possible, for example, that one of the chromatids is 
more susceptible to the TRF2AB-induced loss. This might not be unlikely, since one of 
the chromatids is made by a leading strand synthesis, and the other by lagging strand 
synthesis. Chromosome orientation-FISH (CO-FISH) experiments, which allow for 
discrimination between the two types of chromatid, will be informative in this regard. The 
experiment needs to be performed at a very early timepoint after infection with TRF2AB to 
aid in visualization of the events occurring in the first cell cycle after expression of 
TRF2AB. Disappearance of the signal from both of the sister chromatids, an event that 
was often seen in TRF2AB-expressing cells, could have been due to simultaneous loss of 
a substantial length of telomeric DNA from both chromatids, or replication of a 
chromosome that has lost the telomeric DNA in a previous division. 
Loss of telomeric DNA was also documented on Southern blots visualizing 
telomeric DNA from cells expressing TRF2AB (Figure 4-3 and 4-4). However, the signal 
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never fully disappeared in any of the experiments performed. This could be due to the 
growth arrest that ensues after TRF2AB is expressed. Telomeres of non-cycling cells 
might not participate in the degradation events. Nonetheless, even when cells 
expressing the SV40 T antigen were used for the study, (Figure 4-3) the telomeres never 
completely disappeared. Instead telomere length returned to normal. This was most 
likely due to constant cell death (compare growth curve in Figure 4-8 E to BrdU labeling 
in Figure 4-8 F), and due to selection against the TRF2AB allele. Another possibility 
comes from the proposal that telomeres can be lost from only one chromatid. If this is 
the case, it would take a very long time of constant division without the loss of TRF2AB 
expression, to homogenize telomeres to the low length. In combination with obvious 
deleterious effects of TRF2AB the expression, reaching such state would be impossible. 
A related question pertains to the behavior of the HTC75 S cell lines that express 
TRF2AB. Expression of TRF2AB led to appearance of breaks in these cells (see below); 
however, loss of telomeric DNA was not prominent (van Steensel et al. 1998). The 
telomere blots revealed a mere hint of loss of hybridization intensity, and the loss was 
much less pronounced than in any other cell line studied. It is possible that the 
combination of the already short telomeres present in these clones and the rapid 
induction of the growth arrest after TRF2AB expression, precluded identification of 
telomere signal changes. Increased heterogeneity of the signal might also be missed 
because telomeres in the HTC75 cells already were represented by a heterogenous 
smear under electrophoresis conditions used in the experiments. 
Besides the loss of telomeric DNA, metaphase spreads of cells expressing 
TRF2AB also revealed the presence of chromatid breaks. Although the origin of such 
breaks is unknown at this point, a model that parallels the telomere loss model after 
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TRF2AB expression is presented in Figure 4-9 (right hand side). It is proposed that 
TRF2AB localizes to the interstitial TTAGGG sites and that a t-loop is made by invasion of 
the G-overhang into the interstitial TTAGGG repeats. Subsequent events, identical to 
the ones presented for the telomere loss would lead to a formation of a chromatid break. 
This is also an attractive model for how interstitial (TTAGGG)n sites might be able 
to induce chromosomal breakage, visualized in many studies presented in the 
introduction. TRF2 is proposed to bind to the interstitial telomeric DNA repeats and an 
inappropriate formation of the t-loops and subsequent processing is proposed to lead to 
break formation. Binding of endogenous TRF2 to interstitial sites has been noted in a 
number of hamster cell lines, which are characterized by presence of blocks of telomeric 
DNA sequences at internal sites (Smogorzewska et al. 2000). The influence of telomeric 
proteins on break induction at interstitial sites can now be tested using the system 
described in the introduction, where a block of 800 bp of telomeric DNA has been 
inserted into the APRT locus in the hamster. Based on the proposal presented here 
expression of TRF2 should result in increased rates of rearrangements involving the 
engineered interstitial sites. Expression of the TRF2AB, due to its increased affinity for 
the telomeric DNA should result in even better binding to the interstitial sites giving rise 
to a greater number of rearrangements. 
The chromatid breaks seen in the cells expressing TRF2AB, when repaired, 
should lead to formation of fusions. As seen in Figure 4-7, one of such events has been 
observed. In this case, a broken end seemed to fuse with another broken end or 
possibly a chromosome end, presumably after that end lost telomeric DNA. However, 
not enough fusions of this type were seen on metaphase spreads to explain the levels of 
anaphase bridges noted in cells expressing TRF2AB. Fusions might have also been 
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formed between chromosomes that lost their telomeres. Fusions resulting from joining 
of broken ends or chromosomes devoid of telomeres should not have telomeric DNA at 
the site of fusion. Whether fusions induced by TRF2AB do, or do not have telomeric DNA 
remains to be determined. 
In some of the experiments presented in this chapter, cell overexpressing 
FLTRF2 behaved in a similar way to TRF2AB-expressing cells. For example, formation of 
breaks and fusions was significantly higher in FLTRF2-expressing cells than in control 
cells (Table 4-1), although not as high as in TRF2AB-expressing cells. This behavior of 
cells infected with FLTRF2 could be explained in many ways. First, the alleles in this 
experiment were tagged at their N termini. For a full-length protein a tag would occur 
next to the basic domain. If the tag interfered with the correct functioning of the full 
length protein, a TRF2AB-like phenotype would be expected. Secondly, some TRF2AB 
and possibly TRF2ABAM protein degradation products might be present in cells expressing 
FLTRF2. Presence of degradation products of FLTRF2 was observed on western blots 
of short-term experiments. Since TRF2AB has a higher affinity for DNA, even if it is not 
present at very high level, it might be able to compete out the overexpressed TRF2. It is 
possible that with time the cells that had substantial levels of TRF2AB were lost. The 
finding that the growth of TRF2 expressing cells is a little slower at the beginning of the 
experiments substantiates this interpretation (Figure 4-8, A). With time, the FLTRF2-
expressing cells grew at the same rates as control cells. Finally, FLTRF2 might have 
been titrating away the protein that normally binds to the telomeric TRF2, and in 
particular to the basic domain of TRF2. As a result, there would be less of that protein 
present to telomeres leading to the partial telomere dysfunction. 
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The growth arrest of human primary cells expressing TRF2AB is very reminiscent 
of the growth arrest induced by the dominant negative TRF2 (TRF2ABAM). Based on the 
protein expression profile and the ability of the SV40 Tag to abrogate the arrest, it seems 
that the signaling through the same pathways caused the arrest. It is interesting to 
speculate about the cause of the arrest. Telomere loss is so pronounced in the cells 
expressing TRF2AB, that many, if not all cells in the population might have lost a few of 
their telomeres. Such event would lead to activation of the pathways that are naturally 
activated during senescence, leading to the permanent growth arrest. It is also possible 
that induction of breaks might lead to the growth arrest. This interpretation is supported 
by the findings that the HTC75 expressing TRF2AB, arrest and exhibit chromosome 
breakage but do not exhibit substantial telomere loss. However, as discussed above, 
the inability to visualize telomere shortening in these cells, does not preclude that some 
telomeres did get very short, leading to growth arrest 
Based on the experiments presented here, the basic domain appears to be a 
vital regulatory domain of TRF2. It will be important to identify proteins interacting with 
the basic domain. Such proteins are predicted to be negative regulators of degradation. 
Further studies of such proteins have a potential of elucidating the degradative 
processes at the telomere. 
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C h a p t e r 5 
Centrosomal localization of TRF2 and 
c e n t r o s o m e / g e n o m e reduplication in cells 
expressing T R F 2 ^ M o r TRF2AB 
Introduction 
A complicated network of proteins acting in concert to activate the cdk2 
complexes regulates entry into S phase of the cell cycle (reviewed in Bartek and Lukas 
2001). The CyclinE-Cdk2 complex integrates signals emanating from Rb-E2F and the 
Myc pathways, and is the main effector of these pathways leading to stimulation of DNA 
synthesis. To avoid DNA synthesis when DNA is damaged, multiple pathways are 
employed to keep Cdk2 in a non-active state. These pathways include the degradation 
of cyclin D1 releasing p21 to inhibit Cdk2 (Agami and Bernards 2000), degradation of 
Cdc25A phosphatase leading to persistence of inhibitory phosphates on Cdk2 (Mailand 
et al. 2000), and activation of p53 (reviewed in Vogelstein et al. 2000) leading to 
transcriptional activation of p21 resulting in a more permanent inhibition of S phase 
entry. 
Centrosomes are the microtubule organizing centers of animal cells and they, 
like DNA, replicate once and only once per cell cycle. The cycle of centrosomal 
duplication is in fact coordinated with DNA replication, and the centrosomal duplication is 
also driven by the Cdk2 complexes (reviewed in Winey 1999), although controversy 
exists whether Cyclin A or E is the necessary cyclin partner of Cdk2. Other kinases, 
including the Polo-like, Aurora-related, and NIMA-related kinases, are important for 
proper duplication and/or function of the centrosomes (reviewed in Mayor et al. 1999). 
An inability to control centrosome numbers has been found to be a characteristic 
of many tumor cells (reviewed in Duensing and Munger 2001). It appears that 
centrosomal reduplication is associated with inappropriate function of many proteins 
including p53 (Fukasawa et al. 1996), BRCA1 (Xu et al. 1999), STK15 (Zhou et al. 
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1998), and Skp2 (Nakayama et al. 2000). Based on the very high number of different 
proteins that are found at the centrosome (see Table 1, (Duensing and Munger 2001)), 
the centrosome appears to be a site where many signals could be integrated during cell 
growth. 
A recent study has localized one of the telomeric proteins tankyrase, a TRF1 
interacting factor, to mitotic centrosomes of human cells (Smith and de Lange 1999). 
Tankyrase co-localizes with NuMA (nuclear/mitotic apparatus protein), which resides at 
the periphery of mitotic centrosomes. The function of tankyrase at human centrosomes 
is unknown; however, based on its poly(ADP-ribose) polymerase activity, it has been 
proposed that tankyrase might regulate other centrosomal proteins. 
This chapter presents two unexpected observations of genome and centrosome 
reduplication occurring after expression of jRF2ABAM or TRF2AB, and of centrosomal 
localization of TRF2. 
Results 
While examining metaphase spreads of primary human fibroblasts expressing 
TRF2ABAM and TRF2AB (See Chapter 1 and 4), it was noted that some metaphases 
harbored an increased number of chromosomes. Although it was often impossible to 
determine the exact number of chromosomes on most metaphases, if it appeared that 
there were more than 70 chromosomes on a spread, it was considered to represent 
genome reduplication. According to this criterion -37% of metaphases of cells 
expressing jRF2ABAM and -23% of metaphases of cells expressing TRF2AB showed 
genome reduplication (Table 5-1). In contrast, only -3% of control cells expressing no 
exogenous protein showed reduplication of the genome. FLTRF2-expressing cells 
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Table 5-1 Genomic reduplication in young cells expressing no exogenous protein, FLTRF2, 
TRF2AB, TRF2ABAM. Primary IMR90 cells were infected with a vector control (pLPC), FLTRF2 
(pLPCTRF2), TRF2AB (pLPCTRF2AB), or TRF2ABAM (pLPCTRF2ABAM). Al! alleles were myc-tagged. 
On the day 7 of selection, metaphases were prepared after 90 min colcemid treatment and those 
that had more than 80 chromosomes were scored as reduplicated. 
Cell line % of metaphase spreads with reduplication" 
pLPC 3 % 
PLPCTRF2 16% 
pLPCTRF2AB 23% 7o 
pLPCTRF2ABAM 3 7 % 
* 98 metaphases were scored for pLPC control, 115 for pLPCTRF2, 113 for pLPCTRF2AB, 57 for 
pLPCTRF2ABAM. 
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showed an intermediate level of reduplication (-16%); however, this allele of TRF2 was 
N-terminally tagged, which could have created a partial TRF2AB allele (for a more 
thorough discussion of why FLTRF2 might show some TRF2AB phenotypes, please see 
the discussion to Chapter 4). The striking finding was that the reduplicated 
chromosomes most often occurred in pairs, an arrangement also known in cytogenetic 
literature as a diplochromosome (Figure 5-1). To assure that they were true 
diplochromosomes and not prematurely separated sister chromatids, chromosomes 
were observed under high magnification. Many spreads showed diplochromosomes 
with clearly delineated four chromatids. Some, but not all metaphases that revealed 
diplochromosomes also exhibited end-to-end fusions (Figure 5-1). 
In one experiment, metaphases of TRF2ABAM and TRF2AB-expressing cells 
showed premature chromosome division (PCD) (Figure 5-2), which is characterized by 
dissolution of cohesion between sister chromatids not only along the arms but also at the 
centromere while cells are still in metaphase. Normally, the separation of sister 
chromatids occurs at the metaphase to anaphase transition, thus visualization of this 
event in metaphase spreads is abnormal. Among 44 metaphases of TRF2ABAM-
expressing cells, 87 chromosomes displayed PCDs, and among 10 metaphases of 
TRF2AB-expressing cells, 14 chromosomes displayed PCDs. Premature chromosome 
division was so far only visualized in one experiment in which metaphases were arrested 
for 12 hours by colcemid treatment. No premature chromosome division was visualized 
in control cells (35 metaphases examined) or FLTRF2-expressing cells (10 metaphases 
examined) prepared under identical conditions. In other experiments in which 
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Figure 5-1. Genome reduplication visualized on metaphases of TRF2ABAM and TRF2AB 
expressing IMR90 human primary fibroblasts. Metaphase spreads of IMR90 cells 
expressing TRF2ABAM and TRF2AB were prepared on day 7 of selection. Chromosomes were 
stained with DAPI. The two top metaphase spreads show a reduplication which occurred in the 
division proceeding the metaphase shown. Reduplication shown in the bottom spread might 
have occurred in the preceding or an earlier division since many of the duplicated 
chromosomes do not show the diplochromosome arrangement. Please note that many end-to-
end fusions are visible in the spreads (also see Figure 1-12 C). 
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Figure 5-2. Premature chromosome division (PCD) in metaphase spreads of IMR90 
fibroblasts expressing TRF2ABAM. Multiplex fluorescence in situ hybridization (M-FISH) on 
metaphase spreads of cells expressing TRF2ABAM. Spreads were prepared on day 6 of 
selection, after 12-hour colcemid treatment. Chromosomes 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 
14, 16, 17, 21, and X show premature chromosome division 
(Experiments done in collaboration with Heidi Holtgreve-Grez and Anna Jauch (Institute 
fur Humangenetik, Heidelberg, Germany) 
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DNA replication and duplication of the centrosomes are highly synchronized and occur in 
S phase of cell cycle. The presence of metaphase spreads with twice the genetic 
information should be mirrored by the presence of interphase cells with more than two 
centrosomes, unless DNA replication and the centrosomal cycle were uncoupled. 
Indeed, many TRF2ABAM-expressing interphase cells, when stained with an antibody 
directed against y-tubulin, a protein only found in the pericentriolar region of the 
centrosomes, showed three or more centrosomes (Figure 5-3). They were often found 
in clusters of four, suggesting two rounds of duplication, although some cells carried 
more than 6 centrosomes. Quantification of centrosome numbers in interphase cells 
showed that expression of TRF2ABAM allele led to 3 to 5 fold increase in anaphase cells 
with 2 or more centrosomes (Table 5-2). TRF2AB allele expression in IMR90 primary 
fibroblasts had less influence on centrosome numbers at an early timepoint after 
infection (day 5 of selection), but showed a fourfold increase in % of anaphase cells with 
2 or more centrosomes at day 14 of selection (Table 5-2). In WI38 cells, the background 
of interphase cells with 2 or more centrosomes was higher than in IMR90 cells, reaching 
9% of all interphase cells. This number was possibly higher than in the IMR90 cells 
because WI38 cells were cultured for a longer time before the infections thus they were 
closer to entry into senescence (see below). Nevertheless, there was an almost 3 fold 
increase in the % of cells with more than 3 centrosomes when jRF2ABAM was expressed. 
Expression of TRF2ABAM and TRF2AB was shown to lead to growth arrest with 
characteristics of senescence (Chapter 2 and 4). Population very close to a senescent 
state have been previously observed to have polyploid cells (Saksela and Moorhead 









Figure 5-3. Centrosomal reduplication in IMR90 human primary fibroblasts expressing 
TRF2ABAM. Indirect immunofluorescence against y-tubulin (shown in green) in primary human 
cells infected with TRF2ABAM- DNA was counterstained with DAPI. 
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Table 5-2 Centrosomal reduplication in young cells expressing no exogenous protein, FLTRF2, 
TRF2AB, TRF2ABAM, and in senescent cells. Primary IMR90, WI38, and HS68 cells were infected 
with myc-tagged vector control (pLPC), FLTRF2 (pLPCTRF2), TRF2AB (pLPCTRF2AB), or 
TRF2abam (P|_PCTRF2ABAM). On the indicated days of selection, cells were methanol fixed, 






























































*ln paranthesis number of cells scored is indicated 
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passage 43 (p43) IMR90 cells, which reached senescence a week or two earlier, 
centrosomes were visualized using anti y-tubulin. 27% of cells had three or more 
centrosomes suggesting that centrosomal reduplication is one more characteristic of 
senescent cells. 
In the experiments were numbers of centrosomes in each cell were quantified, 
TRF2 was often used to co-stain the nuclei that were being stained with y-tubulin to 
check for the expression of the TRF2 alleles. It was surprising to find that endogenous 
TRF2 in the control cells besides forming a familiar punctate pattern in the nucleus, 
localized to centrosomes. Two separate antibodies raised against TRF2, rabbit antibody 
647 and a goat antibody to TRF2 (Imgenex), recognized centrosomes both in mitosis as 
well as in interphase cells (Figure 5-4). Staining of centrosomal TRF2 was much 
dimmer in interphase cells, although it was still above background staining. Dimmer 
staining in anaphase cells was noted for other centrosomal components. 
TRF2 staining in immunofluorescent studies surrounded centrin, which gave the 
expected double-dot staining of two centrioles per centrosome (Figure 5-4, top panel). 
Staining of y-tubulin and TRF2 generally overlapped; however, staining of y-tubulin in 
mitotic cells was often broader and seemed to extend onto the microtubules emanating 
from the centrosomes. Overall, the most overlap was found between TRF2 and 
pericentrin, a known component of a centrosome (Figure 5-4, third row). 
Previous studies have localized tankyrase at centrosomes of metaphase and 
early anaphase cells, but not in late anaphase, telophase or interphase cells. To 
compare localization of TRF2 and tankyrase, HeLal.2.11 were stained with antibodies 
recognizing the two proteins. Generally, tankyrase appeared to surround TRF2 in 
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Figure 5-4. Localization of T R F 2 to c e n t r o s o m e s in HeLal.2.11 cells. Indirect 
immuofluorescence with antibodies raised against TRF2 (goat a TRF2 and rabbit a TRF2 
#647), and with mouse a centrin, mouse a pericentrin , or mouse a y-tubulin. HeLal.2.11 were 
fixed in methanol and costained with the indicated antibodies. FITC-conjugated a rabbit or 
FITC-conjugated a goat and TRITC a mouse secondary antibodies were used to visualize the 
primary antibodies. DNA was counterstained ith DAPI. Cells in metaphase and interphase are 
shown as indicated on the left. 
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especially visible in early anaphase cells (Figure 5-5). Consistent with previous results, 
tankyrase staining was not present in some anaphase cells (Figure 5-5) or interphase 
cells. 
Often in colocalization studies a concern arises that the proteins appear to 
colocalize because the signal of one of the proteins is so strong that it is seen in 
adjacent channels (often called bleed-through). The finding that the TRF2 signal did not 
colocalize with the tankyrase signal suggests that the signals were specific for each 
protein. However, to formally prove that there was no bleed-through, a control 
experiment was performed. Cells were stained separately with antibodies recognizing 
TRF2, tankyrase, Y-tubulin, and centrin. Subsequently, pictures were taken in all 
channels. The control channels that should have exhibited no staining stayed blank as 
expected (Figure 5-6), which led to the conclusion that the signal of TRF2 on 
centrosomes was specific. 
Discussion 
Reduplication of the genome is a prevented event when all checkpoints are 
active in the cell. It is surprising that expression of JRF2ABAM and TRF2AB in human 
primary fibroblasts led to a frequent occurrence of apparent reduplication that was 
visualized on metaphase spreads and deduced from the presence of increased numbers 
of centrosomes in interphase cells. As shown in Chapter 2 and 4, expression of 
TRF2ABAM and TRF2AB alleles leads to growth arrest, a result of activation of p53 and Rb 
pathways. Results described here, suggest that the growth arrest is preceded or 
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Figure 5-5. Localization of TRF2 and tankyrase to centrosomes in HeLal.2.11 cells. 
Indirect immuofluorescence with rabbit a TRF2 (#647) and mouse a tankyrase. HeLal.2.11 
were fixed in methanol and costained with the indicated. FITC-conjugated a rabbit and T R I T C 
a m o u s e secondary antibodies w e r e used to visualize the primary antibodies. D N A w a s 



















Figure 5-6. Staining of centrosomes with 647, tankyrase, y-tubulin, and centrin in 
HeLal.2.11 cells. Indirect immuofluorescence with rabbit a TRF2 (647), mouse a tankyrase, 
mouse a y-tubulin, and mouse a centrin. HeLal.2.11 were fixed in methanol and stained 
separately with the indicated antibody. FITC-conjugated a rabbit and TRITC a mouse 
secondary antibodies were used to visualize the primary antibodies. Green and red channels 
were both exposed for 0.2 s with 100% gain as a control for the bleed-through of the signal into 
the other channel. 
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Frequent arrangement of duplicated chromosomes in diplochromosomes implies 
that the events leading to the reduplication occurred in the same cell cycle (Figure 5-7). 
The reasons for reduplication of the genome are unclear at this point. As described in 
the introduction, expression of p53 should preclude any DNA or centrosomal 
reduplication. However, presence of an increased numbers of centrosomes in 
senescent cells might indicate that telomere dysfunction somehow triggers the 
reduplication in spite of high p53 expression. Expression of jRF2ABAM and TRF2AB also 
gives rise to telomere dysfunction and because the events are fairly synchronized, the 
reduplication can be visualized to occur within one cell cycle. It remains to be explored if 
cells that are undergoing reduplication, and presumably characterized by high CyclinE-
Cdk2 activity, also have high p53 levels. 
The events leading to reduplication might be suggested by a finding of premature 
chromosome division on metaphases of TRF2ABAM and TRF2AB-expressing cells 
observed in one experiment (Figure 5-2). Normally, cohesion between sister chromatids 
is established during S phase of the cell cycle and persists until prophase of the M 
phase along the chromosomal arms, or until the metaphase to anaphase transition in the 
centromeric region. Observation of premature separation of centromere regions 
suggests that the cohesion has prematurely failed. These results were obtained by 
observing metaphase spreads that were prepared by arresting cells for 12 hours in 
colcemid. It could be argued that the centromere separation was an artifact of this 
prolonged colcemid treatment; however, the control and FLTRF2-expressing cells did 
not show this phenotype. This argues that presence of TRF2ABAM and TRF2AB, although 
not necessarily directly, might predispose cells to premature centromere division. If such 




Figure 5-7. Model of reduplication of the genome following telomere dysfunction (see text 
for details). 
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undergo another round of DNA synthesis, the next metaphase would show 
diplochromosomes. 
Presence of PCDs and diplochromosomes in metaphase cells might not be 
causally linked; however, they both suggest failure of the cohesion apparatus at some 
point in the cell cycle. Recent evidence suggests that a successful anaphase and 
cytokinesis require a proper dissolution of cohesion (Stratmann and Lehner 1996; Hauf 
et al. 2001). Expression of the non-cleavable SCC1, a component of the cohesion 
complex, which is cleaved at the onset of anaphase to relieve sister chromatid cohesion, 
results in inappropriate dissociation between progression of cytokinesis and progression 
of cyclin-driven cell cycle. This is documented by observation that cells expressing the 
non-cleavable SCC1 frequently exit mitosis and enter interphase without undergoing 
anaphase. These events result in formation of polyploid cells, some of them 
characterized by the presence of diplochromosomes (Hauf et al. 2001). It is interesting 
to speculate that the diplochromosome formation in cells that failed cohesion and cells 
expressing mutant forms of TRF2 might be related. It is possible that without proper 
telomere function, cohesion cannot be properly regulated. Further study of influence of 
telomere status on establishment and dissolution of cohesion will be necessary to 
understand the connection if there is any. 
Another question is whether the reduplicated centrosomes are functional in 
making multiple spindles during subsequent anaphase. Anaphases with tri-polar 
spindles were not observed in the populations expressing TRF2ABAM and TRF2AB, which 
suggests that cells with reduplicated centrosomes were already arrested, or that 
centrosomes once reduplicated stayed together allowing for normal spindle formation. It 
is known that even cells without functional p53, which have multiple centrosomes, are 
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able to form normal bipolar spindles most of the time (Ring et al. 1982; Fukasawa et al. 
1996). 
The observation of the presence of TRF2 on centrosomes is also unexpected. It 
must be stressed that although reduplication of the genome and centrosomal localization 
of TRF2 are discussed in the same chapter, the two occurrences are not yet shown to 
be related in any way. 
Currently, it is not clear what function telomeric proteins could have at 
centrosomes. Another telomeric protein, tankyrase, also localizes to centrosomes and 
its function is also unknown. The most pressing question about the presence of TRF2 at 
centrosomes is whether TRF2ABAM and TRF2AB localize to centrosomes. It would be 
surprising if the Myb domain was necessary for the localization, since after a long debate 
it is currently clear that there is no nucleic acid at the centrosome (Marshall and 
Rosenbaum 2000). It is at this point also unknown, if JRF2ABAM removes the 
endogenous TRF2 from centrosomes. It is very hard to observe overexpressed TRF2 
on centrosomes using immunofluorescence staining. A better approach will be to look if 
Rapl, a TRF2 binding partner, is present at centrosomes when different alleles are 
expressed. To avoid a titration effect; however, TRF2 will have to be engineered to be 
deficient for the Rapl interaction domain. Also, the presence of all other telomeric 
proteins on centrosomes needs to be explored. With the finding of TRF2 and Tankyrase 
at centrosomes it is possible that the whole telomeric complex is also present there. 
The presence of TRF2 on centrosomes might be important for meiosis. In many 
species telomeres form the so-called bouquet by juxtaposing their telomeres against the 
meiotic centrosome (reviewed in Scherthan 2001). There is some evidence that such an 
arrangement aids in the alignment of homologous chromosomes prior to recombination. 
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In S.pombe, Tazl, an ortholog of TRF proteins in mammalian cells, is responsible for the 
association of telomeres with a spindle pole body (SPB), a yeast equivalent of the 
centrosome. Lack of Tazl leads to dissolution of the association between the SPB and 
the telomere, leading to failed alignment and unsuccessful meiosis (Nimmo et al. 1998). 
It will be interesting to learn how Tazl is anchored to the SPB. Such knowledge might 
shed light on how TRF2 localizes to centrosomes. 
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C o n c l u d i n g R e m a r k s 
This thesis has concentrated on exploring the function of TRF2 in human cells. 
TRF2 was cloned by Dominique Broccoli and myself based on homology to the Myb 
domain of TRF1, the first human telomeric protein. Functional analysis has pointed out 
that despite high homology in the Myb domain as well as in the TRFH domain, TRF1 
and TRF2 have completely divergent roles at telomeres. 
As described in detail in the introduction, the main function of the telomere in all 
species is to protect the chromosome end from being recognized as a double-stranded 
break. Although the mechanisms might not be fully understood yet, it is now clear that 
TRF2 is able to supply this protective function to human telomeres. Deprotection after 
removal of TRF2 was observed in multiple human and mouse cell lines including a tumor 
cell line (HTC75), human primary fibroblasts (IMR90, BJ), and MEFs. Inhibition of TRF2 
function led to appearance of end-to-end fusions visible in anaphase and metaphase 
cells. It was deduced that prior to fusion, the deprotected chromosome lost a single-
stranded G-overhang, but not the double-stranded TTAGGG repeat array and the 
fusions were formed through a covalent ligation of the DNA strands. DNA ligase IV was 
responsible for the ligation since MEFs deficient in this ligase were also deficient in 
fusion formation. Division with deprotected telomeres led to induction of genomic 
instability visualized mainly as translocations. 
TRF2 most likely protects telomeres by stimulating formation or stabilization of t-
loops at chromosome ends. T-loops, in turn, are thought to conceal the very end of the 
telomere. The protective function of TRF2 has been uncovered using a dominant 
negative allele TRF2ABAM. Expression of TRF2ABAM efficiently removes endogenous TRF2 
from telomeres as evidenced by using immunofluorescent staining; however, it is 
impossible to say how complete this dominant negative effect is and some telomeres 
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may contain residual TRF2. Therefore, cells null for the protein might exhibit an even 
more dramatic telomere deprotection phenotype. Based on the phenotype of the 
TRF2ABAM-expressing cells, it is very likely that a mouse deficient in TRF2 might not be 
able to develop properly. Thus, a conditional KO system needs to be employed to 
examine the null phenotype of TRF2 in a true in vivo mouse system or in mouse 
embryonic stem (ES) cells. 
The deprotection phenotype observed in cells expressing jRF2ABAM was 
characterized by persistence of the double-stranded telomeric DNA. It is interesting to 
compare this phenotype to deprotection phenotypes seen in other organisms. Lack of 
Cdc13p leads to rapid degradation of the C-strand of the telomere in S. cerevisiae, 
whether as deficiency of Potl in S.pombe results in rapid degradation of both the C and 
the G strands of the telomere. Why is it that a telomere devoid of TRF2 seems to be 
inert towards the degradation processes? One possibility is that TRF2 is needed to 
anchor the degradative machinery to the telomere. Thus, without TRF2 being present at 
the telomere when jRF2ABAM is expressed, the proteins responsible for the degradation 
cannot be recruited there either. This results in maintenance of the double-stranded 
telomeric DNA. 
Although TRF2 is shown to be a crucial protective agent at the telomere, its 
activity does not exclude other protective factors acting in concert or in parallel pathways 
to protect the end. An excellent candidate for such an activity is the newly-discovered 
hPotl, an ortholog of S. pombe Potl, lack of which leads to clear telomere deprotection 
in fission yeast (Baumann and Cech 2001). Since the human protein has biochemical 
activities of a single-stranded binding protein with specificity for the TTAGGG repeats, it 
might protect the G-overhang at specific times in the cell cycle when the t-loop needs to 
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be dissolved, for example during the replication process. Alternatively, hPotl could bind 
to the single-stranded DNA in the D-loop, which has been shown to be present at the 
base of the t-loop (Griffith et al. 1999). The distinction between the two possibilities 
might be made using electron microscopy, as well as the immunofluorescent approach. 
It will be also essential to know if the presence of Potl on telomeres depends on the 
TRF2. This might be done by inspection of telomeric localization of Potl in the cell lines 
expressing TRF2ABAM or TRF2AB. Based on the finding that the deficiency of Potl in S. 
pombe leads to the degradation of the double stranded telomeric DNA, one could 
speculate that the removal of human Potl would also result in such event. However, it is 
also possible that the lack of Potl will result in phenotypes that resemble the phenotypes 
of TRF2ABAM or TRF2AB-expressing cells. Overall, the chromosomal events leading to 
the deprotection after Potl removal might be more easily studied in human cells than in 
the yeast cells. 
More biochemical analysis of TRF2 will be necessary to fully understand how the 
presence of this protein leads to formation or stabilization of the t-loops. Although 
current knowledge suggests that TRF2 forms homo-oligomers and not dimers like TRF1, 
it is not clear at this point how such oligomers might form. The crystal structure of the 
whole protein might aid in answering this question. Moreover, study of the binding 
partners of TRF2 and their participation in t-loop formation and resolution will be also 
necessary to fully understand how the protected state is achieved and maintained at the 
telomere throughout the cell cycle. 
The dynamics of the t-loop formation and dissolution throughout the cell cycle 
need to be studied in detail. One of the times that t-loops need to be dissolved is in S 
phase. TRF2 does not seem to be differentially regulated at any stage of the cell cycle 
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(Karlseder, J. and de Lange, T, unpublished); however, one of the components of the 
TRF2 complex, NBS is differentially regulated. Arrival of NBS at telomeres coincides 
with S phase (Zhu et al. 2000), and it is possible that this changes the activity of the 
Mrel 1 complex and subsequently results in opening of the t-loop. 
Deprotection of telomeres by expression of jRF2ABAM allele led to inhibition of 
growth in human primary fibroblasts. Induction of growth arrest was dependent on the 
activities of the p53 and the Rb pathways, but it did not depend on the activity of the 
ATM kinase. The genetic requirements for the arrest are thus unlike the ones observed 
for the induction of apoptosis after TRF2 inhibition. Entry into apoptosis requires 
function of the ATM kinase and the p53 protein and does not involve the Rb pathway 
(Karlseder et al. 1999). 
It is clear that some cells are predisposed to react to damage by apoptosis and 
some by growth arrest (Di Leonardo et al. 1994; Yeargin and Haas 1995); however, 
such discrepancy in the signaling pathways into arrest or apoptosis is curious. It is 
possible that apoptosis response requires a very strong activation of the checkpoint and 
that ATM pathway is necessary for the achievement of the necessary strength. When it 
is absent, other proteins are able to substitute some of the activity; however, they might 
be unable to reach a level of function normally supplied by the ATM kinase. This results 
in lack of apoptosis and presumed growth arrest. In cells that normally do not undergo 
apoptosis (for example human fibroblasts) signaling through the substitute kinases is 
enough for induction of the arrest. 
Another possibility is that the kinetic requirements of activation of apoptosis and 
arrest are different. Induction of apoptosis is usually a fast event. This event depends 
on p53 and most likely the downstream effectors like Bax (Miyashita et al. 1994). The 
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p16 induction, which seems to play a role in the growth arrest, is induced more slowly 
(Robles and Adami 1998). The proposal is that once the Rb pathway is induced, 
apoptosis is averted and the growth arrest ensues. This hypothesis can be restated to 
suggest that the growth arrest is a dominant response. However, because it is induced 
slowly, it might be defeated by the apoptotic response, which would remove the cells 
before they could arrest. One prediction of this hypothesis would be that the 
simultaneous and fast induction of the Rb pathway together with the generation of 
damage that normally would lead to apoptosis would result in inhibition of the apoptotic 
response and lead to growth arrest. 
High similarity of TRF2ABAM-induced growth arrest and growth arrest naturally 
occurring at the end of the replicative life-span of human primary fibroblasts has led to a 
proposal that critically short telomeres existing in pre-senescent human primary cells 
might be unable to recruit sufficient TRF2, resulting in signaling into arrest. As 
discussed in Chapter 2, the pathways leading to senescence are not very well defined at 
this point and further studies delineating the requirements for the growth arrest after 
TRF2ABAM expression might be useful in understanding telomere directed senescence. 
Besides protecting the telomere and guarding against premature senescence of 
human primary cells, TRF2 is also clearly involved in telomere length regulation. 
Expression of TRF2 leads to telomere shortening and telomere length changes do not 
depend on the presence of telomerase. Thus TRF2 appears to control the shortening 
activities at the telomere. There are a number of ways TRF2 might be able to influence 
the telomere shortening. TRF2 might be able to regulate nucleases involved in telomere 
shortening or it could influence the shortening rate by affecting the replication through 
the terminus. The first proposal is highly testable once the putative nucleases are 
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known. Based on the telomere loss phenotype after expression of the TRF2AB, it was 
proposed that a factor interacting with the basic domain could be involved in the 
regulation of the putative nuclease. Discovery of this putative factor should lead to 
elucidation of the mechanism of how TRF2 affects the shortening rate of the telomeres. 
The ability of TRF2 to influence telomere shortening does not exclude the 
possibility that this molecule is also responsible for recruitment of the regulators of 
telomere elongation. Based on the current data, it is actually very likely that TRF2, 
through its interacting partner Rapl, is able to influence telomere elongation. Direct 
studies of Rapl, will clarify the role of the TRF2 complex in regulation of telomere 
lengthening activities. 
The basic domain was shown to be important for the proper function of TRF2 at 
telomeres. It has been proposed that this domain functions through interacting with yet 
unknown factors. Knowledge of these proteins will be important to fully understand the 
phenotypes of rapid telomere deletion and chromosome breakage in cells expressing 
TRF2AB. Studies of such a factor will be also necessary to show whether TRF2AB is a 
hypomorphic or a gain of function allele of TRF2. The two phenotypes observed in 
TRF2AB-expressing cells are proposed to be created through the same mechanism, in 
which a nick followed by replication results in telomere deletion or internal breakage. 
However, through further studies it may be revealed that the two phenotypes occur 
through different mechanisms. Finally, it is interesting to point out that the TRF2AB-
expressing cells have some characteristics of harboring deprotected telomeres and it 
remains to be seen it this deprotection is caused by loss of telomeric DNA. 
The intriguing possibility that telomere dysfunction can lead to deregulation of the 
cell cycle even in otherwise wild type cells was suggested by genome wide reduplication 
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observed in cells expressing TRF2ABAM and TRF2AB and in cells with critically shortened 
telomeres. The reasons for a connection between telomere status and entry into S 
phase are not obvious. These phenotypes as well as the centrosomal localization of 
TRF2 suggest that the telomeric complex may have an unanticipated role in regulating 
the centrosomal cycle. 
Overall, studies of the human telomeric protein TRF2 have increased our 
understanding of the telomere function. Studies in human cells with their beautiful, 
condensed chromosomes have resulted in the detailed examination of the outcomes of 
telomere dysfunction. Ability to observe chromosomes and telomeres directly gave an 
opportunity to find telomeric DNA at the sites of end-to-end fusions after inhibition of 
TRF2 and allowed for observation of single chromatid deletions after expression of 
TRF2AB. Such ability, in combination with molecular techniques currently available, 
including the retroviral delivery of genes and the KO model systems, make mammals a 
very powerful addition to the traditional organisms of Tetrahymena or yeasts utilized to 
study telomeric complexes. 
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M a t e r i a l s a n d M e t h o d s 
Cell culture: 
Primary cells. Human primary fibroblasts IMR90, WI38, HS68, and packaging 
cells (PhoenixEco and Ampho) were obtained from the ATCC. They were grown in 
Dulbecco Modified Eagle medium (DMEM) supplemented with 100 units of penicillin per 
ml, 0.1 mg streptomycin per ml, L-glutamine (2 mM), non-essential amino acids (0.1 
mM), and 15% (v/v) FBS (Hyclone) for primary cells or 10% (v/v) FBS for packaging 
cells. Fibroblasts from Ataxia Telangiectasia (A-T) patients (AG02496, AG04405, 
AG03058) and controls (AG03057) were obtained from Coriell Cell Repositories and 
cultivated as above, except that the media contained 20% (v/v) of FBS. 
Cells were passaged by treatment with trypsin and seeding at 1x106 cells per 10 
cm dish. Cell numbers were determined by counting a 1:20 dilution of the cell 
suspension using a Coulter Counter. Population doublings were determined by a 
formula: PD=PD at plating+[ln (# of harvested cells/# of plated cells)/ ln(2) ]. For freezing, 
logarithmically growing cells were collected from a 15 cm plate (around 7x106 cells) were 
resuspended in 1 ml of 2xA freezing media (2xA is made by combining 40 ml FBS 
[Hyclone], 0.4 ml gentamycin stock solution [stock solution is 50 mg/ ml gentamycin, 
Sigma], 4 ml HEPES stock solution [stock solution is 1M HEPES, {pH 7.6} ], and 156 ml 
L15 media [Sigma], and sterilization through a 0.2 urn filter). Subsequently 1 ml of 2xD 
freezing media were added (2xD is made by combining 40 ml PVP stock solution [stock 
solution is 100 mg PVP [Sigma #P2307] per ml of HEPES buffered saline],.30 ml DMSO 
[Sigma], 4 ml HEPES stock solution [stock solution is 1M HEPES, {pH 7.6} ], and 126 ml 
L15 media [Sigma], and sterilization through a 0.2 um filter) and the cell suspension was 
aliquoted into 2 cryogenic vials. The vials were placed in a Styrofoam box at -80°C. 
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After at least one day, but no more than 3 months, the cells were moved to liquid 
nitrogen. 
HTC75 and its derivatives. HTC75 is a hygromycin-resistant HT1080-derived 
clonal cell line that stably expresses the tetracyclin-controlled transfected activator (tTA) 
(Gossen and Bujard 1992; van Steensel and de Lange 1997). Cells were grown in 
DMEM supplemented with 10% (v/v) bovine calf serum free of Tetracyclin or its 
derivatives (HyClone), penicillin-streptomycin, L-glutamine, non-essential amino acids 
and either Hygromycin (90 ng/ml) or G418 (150 ng/ml). Drugs were alternated every 
other week. Cells were passaged at 1:16 when they reached 80% confluence. Non-
induced and induced cells were grown in parallel with or without doxycycline (Sigma, 
100 ng/ml). After induction, P12, P33, P4, and P7 cell lines expressed untagged full-
length TRF2; T4, T19, and T22 cell lines expressed myc-tagged TRF2ABAM; S13 and S19 
cell lines expressed flag-tagged TRF2AB, and B27 did not express any exogenous 
proteins and served as control. 
Mouse cells. Primary Lig4+/+p53-/- and Lig4-/- p53-/- MEFs were obtained from 
the Alt laboratory (Frank et al. 2000). They were grown in DMEM supplemented with 
10% (v/v) fetal calf serum, non-essential amino acids, glutamine, and antibiotics. Early 
passage (p3 for experiment #1 and p5 for experiment #2) cells were used for infections. 
Other cells. Hela 1.2.11 and HeLa 2 were grown in DMEM supplemented with 
penicillin-streptomycin, L-glutamine, non-essential amino acids, and 10% (v/v) bovine 
calf serum (HyClone). 
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Plasmids and retroviral vectors 
Standard techniques were used for cloning. TRF2 constructs were generated by 
PCR from a full-length cDNA clone (clone 16-1, (Broccoli et al. 1997)). The pUHD 10-3 
Tet-vector was used to clone TRF2 alleles for transfection into HTC75 cells. pBabepuro, 
pLPCpuro, and pWZLhygro (gifts from Scott Lowe, CSHL) were used to clone N-
terminally myc tagged and untagged alleles of TRF2. The untagged versions were used 
in most of the experiments and there were no expression level or phenotypic differences 
between infections with the three different vectors. pBabeTag was a gift from Greg 
Hannon and did not express SV40 small T antigen. PLXSNeoHPV16E6, 
pLXSNeoHPV16E7, and pLXSNeoHPV16E6E7 (Halbert et al. 1991),(Kiyono et al. 1998) 
were gifts from Denise Galloway, and pWZLp53175H mutant (p53DN) from Scott Lowe 
(Serrano et al. 1997). 
Stable transfections of HTC75 cells (performed by Bas van Steensel) 
The empty vector pUHD10-3 and the pUHD10-3-derived constructs for expression of the 
TRF2 alleles were each cotransfected with neomycin resistance plasmid pNY-HI (H. 
Tommerup and T. d. L., unpublished data) into cell line HTC75 using the calcium 
phosphate coprecipitation. Transfected cells were grown in the presence of doxycyclin 
(100 ng/ml) and G418 (600uo,/ml). For each construct, approximately 25 G418-resistant 
cell lines were isolated by ring cloning and tested for expression of TRF2 polypeptides 
after 24 hr of induction by omission of doxycyclin from the media (doxycyclin acts as a 
repressor of gene expression in this system). Expression of TRF2ABAM and TRF2AB was 
determined by immunofluorescence microscopy and western blotting using anti-FLAG 
antibody M2 (Eastman Kodak or Sigma); expression of wild-type TRF2 was determined 
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by gelshift assays using a TTAGGG-repeat probe and by western blotting using antibody 
508 or 647. 
Retroviral infections 
Procedures were as described (Serrano et al. 1997). Phoenix cells were plated 
at 5x106 cells per 10 cm plate and transfected on the following day using calcium 
phosphate precipitation in the presence of 100 p,M chloroquine per ml. For the 
transfection, 20 ng of DNA prepared by the CsCI method were combined with 62.5 nl of 
2 M CaCI2 and sterile water to 500nl and added dropwise into 500nl of 2xHBS (50 mM 
HEPES [pH 7.05], 10 mM KCI, 12 mM Dextrose, 280 mM NaCl, 1.5 mM Na2HP04) while 
making bubbles. This solution was added directly to plates already containing 8 ml of 
media with chloroquine. The media were replaced with fresh 8 ml of media without 
chloroquine after 5 hours and replaced with 6 ml of media approximately 12 hours later. 
Media containing retroviral particles were collected for two days (30 ml total- first 
collection 6 ml, subsequent collections, 4 ml each) starting 24 hours after transfection 
and kept on ice in the cold room. The supernatant was not spinned prior to filtering into 
a new tube through a 0.45 nm filter. To avoid contamination with the packaging cells, a 
fresh cap was used to close the conical tube with the filtered supernatant. The 
supernatant was supplemented with 3 ml of FBS and 4 ng polybrene per ml and used for 
three infections (every 5 hours) of a 15 cm plate of fibroblasts plated the day before at 
2.5x106 cells per plate. The following evening cells were placed under selection with 2 
ng of puromycin per ml, 90 n9 of hygromycin per ml, or 600 n9 of G418 per ml, 
depending on the vector used. Selection was completed after 3 days for puromycin, 5 
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days for hygromycin, and 2 weeks for G418 treatment. Expression of proteins after 
selection was confirmed by immunofluorescence or western blotting. 
Transient transfection by electroporation 
8x106 logarithmically growing cells were resuspended in 800 nl of transfection 
buffer (21 mM Hepes [pH 7.05], 137 mM NaCl, 0.7 mM Na2HP04, 5 mM KCI, 6 mM 
glucose) and mixed with 15 n9 of plasmid in an electroporation cuvette. Cells were 
electroporated at 300 mV with 960 nF capacitance. The time constant was between 10 
and 13 miliseconds. The debris was removed with a pipette tip and one-third of the 
remaining cells were added to a 10 cm dish with media overlaying autoclaved coverslips 
for immunofluorescence. For protein extractions two-thirds of the cells were plated in a 
10 cm dish with appropriate media. All transient transfections were analyzed after 24 
hours. 
Growth curves and BrdU labeling 
On the 4th day of puromycin selection following retroviral infection, for each day 
of the growth curve, cells were plated in duplicate at 3x104 cells per well in a six-well 
plate. On the subsequent days, the cells were washed, trypsinized and counted using a 
Coulter counter. For BrdU labeling, the method was adapted from the in situ cell 
proliferation kit (Roche), (Gratzner 1982). One day prior to labeling (day 4, 9, and 14), 
cells were plated on autoclaved coverslips at 1x105 cells per well of a six-well plate in 
total of 3 ml of media. 24 hours later BrdU (Roche) was added to a final concentration of 
10 nM (from a 100 nM stock made in media) without replacing the original media. After 
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an 1 hour incubation (or a 5 hour incubation for the A-T cells), the coverslips were 
washed once with PBS, fixed in 70% (v/v) ethanol in 50 mM glycine buffer (pH 2.0) for 
45 minutes at room temperature, washed twice in PBS, denatured for 10 min in cold 
(4°C) 4 N HCI, washed 3 times in PBS 5 min each, and blocked in PBG (0.2% [w/v] Cold 
Water Fish Gelatin [Sigma], 0.5% [w/v] BSA [Sigma] in PBS). This was followed by a 2 
hour incubation with affinity purified antibody 647 against TRF2 (Zhu et al. 2000) diluted 
1:1000-1:2000 in PBG, three 5 minute washes each in PBG and a 45 minute incubation 
with a TRITC-conjugated donkey anti-rabbit secondary antibody (Jackson) at 1:100 
dilution in PBG and FITC anti-BrdU antibody (Becton Dickinson) at 1:4 dilution in PBG. 
Following a 5 minute wash in PBG, 5 minute wash in PBG supplemented with 0.2 ng of 
DAPI per ml, another 5 minute wash with PBG, and a rinse with PBS, coverslips were 
embedded in 90% (v/v) glycerol/10% (v/v) PBS containing 1 mg p-phenylene diamine 
(Sigma) per ml and sealed with nail polish. Such dual labeling allowed scoring for BrdU 
positive cells that were also expressing TRF2 alleles of interest. The numbers were 
normalized using the formula: (% of BrdU positive cells in TRF2 or TRF2ABAM-expressing 
cells/ % of BrdU positive cells in control vector cells) x100%. 
Fluorescence activated cell sorting (FACS) analysis 
Cells were collected from a 10 cm plate by trypsinization, spun down at 1000 
rpm, washed in 5 ml PBS, spun down again and resuspended in 100 nl of phosphate 
buffered saline (PBS). While vortexing, 2 ml of ice cold 70% (v/v) ethanol were added 
dropwise and the suspension was stored at 4°C at least overnight. 30 min before FACS, 
the cells were spun down and resuspended in propidium iodine (PI) mix (500 n' PBS, 10 
nl RNase [of stock solution of 10 mg/ml], 25 nl PI [of stock solution of 1 mg/ml]), and 
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incubated for 30 min at 37°C before analyzing on a Becton Dickinson FACS-SCAN II. 
Analysis was done without gating. 
P-gal assay 
The procedure used was adapted from (Dimri et al. 1995). Cells were plated in 2 
well chamber glass slides (Lab-Tek. #177380) at a density of 1-3X104 cells per chamber. 
On the second or third day after plating, the cells were washed in phosphate-buffered 
saline (PBS) (pH 7.2), fixed for 5 min in 2% (v/v) formaldehyde/0.2% (v/v) glutaraldehyde 
solution in PBS , washed again in PBS, and stained with 1 mg X-gal per ml of 150 mM 
NaCl, 2 mM MgCI2, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, and 40 mM NaPi (pH 6.0, pH 4.0 
or pH 7.0) for 6-12 hr at 37°C. 
Immunofluorescence and microscopy 
Cells were plated at a density of 1x106 in a 10 cm plate on autoclaved coverslips. 
In preparation for immunofluorescence they were rinsed with phosphate-buffered-saline 
(PBS) and fixed in 2% (w/v) formaldehyde in PBS for 10 minutes at room temperature, 
or in ice-cold methanol for 10 minutes at -20°C. If the cells were fixed with 
formaldehyde, they were washed once with PBS, permeabilized in 0.5% (v/v) NP40 in 
PBS for 10 minutes, washed again in PBS, and incubated with PBG (0.2% [w/v] cold fish 
gelatin, 0.5% [w/v] BSA in PBS) for 20 minutes to block non-specific binding. If cells 
were fixed in methanol, no permeabilization was necessary, and cells were washed 3 
times for 5 minutes each in PBS and incubated with PBG for 20 minutes. Coverslips 
were then incubated for 2 hours at room temperature in a humidified chamber with a 
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primary antibody appropriately diluted in PBG (dilutions were highly dependent on the 
antibody but typically they were around 1-500 to 1:2000 for polyclonal anti TRF1 and 2 
antibodies, and 1:20 for monoclonal anti p53 and Tag antibodies). Subsequently, 
coverslips were washed 3 times 5 minutes each with PBG, and incubated with FITC or 
TRITC conjugated sheep-anti-mouse or donkey-anti-rabbit antibodies (Jackson) diluted 
1:100 in PBG. Following a 5 minute wash in PBG, 5 minute wash in PBG supplemented 
with 0.2 ng of DAPI per ml, another 5 minute wash with PBG, and a rinse with PBS, 
coverslips were embedded in 90% (v/v) glycerol/10% (v/v) PBS containing 1 mg p-
phenylene diamine (Sigma) per ml and sealed with nail polish. Pictures were taken on 
an Axioplan Zeiss microscope with a Photometries digital camera or on an Axioplan2 
Zeiss microscope with a Hamamatsu digital camera supported by OpenLab software. 
Methanol: glacial acidic acid metaphase spreads 
Cells grown to -50-70% confluence in a 15 cm dish were incubated in 0.1 ng of 
demecolcin per ml of medium for 90 min to 4 hr depending on the experiment. Cells 
were harvested by trypsinization, and spun down at 1000 rpm for 5 minutes. 
Sometimes, in order to enrich for mitotic cells, just after addition of trypsin plates were hit 
hard on the side and the detached cells were collected and spun down as above. The 
supernatant was completely removed and cells were gently resuspended in 5 ml of 
0.075 M KCI. After 7 minutes of incubation at 37°C, the cells were again spun down at 
1000 rpm for 5 minutes and the supernatant was decanted. The cells were gently 
resuspended in the remaining fluid by tapping. 1 ml of freshly prepared fixative (3:1 
[vol/vol] methanol: glacial acidic acid) was added dropwise to the cells while the tube 
was being tapped. The tube was filled up with fixative and stored overnight or longer 
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before dropping cells onto slides. When ready to prepare spreads, the cells were spun 
down at 1000 rpm for 5 minutes and the supernatant was replaced with approximately 
500 nl of fresh fixative (this volume was adjusted to achieve a slightly cloudy 
suspension). The cells were dropped on the (room-temperature) water-wetted slide, air 
dried for a couple of seconds, washed with fresh fixative, and placed for about a minute 
on water-soaked paper towels positioned on a heat block warmed to 70-80°C. If 
spreads were to be used for fluorescence in-situ hybridization (FISH) they were left 
overnight in a chemical hood to age and used at that point or stored at 4° for later use. 
For staining of chromosomes with 4',6'-diamidino-2-phenylindole (DAPI), without FISH, 
cells were used immediately without aging. Slides were incubate for 5 minutes in 0.2 ng 
of DAPI per ml of phosphate-buffered saline (PBS), washed in PBS, and embedded in 
90% (v/v) glycerol/10% (v/v) PBS containing 1 mg p-phenylene diamine (Sigma) per ml. 
Formaldehyde metaphase spreads 
The procedure was essentially as described in (Compton et al. 1991). Cells 
grown to -50-70% confluence in a 15 cm dish were incubated in 0.1 ng of demecolcin 
per ml of medium for 90 min to 4 hr depending on the experiment. Cells were harvested 
by trypsinization, and spun down at 1000 rpm for 5 minutes. The supernatant was 
completely removed and cells were gently resuspended in 300 nl of RSB buffer (10 mM 
Tris-HCl, [pH 7.4], 10 mM NaCl, 5 mM MgCI2) and incubated at 37°C for 10 minutes. 50 
nl of this cell suspension was gently pipetted onto a 22 mm square coverslip at the 
bottom of a bucket of a RT6000 Sorvall tabletop centrifuge. The centrifuge was allowed 
to reach 3000 rpm and was immediately stopped. The coverslip was removed and cells 
spread on it were fixed with 2% (w/v) formaldehyde in PBS for 10 minutes, washed once 
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with PBS, permeabilized in 0.5% (v/v) NP40 in PBS for 10 minutes, washed again in 
PBS and used with a standard immunofluorescence protocol as described above. 
Peptide nucleic acid (PNA) fluorescence in-situ hybridization (FISH) on metaphase 
spreads 
The method was adapted from (Lansdorp et al. 1996). The slide with 
methanokglacial acidic acid metaphase spreads (prepared as above) were rehydrated 
for 5 minutes in phosphate-buffered saline (PBS) (pH 7.4 throughout this procedure), 
fixed for 2 minutes in 4% (v/v) formaldehyde in PBS, washed 3 times for 5 minutes each 
in PBS, treated with 1 mg pepsin per ml of HCI acidified water (pH 2.0) for 10 minutes at 
37°C, washed twice for 2 minutes each in PBS, fixed again in 4% (v/v) formaldehyde in 
PBS, washed 3 times for 5 minutes each in PBS, dehydrated in an alcohol series (5 
minutes in 70% (v/v) ethanol, 5 minutes in 95% (v/v) ethanol, and 5 minutes in 100% 
(v/v) ethanol) and air-dried. A small amount (-50-100 nO of a hybridization mix (10 mM 
Tris [pH 7.2], 70% (v/v) deionized formamide, 0.5% (w/v) blocking solution [Boehringer 
Mannheim], 0.5 ng Peptide-Nucleic Acid (PNA) probe per ml) was placed on the 
coverslip. The coverslip was then picked up by turning the slide upside down, touching 
the hybridization mix, and immediately turning the slide back up. This assured that there 
were no bubbles that would interfere with hybridization. The DNA was denatured by 
placing the slide at 80°C for 3 minutes, and the probe was allowed to hybridize for 2 
hours in a humidified chamber at room temperature in the dark. Subsequently, the slide 
was washed 2 times, 15 minutes each in 10 mM Tris [pH 7.2], 70% (v/v) deionized 
formamide, 0.1% (w/v) BSA, washed 3 times 5 minutes each in 0.1 M Tris-HCl [pH 7.4], 
0.15 M NaCl, 0.08% (v/v) Tween and dehydrated in an alcohol series as above. If the 
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PNA probe was FITC conjugated (FITC-CCCTAACCCTAACCCTAA, synthesized by 
Biotech GmbH) the DNA was counterstained with 4',6'-diamidino-2-phenylindole (DAPI) 
by adding 0.2 ng of DAPI per ml to a second 5 minute wash (see above), followed by 
washing for the third time, dehydration, air-drying and embedding in 90% (v/v) 
glycerol/10% (v/v) PBS containing 1 mg p-phenylene diamine (Sigma) per ml. If the 
PNA probe was biotynylated (bio-OO-CCCTAACCCTAACCCTAA, synthesized by 
PerSeptive Biosystems) the DNA was not counterstained at this point. After dehydration 
steps the slides were incubated with PBG (0.2% [w/v] cold fish gelatin, 0.5% [w/v] BSA 
in PBS) 2 times for 10 minutes each to block non-specific binding, and then incubated 
for 30 min at 37°C with fluorescein-conjugated avidin (AVIDIN DCS-FITC, Vectorlabs) 
diluted 1:400 in PBG. The slides were washed in PBG for 5 minutes, in PBG 
supplemented with 0.2 ng of DAPI per ml for 5 minutes, with PBG alone for 5 minutes, 
and with PBS for 5 minutes. Spreads were then embedded in 90% (v/v) glycerol/10% 
(v/v) PBS containing 1 mg p-phenylene diamine (Sigma) per ml and sealed with nail 
polish. Pictures were taken on Axioplan Zeiss microscope with a Photometries digital 
camera or on Axioplan2 Zeiss microscope with a Hamamatsu digital camera supported 
by OpenLab software. Ambiguous abnormalities seen in the pictures were assessed 
directly under the microscope. 
Multiplex fluorescence in situ hybridization (M-FISH) (performed by Anna Jauch in 
Heidelberg) 
M-FISH was performed as described (Speicher et al. 1996; Eils et al. 1998) with 
minor modifications. Briefly, five pools of flow-sorted whole chromosome painting probes 
(kindly provided by Ferguson-Smith, Cambridge, UK) were amplified and labeled by 
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DOP-PCR using five different fluorochromes: FITC, Cy3, Cy3.5, Cy5, and Cy5.5, 
repectively. About 100 ng of each probe was precipitated in the presence of 30 ng Cot-1 
DNA, dissolved in 10 nl hybridization mixture (15% (w/v) dextrane sulfate, 2xSSC) and 
hybridized for 48 hours. Microscopic evaluation was performed using a Leica DMRXA 
microscope (Leica, Wetzlar, Germany) equipped with a Sensys CCD camera 
(Photometries, Tucson, AZ, USA) with a Kodak KAF 1400 chip. Images for each 
fluorochrome were acquired separately using highly specific filter sets (Chroma 
Technology Corp., Brattleboro, VT, USA) and processed using the Leica MCK software 
(Leica Microsystems Imaging Solutions Ltd., Cambridge, UK). 
DNA extraction 
The procedure was based on (de Lange 1992). Around 1x107 cells were 
harvested by trypsinization on the indicated days, washed in cold PBS, collected by 
centrifugation, resuspended in 1 ml of TNE (10 mM Tris [pH 7.4], 100 mM NaCl, 10 mM 
EDTA) and squirted into 1 ml of TNES (10 mM Tris [pH 7.4], 10 mM EDTA, 100 mM 
NaCl, 1% (w/v) SDS) freshly supplemented with 100ng proteinase K per ml placed in a 
15 ml phase lock heavy tube (Eppendorf) pre-spun as suggested by the manufacturer. 
After an overnight incubation at 37°C, the lysate was extracted with 2 ml of phenol: 
chloroform: isoamyl alcohol (25:24:1 [vol/vol/vol]), and the DNA in the aqueous fraction 
was precipitated by mixing the lysate with 2 ml iso-propanol and 0.22 ml 2 M NaAcetate 
(pH 5.2). The spooled DNA was added to 0.3 ml of TNE supplemented with 100 ng 
RNAse per ml, incubated for 30 min at 37°C, gently resuspended with a wide tip and 
incubated for 2 more hours at 37°C. 0.3 ml of TNES supplemented with 100 ng 
proteinase K per ml were added, and the incubation at 37°C was continued for another 
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hour. This DNA solution was extracted with 0.6 ml of phenol: chloroform: isoamyl 
alcohol (25:24:1 [vol/vol/vol]), and the DNA was precipitated by mixing the aqueous 
phase with 0.6 ml iso-propanol and 60 nl of 2 M NaAcetate (pH 5.2). The DNA was 
spooled and resuspended without shearing in 100 nl of TE (10 mM Tris HCI [pH 7.4], 0.1 
mM EDTA). DNA was cleaved with a combination of Hinfl and Rsal or Mbol and Alul 
restriction enzymes as indicated in the text and quantified by fluorometry using Hoechst 
33258. 
DNA electrophoresis and Southern blots with a telomeric probe 
The procedure was based on (de Lange et al. 1990). 1.5-3 ng of digested DNA was 
fractionated on a 0.7% (w/v) agarose gel in 0.5x Tris-borate- EDTA (TBE) in the 
presence of some ethidium bromide. During the run, the gel was photographed to check 
for equal loading of samples. After the run, the gel was photographed, soaked in 0.25 M 
HCI for 30 minutes, in denaturating solution (1.5 M NaCl, 0.5 M NaOH) twice for 30 
minutes each, and in neutralizing solution (3 M NaCl, 0.5 M Tris-HCl, [pH 7.0]) twice for 
30 minutes each, rinsed in 20x SSC (3 M NaCl, 0.3 M Sodium Citrate [pH 7.0] and 
blotted overnight in 20x SSC onto a nylon membrane (Hybond). Subsequently, the DNA 
was crosslinked to the membrane using UV, membrane was rinsed in water and was 
prehybridized in Church buffer (0.5 M NaP04, [pH 7.2], 1 mM EDTA [pH 8.0], 7% (w/v) 
SDS, 1% (w/v) BSA) for 45 min at 65gC, hybridized overnight at 65°C with a telomeric 
probe prepared as described below, and washed 3 times 15 minutes each in Church 
wash (40 mM NaP04, [pH 7.2], 1 mM EDTA [pH 8.0], 1% (w/v) SDS). The membrane 
was exposed overnight on the phosphorimager. To make a telomeric probe, 
pSP73.Sty11 plasmid was digested with EcoRI, and the 800bp fragment corresponding 
204 
to the telomeric repeats was isolated using QIAEXII (Qiagen) and diluted to about 20 ng 
DNA per p,l. To label the probe, 10pl of this insert were combined with 5 ng of 
(CCCTAA)3 oligonucleotide in a total volume of 39 pi, boiled for 5 min, cooled down for 
one minute and mixed with 5 nl of 10xOLB (0.5 M Tris HCI [pH.6.8]. 0.1 M MgOAc, 1 
mM DTT, 0.5 mg Bovine Serum Albumin per ml, 0.6 mM dATP, 0.6 mM dGTP, 0.6 mM 
dTTP), 5 nl of a-32P -dCTP (3000 Ci/mmol), and 1 pi of Klenow polymerase. Labeling 
reaction was performed for 90 minutes at room temperature and was stopped by 
addition of 50 nl TES (10 mM Tris-HCl, 10 mM EDTA [pH 8.0], 0.1% (w/v) SDS), loaded 
onto a Sephasdex G-50 fine column made in a 3 ml syringe packed to the top with the 
resin, washed with 1000 pi of TES, eluted with 800 n' of TES, incubated at 100°C for 10 
min, and added to 30 ml of Church buffer. The probe was filtered through a 0.2 pm 
syringe filter. Half of the probe was used for a 20 cm x 20 cm membrane. 
In-gel G-overhang assay 
The procedure was adapted from (Hemann and Greider 1999) with multiple 
changes. 5 ng of digested DNA was fractionated on a 0.7% (w/v) agarose gel in 0.5x 
Tris-borate-EDTA (TBE) in the presence of some ethidium bromide. During the run, the 
gel was photographed to check for equal loading of the samples. After the run, the gel 
was dried on two pieces of Whatman 3MM paper for 1 hour at 50°C with vacuum 
resulting in a paper-thin gel that could be treated like a membrane. The gel was 
removed from the paper by soaking it in water and without denaturing was prehybridized 
in Church buffer (0.5 M NaP04, [pH 7.2], 1 mM EDTA [pH 8.0], 7% (w/v) SDS, 1% (w/v) 
BSA) for 45 min at 55°C, hybridized overnight at 55°C with an oligonucleotide probe 
prepared as described below, and after hybridization washed 3 times 20 min each in 4x 
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SSC at room temperature. If there was a very high signal in the background, the gel 
was washed twice more, 20 minutes each in 4x SSC, and 0.1% (w/v) SDS at 57°C. The 
gel was exposed overnight in the phosphorimager cassette. Subsequently, the gel was 
denatured for 25 minutes in a denaturating solution (1.5 M NaCl, 0.5 M NaOH), 
neutralized for 25 min in a neutralizing solution (3 M NaCl, 0.5 M TrisHCI [pH 7.0]) and 
after rinsing with water and 45 min prehybridization at 55°C in Church buffer, 
hybridization was repeated using the same probe that was used for the hybridization 
with the native gel. The wash steps were identical to those given above for the native 
gel. To make a probe for the G-overhang, 50 ng of TELC oligonucleotide (CCCTAA)4 or 
50 ng of TELG oligonucleotide (TTAGGG)4, which served as a strand-specificity 
control, were mixed with 1 n' of T4 polynucleotide kinase buffer (NEB), 2nl of water, 5 nl 
of 32P-gamma-ATP (6000 Ci/mMol, 10 mCi/ml), and 1 \i\ of T4 polynucleotide kinase 
(NEB), and incubated at 37°C for 45 minutes. After adding 90 pi TES (10 mM Tris-HCl, 
10 mM EDTA [pH 8.0], 0.1% (w/v) SDS), the reaction was loaded onto a Sephadex G-25 
fine column made in a 3 ml syringe packed to the 3 ml mark with the resin. The column 
was washed with 700 nl of TES and the labeled oligonucleotide was eluted with 800 nl of 
TES and used after addition of 15 ml of Church buffer and filtering through a 0.2 nm 
filter. The same probe was used for hybridization with native and denaturing gels. 
Alkaline gels 
This procedure was based on (McDonell et al. 1977). 1.5-3ng of DNA were 
ethanol precipitated, and resuspended in 50 mN NaOH, 1 mM EDTA, mixed with 0.2 
volumes of 6 x alkaline loading buffer (300 mM NaOH, 6 mM EDTA, 18% (v/v) Ficoll, 
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0.15% (w/v) bromocresol green, 0.25% (w/v) xylene cyanol FF) and run on a 0.5% (w/v) 
alkaline agarose gel in 50 mM NaOH and 1mM EDTA (pH 8.0) for 27 hr at 50 V at 4°C 
with two changes of running buffer. The gel was subsequently treated like described in 
section about Southern blotting or G-overhang assay. Markers were prepared by 
digesting a TTAGGG repeat bearing 2.6 kbp pTH5 plasmid (de Lange et al. 1990) with 
Hindlll and self religation of the cut plasmid. 
Estimation of telomere length 
The median length of the telomeric restriction fragments was determined by 
using ImageQuant software after scanning with a Phosphorlmager and was not 
corrected for dependence of signal intensity on telomere length. 
Cell extracts 
For buffer C-extracts, cells grown in 10 cm dishes were harvested by scraping in 
5 ml cold phosphate-buffered saline (PBS) and centrifugation at 1000 rpm for 5 min. 
Cell pellets were resuspended in 4-6 volumes (50-200 nO ice-cold buffer C (20 mM 
Hepes-KOH pH 7.9, 420 mM KCI, 25% (v/v) glycerol, 0.1 mM EDTA, 5 mM MgCI2, 1 mM 
dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 0.2% (v/v) Nonidet P-
40, 1 ng °f leupeptin, pepstatin, and aprotinin per ml, incubated for 30 min on ice and 
centrifuged 10 min at 14,000 g at 4°C. The supernatant was dialyzed for 2 hrs against 
buffer D (20 mM Hepes-KOH [pH 7.9], 100 mM KCI, 20% (v/v) glycerol, 0.2 mM EDTA, 
0.2 mM EGTA, 0.5 mM DTT, and 0.5 mM PMSF) at 4°C, snap-frozen in liquid nitrogen 
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and stored at -80°C. Protein concentrations were determined using the Bradford assay 
(BioRad, Hercules, CA) using bovine serum albumin as a standard. 
For whole cell lysates, cells were harvested by trypsinization, washed in cold 
PBS, counted, collected by centrifugation, and resuspended at 1x10" cells per nl of 
Laemmli loading buffer (Laemmli loading buffer is made by combining 4 ml Buffer B [see 
below], 8 ml glycerol, 2 ml p-mercaptoethanol, 16 ml SDS stock solution [stock solution 
is 10% (w/v) SDS in water], 2 ml bromophenol blue stock solution [stock solution is 1% 
(w/v) bromophenol blue in water], and 8 ml H20. Buffer B is made by combining 7.6 g 
Tris base, 5 ml SDS stock solution [stock solution is 10% (w/v) SDS in water], 5 ml 
concentrated HCI, and 30 ml of H20, adjusting the pH to 6.8 and adjusting the total 
volume to 50 ml with H20). The DNA was sheared by passing several times through a 
25 G 5/8 needle. 
For westerns visualizing ATM, the cells were harvested by trypsinization, washed 
in cold PBS, counted, collected by centrifugation and the extract was prepared by 
sonicating 5x106 cells in a 250 n' cold buffer containing 50 mM Tris HCI, pH 7.5, 150 mM 
NaCl, 10% (v/v) glycerol, 1% (v/v) Tween 20, 50 mM NaP-glycerophosphate, 1 mM NaF, 
1 mM NaV04, 0.1 mM DTT, 0.5 mM PMSF, 0.5 pg/ml Leupeptin. The extract was 
centrifuged 10 min at 14,000 g at 4°C and the pellet was discarded. 
Western blotting 
For buffer C extracts, 30 ng were separated on a 9% (w/v) SDS-polyacrylamide 
gel (Sambrook et al. 1989) and transferred to nitrocellulose by electroblotting for 1 hour 
at 90 V at 4°C or overnight at 100 mA at room temperature. Membranes were stained 
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with Ponceau S (20 mg/ml in H20) (Sambrook et al. 1989) for 2 min to verify that equal 
amounts of protein were fractionated in each lane. For whole cell extracts, 15 nl of the 
extract were fractionated on SDS-polyacrylamide gels and transferred onto nitrocellulose 
or PVDF (Millipore) (for anti E7 and anti ATM westerns) membranes. Blocking and 
incubation with primary and secondary antibodies was performed in 5% (w/v) milk and 
0.1% (v/v) Tween in PBS. Antibodies were as follows: anti-TRF2- 647, 508 or mouse 
anti-TRF2 (Cat# 05-521, Upstate Biotechnology), anti p53-1801 (Levine lab), HDM2-3F3 
(Levine lab), anti p21-F-5 (Santa Cruz Biotechnology), anti Rb (cat# 14001A, 
PharMingen), anti p16-NCLp16 (Novocastra laboratories), anti cyclin A- cat#sc-239 
(Santa Cruz), anti Y-tubulin-clone GTU88 (Sigma), anti SV40 Tag-PAB416 (Levine lab), 
anti E7-Clone 8C9 (Zymed), ATM antibody 2C1 (GeneTex). After incubations with 
secondary antibodies (Amersham) all blots were developed using the ECL kit 
(Amersham) 
RNA isolation 
Total RNA was isolated as described (Auffray and Rougeon 1980). 1x107 cells 
were washed in PBS, lysed in 3 M LiCI/6 M urea, sonicated, and incubated on ice for 6 
hours. RNA was collected by centrifugation in a microcentrifuge at maximum speed for 
20 min at 4°C, treated with proteinase K (50 mg/ml) in 200 pi 10 mM Tris-HCl (pH 7.5), 
10 mM EDTA, 100 mM NaCl, 1% (w/v) SDS for 10 min at 37°C, extracted with 
phenol/chloroform/iso-amylalcohol (25:24:1), and precipitated with isopropanol in the 
presence of 0.2 M Na-acetate pH 5.5. 
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RNase protection 
The hTERT sequence was subcloned from pCI Neo-hEST2-HA (a gift from R. A. 
Weinberg; (Meyerson et al. 1997)) into pcDNA3 (Invitrogen). A Styl fragment containing 
part of the hTERT sequence (nucleotide 3229-3452) and flanking vector sequences was 
purified and used in the MAXIscript in vitro transcription reaction (Ambion) using a-32P-
UTP (800 Ci/mmol, 10 mCi/ml). The template for the hTR RNase protection probe was 
similarly prepared by digesting pGRN78 (Kim et al. 1994) with Xbal, and the p-actin 
probe was obtained from Ambion. The P-actin probe was labeled to 200-fold lower 
specific activity than the hTERT and hTR probes by diluting out the radiolabeled UTP 
with cold UTP. RNase protection reactions were performed using solutions from the 
Direct Protect Lysate Ribonuclease Protection Assay Kit (Ambion) with 20 ng of total 
RNA (isolated as described above) instead of cell lysates. 
TRAP assay 
The assay was essentially performed as described (Broccoli et al. 1995). 0.5 ng 
protein of buffer C extract was mixed with 49 nl of premixed 5 n' of 10X buffer B (200 
mM Tris HCI [pH 8.3], 15 mM MgCI2, 630 mM KCI, 0.05% (v/v) Tween 20, 10 mM 
EGTA, 1 mg BSA per ml), 2.5 mM dNTPs, 5 nl TS primer labeled as below, 0.05 nl T4 
gene 32 protein, 2 units of Taq polymerase and water. The reaction was incubated at 
room temperature for 30 minutes to allow extension of the TS primer by telomerase. 
Subsequently, telomerase was inactivated by heating at 65°C for 3 minutes, and after 
addition of 1 n1 of reverse primer CX, PCR was done for 27 cycles at 94°C for 30 
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seconds, at 50°C for 30 seconds, and at 72°C for 1 minute. RNase digestions were 
done in parallel to the untreated reaction by addition of 0.2 ng DNase-free RNAse A to 
the telomerase extension reaction. Each experiment also contained a negative control 
reaction where one pi of buffer C was used instead of the extract. 
TS primer (0.1 ng) was radioactively labeled by mixing with 2 nl of T4 
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polynucleotide kinase buffer (NEB), 4 nl of water, 12 nl of y- P-ATP (6000 Ci/mMol, 10 
mCi/ml), and 1 nl of T4 polynucleotide kinase (NEB), and incubating at 37°C for 45 
minutes. After adding 10 ng of unlabeled TS primer, and TES (10 mM Tris-HCl, 10 mM 
EDTA [pH 8.0], 0.1% (w/v) SDS) to 100 pi, the reaction was loaded onto a Sephadex G-
25 fine column made in a 3 ml syringe packed to the top with the resin. The column was 
washed with 1000 pi of TES and the labeled oligonuclotide was eluted with 800 pi of 
TES and extracted with phenol:chloroform:isoamyl alcohol (25:24:1), ethanol 
precipitated and resuspended in 500 nl double-distilled water. 
For some experiments (Figure 3-6) the Trapeze telomerase detection kit 
(Intergen) was used according to the manufacturer's instructions. 
t-loop assay 
2x108 cells were collected from about 50 15 cm plates by trypsinization, washed 
with PBS and carefully resuspended in 20 ml of homogenization buffer (10 mM Tris-HCl 
[pH 7.5], 15 mM NaCl, 60 mM KCI, 1 mM EDTA, 0.1 mM EGTA, 0.15 mM spermine, 0.5 
mM spermidine, 0.2% (v/v) NP-40 (IPEGAL), 5% sucrose [w/v]). The cells were 
incubated on ice for 15 minutes, centrifuged at 1300 g (3800 rpm in the table-top 
centrifuge) in the cold for 15 min. The buffer was discarded and the nuclei were gently 
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resuspended in 16 ml of fresh homogenization buffer, spun down as above, and 
resuspended in 3 ml of homogenization buffer. 750 pi of 1 mg 4'-aminomethyltrioxsalen 
(AMT; SIGMA) per ml was added and the mixture was placed in a 10 cm dish on ice. 
The DNA was crosslinked by exposing the nuclei to 365 nm UV light for 30 minutes. 
The hand-held UV light was positioned 2 cm away from the sample which was being 
mixed with a tiny stirring bar. The crosslinked nuclei were collected, snap frozen in liquid 
nitrogen, and sent for analysis to Jack Griffith. Further processing and analysis were 
done as described (Griffith et al. 1999). Nuclear suspensions were treated with 
proteinase K in the presence of SDS, and DNA was isolated by phenol/chloroform 
extraction and ethanol precipitation. The deproteinized sample was suspended in 9 ml of 
10 mM Tris (pH 7.5), 1 mM EDTA (TE) and cleaved with Alul and Mbol for 12 hr at 37°C. 
During the final hour, RNase (Pharmacia) was added to 20 ng/ml. The sample was then 
extracted one time with phenol:chloroform:isoamyl alcohol, precipitated with ethanol, and 
suspended in 3 ml of TE. The sample was applied to a 2.5 x 100 cm Biogel A5M column 
(Biorad) and eluted at a flow rate of 0.2 ml/min. Fractions of 0.6 ml were taken and the 
OD260 of each determined. The droplet variation of the Kleinschmidt method 
(Kleinschmidt and Zahn 1959) was used for surface-spreading DNA. A 50 nl aliquot of 
DNA in TE was mixed with ammonium acetate (pH 7.9) to a final concentration of 0.25 
M. Cytochrome C, Sigma Inc.) was added to 4 ng/ml and the drop placed on 
Parafilm Semifor 90 s. A parlodion-covered EM grid was touched to the drop and 
then dehydrated through two washes of 80% (v/v) ethanol followed by air drying and 
rotary shadowcast with platinum-paladium (80:20). 
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